1	AIDS	NNP	MISC	AIDS	nn	2	SENT_1	[p1l59t81r135b107],
2	RESEARCH	NNP	O	RESEARCH	_	0	SENT_1	[p1l150t81r329b107],
3	AND	CC	O	and	_	0	SENT_1	[p1l342t82r410b107],
4	HUMAN	NNP	O	HUMAN	nn	5	SENT_1	[p1l425t82r542b107],
5	RETROVIRUSES	NNP	O	RETROVIRUSES	conj_and	2	SENT_1	[p1l557t81r815b107],
6	Volume	NN	O	volume	dep	2	SENT_1	[p1l59t119r170b144],
7	28	CD	NUMBER	28	num	6	SENT_1	[p1l182t120r225b148],
8	,	,	O	,	_	0	SENT_1	[p1l182t120r225b148],
9	Number	NNP	DATE	Number	appos	6	SENT_1	[p1l241t119r356b144],
10	9	CD	DATE	9	num	9	SENT_1	[p1l368t120r392b148],
11	,	,	DATE	,	_	0	SENT_1	[p1l368t120r392b148],
12	2012	CD	DATE	2012	num	16	SENT_1	[p1l406t119r478b144],
13	©	CD	NUMBER	©	num	16	SENT_1	[p1l60t157r84b181],
14	Mary	NNP	PERSON	Mary	nn	16	SENT_1	[p1l98t156r169b187],
15	Ann	NNP	PERSON	Ann	nn	16	SENT_1	[p1l181t156r238b180],
16	Liebert	NNP	PERSON	Liebert	appos	6	SENT_1	[p1l253t156r358b185],
17	,	,	O	,	_	0	SENT_1	[p1l253t156r358b185],
18	lnc	NN	O	lnc	appos	6	SENT_1	[p1l374t156r423b181],
19	.	.	O	.	_	0	SENT_1	[p1l374t156r423b181],

1	DOI	NNP	O	DOI	_	0	SENT_2	[p1l61t192r125b218],
2	:	:	O	:	_	0	SENT_2	[p1l61t192r125b218],
3	10.1089	CD	NUMBER	10.1089	dep	1	SENT_2	[p1l141t192r470b218],
4	/	:	O	/	punct	5	SENT_2	[p1l141t192r470b218],
5	aid	NN	O	aid	dep	3	SENT_2	[p1l141t192r470b218],
6	.2011.0261	CD	NUMBER	.2011.0261	num	5	SENT_2	[p1l141t192r470b218],

1	Short	JJ	O	short	amod	2	SENT_3	[p1l724t293r897b350],
2	Communication	NN	O	communication	_	0	SENT_3	[p1l927t293r1436b350],

1	UGT1A1	NN	O	ugt1a1	_	0	SENT_4	[p1l245t376r642b433],
2	*	CD	NUMBER	*	num	1	SENT_4	[p1l245t376r642b433],
3	28	CD	NUMBER	28	num	5	SENT_4	[p1l245t376r642b433],
4	Variant	JJ	O	variant	amod	5	SENT_4	[p1l664t377r896b433],
5	Allele	NN	O	allele	nsubj	8	SENT_4	[p1l924t377r1102b433],
6	Is	VBZ	O	be	cop	8	SENT_4	[p1l1136t377r1185b433],
7	a	DT	O	a	det	8	SENT_4	[p1l1215t391r1252b433],
8	Predictor	NN	O	predictor	rcmod	1	SENT_4	[p1l1285t377r1577b433],
9	of	IN	O	of	_	0	SENT_4	[p1l1604t376r1663b433],
10	Severe	JJ	O	severe	prep_of	8	SENT_4	[p1l1692t376r1922b433],

1	Hyperbilirubinemia	NN	O	hyperbilirubinemia	_	0	SENT_5	[p1l370t460r978b530],
2	in	IN	O	in	_	0	SENT_5	[p1l1009t460r1058b514],
3	HIV-Infected	JJ	O	hiv-infected	amod	4	SENT_5	[p1l1092t459r1498b515],
4	Patients	NNS	O	patient	prep_in	1	SENT_5	[p1l1533t460r1793b515],
5	on	IN	O	on	dep	1	SENT_5	[p1l592t556r668b598],
6	HAART	NNP	O	HAART	pobj	5	SENT_5	[p1l703t542r949b597],
7	in	IN	O	in	dep	1	SENT_5	[p1l980t542r1028b597],
8	Southern	NNP	LOCATION	Southern	nn	9	SENT_5	[p1l1061t541r1355b598],
9	Brazil	NNP	LOCATION	Brazil	pobj	7	SENT_5	[p1l1390t542r1566b598],

1	Lisiane	NNP	PERSON	Lisiane	nn	2	SENT_6	[p1l227t681r353b712],
2	Turatti	NNP	PERSON	Turatti	_	0	SENT_6	[p1l369t673r494b717],
3	,	,	O	,	_	0	SENT_6	[p1l369t673r494b717],
4	‘	NNP	O	‘	nn	8	SENT_6	[p1l369t673r494b717],
5	Eduardo	NNP	PERSON	Eduardo	nn	8	SENT_6	[p1l516t681r670b712],
6	Sprinz	NNP	PERSON	Sprinz	nn	8	SENT_6	[p1l686t673r824b720],
7	,2	CD	NUMBER	,2	num	8	SENT_6	[p1l686t673r824b720],
8	Rosmeri	NNP	PERSON	Rosmeri	appos	2	SENT_6	[p1l842t681r987b712],
9	K.	NNP	PERSON	K.	nn	10	SENT_6	[p1l1007t681r1039b711],
10	Lazzaretti	NNP	PERSON	Lazzaretti	dep	8	SENT_6	[p1l1060t673r1257b717],
11	?	.	O	?	_	0	SENT_6	[p1l1060t673r1257b717],

1	Regina	NNP	PERSON	Regina	nn	2	SENT_7	[p1l1275t681r1402b720],
2	Kuhmmer	NNP	PERSON	Kuhmmer	_	0	SENT_7	[p1l1420t673r1618b717],
3	,2	CD	NUMBER	,2	num	5	SENT_7	[p1l1420t673r1618b717],
4	Grasiela	NNP	PERSON	Grasiela	nn	5	SENT_7	[p1l1635t680r1786b712],
5	Agnes	NNP	PERSON	Agnes	dep	2	SENT_7	[p1l1801t673r1931b720],
6	,	,	O	,	_	0	SENT_7	[p1l1801t673r1931b720],
7	‘	CD	NUMBER	‘	appos	5	SENT_7	[p1l1801t673r1931b720],

1	Jussara	NNP	PERSON	Jussara	nn	3	SENT_8	[p1l288t730r431b761],
2	M.	NNP	PERSON	M.	nn	3	SENT_8	[p1l449t730r487b761],
3	Si	NNP	PERSON	Si	nsubj	4	SENT_8	[p1l507t722r660b766],
4	|	VBD	O	|	_	0	SENT_8	[p1l507t722r660b766],
5	veira	NN	O	veira	dobj	4	SENT_8	[p1l507t722r660b766],
6	,3	CD	NUMBER	,3	num	5	SENT_8	[p1l507t722r660b766],
7	Rossana	NNP	PERSON	Rossana	nn	9	SENT_8	[p1l678t730r835b761],
8	P.	NNP	PERSON	P.	nn	9	SENT_8	[p1l853t730r882b761],
9	Basso	NNP	PERSON	Basso	dep	5	SENT_8	[p1l903t722r1038b766],
10	?	.	O	?	_	0	SENT_8	[p1l903t722r1038b766],

1	’	NN	O	’	nn	3	SENT_9	[p1l903t722r1038b766],
2	Cezar	NNP	PERSON	Cezar	nn	3	SENT_9	[p1l1054t729r1162b761],
3	A.T.	NNP	PERSON	A.T.	nsubj	9	SENT_9	[p1l1177t730r1246b761],
4	Pinheirof	NNP	PERSON	Pinheirof	nn	8	SENT_9	[p1l1267t722r1435b766],
5	‘	NNP	O	‘	nn	8	SENT_9	[p1l1267t722r1435b766],
6	Mariangela	NNP	PERSON	Mariangela	nn	8	SENT_9	[p1l1453t730r1655b769],
7	F.	NNP	PERSON	F.	nn	8	SENT_9	[p1l1672t730r1700b760],
8	Si	NNP	PERSON	Si	dep	3	SENT_9	[p1l1719t722r1872b766],
9	|	VBD	O	|	_	0	SENT_9	[p1l1719t722r1872b766],
10	veira	NN	O	veira	dobj	9	SENT_9	[p1l1719t722r1872b766],
11	,4	CD	NUMBER	,4	num	10	SENT_9	[p1l1719t722r1872b766],

1	Silvana	NNP	PERSON	Silvana	nn	6	SENT_10	[p1l491t778r622b810],
2	de	NNP	PERSON	de	nn	6	SENT_10	[p1l639t779r683b810],
3	Almeidal	NNP	PERSON	Almeidal	nn	6	SENT_10	[p1l699t771r861b814],
4	Jorge	NNP	PERSON	Jorge	nn	6	SENT_10	[p1l881t779r984b818],
5	P.	NNP	PERSON	P.	nn	6	SENT_10	[p1l1003t779r1032b809],
6	Ribeiro	NNP	PERSON	Ribeiro	_	0	SENT_10	[p1l1053t771r1203b814],
7	,2	NN	O	,2	dep	6	SENT_10	[p1l1053t771r1203b814],
8	and	CC	O	and	_	0	SENT_10	[p1l1220t779r1286b810],
9	Vanessa	NNP	PERSON	Vanessa	nn	11	SENT_10	[p1l1303t779r1461b810],
10	S.	NNP	PERSON	S.	nn	11	SENT_10	[p1l1477t778r1508b810],
11	Mattevil	NNP	PERSON	Mattevil	dep	6	SENT_10	[p1l1528t771r1665b810],

1	Abstract	JJ	O	abstract	_	0	SENT_11	[p1l60t893r209b921],

1	Highly	RB	O	highly	advmod	2	SENT_12	[p1l60t984r186b1027],
2	active	JJ	O	active	amod	7	SENT_12	[p1l204t986r309b1016],
3	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_12	[p1l328t984r567b1016],
4	therapy	NN	O	therapy	nn	7	SENT_12	[p1l585t984r725b1027],
5	(	CD	NUMBER	(	num	7	SENT_12	[p1l745t985r918b1024],
6	HAART	NN	O	haart	nn	7	SENT_12	[p1l745t985r918b1024],
7	)	NN	O	)	nsubj	9	SENT_12	[p1l745t985r918b1024],
8	has	VBZ	O	have	aux	9	SENT_12	[p1l937t984r998b1016],
9	increased	VBN	O	increase	_	0	SENT_12	[p1l1016t984r1187b1016],
10	the	DT	O	the	det	11	SENT_12	[p1l1205t984r1260b1016],
11	survival	NN	O	survival	dobj	9	SENT_12	[p1l1279t984r1427b1016],
12	of	IN	O	of	_	0	SENT_12	[p1l1445t984r1481b1016],
13	HlV	NN	O	hlv	prep_of	11	SENT_12	[p1l1497t984r1732b1016],
14	—	CD	NUMBER	—	num	16	SENT_12	[p1l1497t984r1732b1016],
15	infected	JJ	O	infected	amod	16	SENT_12	[p1l1497t984r1732b1016],
16	patients	NNS	O	patient	dep	13	SENT_12	[p1l1749t986r1901b1027],
17	.	.	O	.	_	0	SENT_12	[p1l1749t986r1901b1027],

1	However	RB	O	however	advmod	5	SENT_13	[p1l1922t986r2100b1021],
2	,	,	O	,	_	0	SENT_13	[p1l1922t986r2100b1021],
3	adverse	JJ	O	adverse	amod	4	SENT_13	[p1l60t1034r200b1065],
4	effects	NNS	O	effect	nsubj	5	SENT_13	[p1l219t1034r332b1065],
5	play	VBP	O	play	_	0	SENT_13	[p1l350t1034r430b1076],
6	a	DT	O	a	det	8	SENT_13	[p1l448t1045r467b1065],
7	major	JJ	O	major	amod	8	SENT_13	[p1l486t1036r590b1076],
8	role	NN	O	role	dobj	5	SENT_13	[p1l609t1034r677b1065],
9	in	IN	O	in	_	0	SENT_13	[p1l695t1036r730b1065],
10	adherence	NN	O	adherence	prep_in	8	SENT_13	[p1l749t1034r933b1065],
11	to	TO	O	to	_	0	SENT_13	[p1l952t1039r986b1065],
12	HAART	NNP	O	HAART	prep_to	5	SENT_13	[p1l1005t1035r1163b1065],
13	.	.	O	.	_	0	SENT_13	[p1l1005t1035r1163b1065],

1	Some	DT	O	some	det	3	SENT_14	[p1l1184t1035r1282b1065],
2	protease	NN	O	protease	nn	3	SENT_14	[p1l1301t1038r1453b1076],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_14	[p1l1472t1034r1645b1065],
4	(	CD	NUMBER	(	num	6	SENT_14	[p1l1666t1034r1804b1076],
5	mainly	RB	O	mainly	advmod	6	SENT_14	[p1l1666t1034r1804b1076],
6	atazanavir	NN	O	atazanavir	dep	3	SENT_14	[p1l1823t1036r2014b1065],
7	and	CC	O	and	_	0	SENT_14	[p1l2033t1034r2100b1065],
8	indinavir	NN	O	indinavir	dep	3	SENT_14	[p1l59t1083r238b1122],
9	)	CD	NUMBER	)	num	10	SENT_14	[p1l59t1083r238b1122],
10	act	NN	O	act	dep	3	SENT_14	[p1l256t1087r307b1114],
11	as	IN	O	as	_	0	SENT_14	[p1l323t1094r358b1114],
12	inhibitors	NNS	O	inhibitor	prep_as	10	SENT_14	[p1l374t1083r547b1114],
13	of	IN	O	of	_	0	SENT_14	[p1l564t1083r600b1114],
14	uridine	NN	O	uridine	nn	15	SENT_14	[p1l614t1083r745b1114],
15	diphosphate-glucuronosyltransferase	NN	O	diphosphate-glucuronosyltransferase	prep_of	12	SENT_14	[p1l761t1083r1437b1125],
16	(	CD	NUMBER	(	num	18	SENT_14	[p1l1454t1083r1650b1122],
17	UGT1Al	NN	O	ugt1al	nn	18	SENT_14	[p1l1454t1083r1650b1122],
18	)	NN	O	)	dep	3	SENT_14	[p1l1454t1083r1650b1122],
19	,	,	O	,	_	0	SENT_14	[p1l1454t1083r1650b1122],
20	the	DT	O	the	det	21	SENT_14	[p1l1667t1083r1722b1114],
21	enzyme	NN	O	enzyme	appos	18	SENT_14	[p1l1738t1094r1879b1125],
22	responsible	JJ	O	responsible	amod	21	SENT_14	[p1l1895t1083r2101b1125],
23	for	IN	O	for	_	0	SENT_14	[p1l60t1132r111b1164],
24	hepatic	JJ	O	hepatic	amod	25	SENT_14	[p1l132t1132r263b1175],
25	conjugation	NN	O	conjugation	prep_for	22	SENT_14	[p1l286t1134r500b1175],
26	of	IN	O	of	_	0	SENT_14	[p1l522t1132r557b1164],
27	bilirubin	NN	O	bilirubin	prep_of	25	SENT_14	[p1l577t1132r742b1164],
28	.	.	O	.	_	0	SENT_14	[p1l577t1132r742b1164],

1	Variations	NNS	O	variation	_	0	SENT_15	[p1l766t1134r953b1164],
2	in	IN	O	in	_	0	SENT_15	[p1l976t1134r1011b1163],
3	the	DT	O	the	det	5	SENT_15	[p1l1033t1132r1088b1164],
4	promoter	NN	O	promoter	nn	5	SENT_15	[p1l1110t1137r1281b1175],
5	region	NN	O	region	prep_in	1	SENT_15	[p1l1303t1134r1419b1175],
6	of	IN	O	of	_	0	SENT_15	[p1l1441t1132r1477b1164],
7	the	DT	O	the	det	10	SENT_15	[p1l1497t1132r1553b1164],
8	LIGTIAI	NN	O	ligtiaus	nn	10	SENT_15	[p1l1578t1133r1729b1164],
9	gene	NN	O	gene	nn	10	SENT_15	[p1l1756t1143r1839b1175],
10	(	NN	O	(	prep_of	5	SENT_15	[p1l1864t1133r2100b1172],
11	l	NN	O	l	tmod	5	SENT_15	[p1l1864t1133r2100b1172],
12	,	,	O	,	_	0	SENT_15	[p1l1864t1133r2100b1172],
13	IGT1A1	NN	O	igt1a1	appos	1	SENT_15	[p1l1864t1133r2100b1172],
14	*	CD	NUMBER	*	number	15	SENT_15	[p1l1864t1133r2100b1172],
15	28	CD	NUMBER	28	dep	13	SENT_15	[p1l1864t1133r2100b1172],
16	,	,	O	,	_	0	SENT_15	[p1l1864t1133r2100b1172],
17	rs8175347	CD	NUMBER	rs8175347	num	18	SENT_15	[p1l60t1182r249b1221],
18	)	NN	O	)	nsubj	20	SENT_15	[p1l60t1182r249b1221],
19	can	MD	O	can	aux	20	SENT_15	[p1l263t1193r325b1213],
20	inﬂuence	VB	O	inﬂuence	dep	1	SENT_15	[p1l337t1182r502b1213],
21	bilirubin	NN	O	bilirubin	nn	23	SENT_15	[p1l513t1182r671b1213],
22	plasma	NN	O	plasma	nn	23	SENT_15	[p1l682t1182r813b1224],
23	levels	NNS	O	level	dobj	20	SENT_15	[p1l826t1182r937b1219],
24	,	,	O	,	_	0	SENT_15	[p1l826t1182r937b1219],
25	modulating	VBG	O	modulate	partmod	1	SENT_15	[p1l950t1182r1163b1224],
26	the	DT	O	the	det	27	SENT_15	[p1l1175t1182r1230b1213],
27	susceptibility	NN	O	susceptibility	dobj	25	SENT_15	[p1l1243t1182r1483b1224],
28	to	TO	O	to	_	0	SENT_15	[p1l1495t1187r1529b1213],
29	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	25	SENT_15	[p1l1541t1182r1902b1224],
30	.	.	O	.	_	0	SENT_15	[p1l1541t1182r1902b1224],

1	Aiming	VBG	O	aim	partmod	22	SENT_16	[p1l1916t1183r2054b1224],
2	to	TO	O	to	aux	3	SENT_16	[p1l2066t1187r2100b1213],
3	analyze	VB	O	analyze	xcomp	1	SENT_16	[p1l60t1232r199b1274],
4	the	DT	O	the	det	5	SENT_16	[p1l214t1232r269b1263],
5	association	NN	O	association	dobj	3	SENT_16	[p1l285t1233r485b1263],
6	between	IN	O	between	_	0	SENT_16	[p1l498t1232r652b1263],
7	l	NN	O	l	prep_between	5	SENT_16	[p1l669t1232r881b1263],
8	,	,	O	,	_	0	SENT_16	[p1l669t1232r881b1263],
9	IGT1A1	NN	O	igt1a1	prep_between	5	SENT_16	[p1l669t1232r881b1263],
10	*	CD	NUMBER	*	number	11	SENT_16	[p1l669t1232r881b1263],
11	28	CD	NUMBER	28	num	12	SENT_16	[p1l669t1232r881b1263],
12	allele	NN	O	allele	dep	9	SENT_16	[p1l897t1232r990b1263],
13	and	CC	O	and	_	0	SENT_16	[p1l1006t1232r1074b1263],
14	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_between	5	SENT_16	[p1l1089t1232r1440b1274],
15	in	IN	O	in	_	0	SENT_16	[p1l1456t1233r1491b1262],
16	individuals	NNS	O	individual	prep_in	3	SENT_16	[p1l1505t1232r1711b1263],
17	exposed	VBN	O	expose	partmod	16	SENT_16	[p1l1727t1232r1875b1274],
18	to	TO	O	to	_	0	SENT_16	[p1l1891t1236r1925b1263],
19	HAART	NNP	LOCATION	HAART	prep_to	17	SENT_16	[p1l1940t1233r2100b1268],
20	,	,	O	,	_	0	SENT_16	[p1l1940t1233r2100b1268],
21	we	PRP	O	we	nsubj	22	SENT_16	[p1l59t1292r112b1312],
22	evaluated	VBD	O	evaluate	_	0	SENT_16	[p1l125t1281r302b1312],
23	375	CD	NUMBER	375	num	25	SENT_16	[p1l315t1282r376b1312],
24	HIV-positive	JJ	O	hiv-positive	amod	25	SENT_16	[p1l389t1282r623b1323],
25	individuals	NNS	O	individual	dobj	22	SENT_16	[p1l636t1281r841b1312],
26	on	IN	O	on	_	0	SENT_16	[p1l855t1292r900b1312],
27	antiretroviral	JJ	O	antiretroviral	amod	28	SENT_16	[p1l913t1281r1152b1312],
28	therapy	NN	O	therapy	prep_on	22	SENT_16	[p1l1164t1281r1312b1323],
29	.	.	O	.	_	0	SENT_16	[p1l1164t1281r1312b1323],

1	Individuals	NNS	O	individual	nsubj	8	SENT_17	[p1l1327t1281r1535b1312],
2	carrying	VBG	O	carry	partmod	1	SENT_17	[p1l1548t1283r1699b1323],
3	the	DT	O	the	det	7	SENT_17	[p1l1712t1281r1767b1312],
4	LIGT1A1	NN	O	ligt1a1	nn	7	SENT_17	[p1l1783t1282r1994b1312],
5	*	CD	NUMBER	*	number	6	SENT_17	[p1l1783t1282r1994b1312],
6	28	CD	NUMBER	28	num	7	SENT_17	[p1l1783t1282r1994b1312],
7	allele	NN	O	allele	dobj	2	SENT_17	[p1l2008t1281r2100b1312],
8	had	VBD	O	have	_	0	SENT_17	[p1l59t1330r128b1361],
9	a	DT	O	a	det	11	SENT_17	[p1l142t1341r160b1361],
10	higher	JJR	O	higher	amod	11	SENT_17	[p1l173t1330r290b1372],
11	risk	NN	O	risk	dobj	8	SENT_17	[p1l303t1330r370b1361],
12	of	IN	O	of	_	0	SENT_17	[p1l383t1330r418b1361],
13	developing	VBG	O	develop	prepc_of	11	SENT_17	[p1l431t1330r634b1372],
14	severe	JJ	O	severe	amod	21	SENT_17	[p1l647t1341r760b1361],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	21	SENT_17	[p1l772t1330r1124b1372],
16	[	NN	O	[	nn	21	SENT_17	[p1l1140t1330r1346b1372],
17	prevalence	NN	O	prevalence	nn	21	SENT_17	[p1l1140t1330r1346b1372],
18	ratio	NN	O	ratio	nn	21	SENT_17	[p1l1359t1332r1442b1361],
19	(	CD	NUMBER	(	num	21	SENT_17	[p1l1457t1330r1532b1369],
20	PR	NN	O	pr	nn	21	SENT_17	[p1l1457t1330r1532b1369],
21	)	NN	O	)	dobj	13	SENT_17	[p1l1457t1330r1532b1369],
22	=	JJ	O	=	amod	21	SENT_17	[p1l1541t1331r1653b1367],
23	2.43	CD	NUMBER	2.43	tmod	22	SENT_17	[p1l1541t1331r1653b1367],
24	,	,	O	,	_	0	SENT_17	[p1l1541t1331r1653b1367],
25	95	CD	PERCENT	95	number	26	SENT_17	[p1l1666t1331r1741b1361],
26	%	NN	PERCENT	%	amod	27	SENT_17	[p1l1666t1331r1741b1361],
27	confidence	NN	O	confidence	appos	21	SENT_17	[p1l1754t1330r1948b1361],
28	interval	NN	O	interval	nn	31	SENT_17	[p1l1962t1330r2101b1361],
29	(	CD	NUMBER	(	num	31	SENT_17	[p1l61t1379r127b1418],
30	CI	NN	O	ci	nn	31	SENT_17	[p1l61t1379r127b1418],
31	)	NN	O	)	dep	27	SENT_17	[p1l61t1379r127b1418],
32	1.08-5	CD	NUMBER	1.08-5	num	33	SENT_17	[p1l147t1381r320b1416],
33	.45	CD	NUMBER	.45	dep	13	SENT_17	[p1l147t1381r320b1416],
34	,	,	O	,	_	0	SENT_17	[p1l147t1381r320b1416],
35	p	NN	O	p	nsubj	44	SENT_17	[p1l337t1379r500b1421],
36	=	JJ	O	=	amod	38	SENT_17	[p1l337t1379r500b1421],
37	0.032	CD	NUMBER	0.032	tmod	36	SENT_17	[p1l337t1379r500b1421],
38	]	NN	O	]	dep	35	SENT_17	[p1l337t1379r500b1421],
39	as	RB	O	as	_	0	SENT_17	[p1l520t1390r556b1410],
40	well	RB	O	well	_	0	SENT_17	[p1l573t1379r650b1410],
41	as	IN	O	as	_	0	SENT_17	[p1l667t1390r703b1410],
42	atazanavir	NN	O	atazanavir	nn	43	SENT_17	[p1l721t1381r912b1410],
43	users	NNS	O	user	nsubj	44	SENT_17	[p1l929t1390r1022b1410],
44	(	VBP	O	(	ccomp	8	SENT_17	[p1l1041t1379r1224b1418],
45	PR	NN	O	pr	dobj	44	SENT_17	[p1l1041t1379r1224b1418],
46	=	JJ	O	=	amod	45	SENT_17	[p1l1041t1379r1224b1418],
47	7.72	CD	NUMBER	7.72	tmod	46	SENT_17	[p1l1041t1379r1224b1418],
48	,	,	O	,	_	0	SENT_17	[p1l1041t1379r1224b1418],
49	95	CD	PERCENT	95	number	50	SENT_17	[p1l1242t1380r1316b1411],
50	%	NN	PERCENT	%	amod	51	SENT_17	[p1l1242t1380r1316b1411],
51	CI	NN	O	ci	dep	60	SENT_17	[p1l1334t1380r1610b1416],
52	=	JJ	O	=	amod	51	SENT_17	[p1l1334t1380r1610b1416],
53	3.14	CD	NUMBER	3.14	tmod	52	SENT_17	[p1l1334t1380r1610b1416],
54	—	CD	NUMBER	—	number	55	SENT_17	[p1l1334t1380r1610b1416],
55	18.98	CD	NUMBER	18.98	amod	51	SENT_17	[p1l1334t1380r1610b1416],
56	,	,	O	,	_	0	SENT_17	[p1l1334t1380r1610b1416],
57	p	NN	O	p	npadvmod	58	SENT_17	[p1l1627t1379r1799b1421],
58	<	JJR	O	<	dep	55	SENT_17	[p1l1627t1379r1799b1421],
59	0.001	CD	NUMBER	0.001	num	60	SENT_17	[p1l1627t1379r1799b1421],
60	)	NN	O	)	ccomp	8	SENT_17	[p1l1627t1379r1799b1421],
61	.	.	O	.	_	0	SENT_17	[p1l1627t1379r1799b1421],

1	This	DT	O	this	nsubj	5	SENT_18	[p1l1818t1379r1895b1410],
2	is	VBZ	O	be	cop	5	SENT_18	[p1l1912t1381r1940b1410],
3	the	DT	O	the	det	5	SENT_18	[p1l1957t1379r2013b1410],
4	first	JJ	ORDINAL	first	amod	5	SENT_18	[p1l2030t1379r2101b1411],
5	description	NN	O	description	_	0	SENT_18	[p1l60t1428r263b1470],
6	of	IN	O	of	_	0	SENT_18	[p1l278t1428r314b1459],
7	such	PDT	O	such	predet	9	SENT_18	[p1l328t1428r411b1459],
8	an	DT	O	a	det	9	SENT_18	[p1l426t1439r469b1459],
9	association	NN	O	association	prep_of	5	SENT_18	[p1l484t1430r683b1459],
10	in	IN	O	in	_	0	SENT_18	[p1l698t1430r733b1459],
11	Brazilian	JJ	MISC	brazilian	amod	13	SENT_18	[p1l747t1428r909b1459],
12	HIV	NN	O	hiv	nn	13	SENT_18	[p1l924t1429r1001b1459],
13	patients	NNS	O	patient	prep_in	9	SENT_18	[p1l1015t1430r1168b1470],
14	,	,	O	,	_	0	SENT_18	[p1l1015t1430r1168b1470],
15	which	WDT	O	which	nsubj	16	SENT_18	[p1l1184t1428r1296b1459],
16	shows	VBZ	O	show	rcmod	13	SENT_18	[p1l1311t1428r1424b1459],
17	that	IN	O	that	complm	31	SENT_18	[p1l1440t1428r1511b1459],
18	in	IN	O	in	_	0	SENT_18	[p1l1525t1430r1560b1459],
19	African-American	JJ	MISC	african-american	amod	23	SENT_18	[p1l1574t1428r1902b1459],
20	and	CC	O	and	_	0	SENT_18	[p1l1917t1428r1985b1459],
21	Euroamerican	NNP	MISC	Euroamerican	conj_and	19	SENT_18	[p1l2000t1429r2101b1459, p1l60t1478r226b1508],
22	HAART	NNP	MISC	HAART	nn	23	SENT_18	[p1l237t1478r388b1508],
23	users	NNS	O	user	prep_in	31	SENT_18	[p1l399t1488r503b1514],
24	,	,	O	,	_	0	SENT_18	[p1l399t1488r503b1514],
25	the	DT	O	the	det	26	SENT_18	[p1l515t1477r570b1508],
26	LIGT1A1	NN	O	ligt1a1	appos	23	SENT_18	[p1l585t1478r797b1508],
27	*	CD	NUMBER	*	number	28	SENT_18	[p1l585t1478r797b1508],
28	28	CD	NUMBER	28	num	29	SENT_18	[p1l585t1478r797b1508],
29	allele	NN	O	allele	nsubj	31	SENT_18	[p1l810t1477r903b1508],
30	also	RB	O	also	advmod	31	SENT_18	[p1l915t1477r986b1508],
31	predisposes	VBZ	O	predispose	ccomp	16	SENT_18	[p1l997t1477r1212b1519],
32	to	TO	O	to	_	0	SENT_18	[p1l1225t1481r1259b1508],
33	severe	JJ	O	severe	amod	34	SENT_18	[p1l1271t1488r1385b1508],
34	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_to	31	SENT_18	[p1l1396t1477r1758b1519],
35	,	,	O	,	_	0	SENT_18	[p1l1396t1477r1758b1519],
36	especially	RB	O	especially	advmod	31	SENT_18	[p1l1771t1477r1948b1519],
37	in	IN	O	in	_	0	SENT_18	[p1l1959t1479r1994b1508],
38	those	DT	O	those	prep_in	31	SENT_18	[p1l2006t1477r2101b1508],
39	exposed	VBN	O	expose	partmod	38	SENT_18	[p1l11t1535r325b1623],
40	to	TO	O	to	_	0	SENT_18	[p1l358t1544r430b1601],
41	atazanavir	NN	O	atazanavir	prep_to	39	SENT_18	[p1l464t1538r886b1600],
42	.	.	O	.	_	0	SENT_18	[p1l464t1538r886b1600],

1	HIGHLY	RB	O	highly	advmod	2	SENT_19	[p1l16t1783r398b1936],
2	ACTIVE	JJ	O	active	amod	4	SENT_19	[p1l434t1800r672b1840],
3	ANTIRETROVIRAL	NN	O	antiretroviral	nn	4	SENT_19	[p1l709t1800r1291b1840],
4	therapy	NN	O	therapy	nsubj	29	SENT_19	[p1l1329t1782r1596b1862],
5	(	CD	NUMBER	(	num	7	SENT_19	[p1l1635t1782r1965b1856],
6	HAART	NN	O	haart	nn	7	SENT_19	[p1l1635t1782r1965b1856],
7	)	NN	O	)	nsubj	10	SENT_19	[p1l1635t1782r1965b1856],
8	has	VBZ	O	have	aux	10	SENT_19	[p1l2003t1782r2119b1841],
9	completely	RB	O	completely	advmod	10	SENT_19	[p1l199t1878r578b1958],
10	changed	VBN	O	change	rcmod	4	SENT_19	[p1l612t1878r902b1958],
11	the	DT	O	the	det	12	SENT_19	[p1l936t1878r1042b1937],
12	prognosis	NN	O	prognosis	dobj	10	SENT_19	[p1l1075t1881r1413b1958],
13	of	IN	O	of	_	0	SENT_19	[p1l1449t1878r1517b1937],
14	HIV-infected	JJ	MISC	hiv-infected	amod	15	SENT_19	[p1l1548t1878r1994b1937],
15	individuals	NNS	O	individual	prep_of	12	SENT_19	[p1l2029t1881r2120b1936, p1l11t1960r428b2034],
16	.1	CD	NUMBER	.1	num	17	SENT_19	[p1l2029t1881r2120b1936, p1l11t1960r428b2034],
17	’	NN	O	’	dep	15	SENT_19	[p1l2029t1881r2120b1936, p1l11t1960r428b2034],
18	2	CD	NUMBER	2	dep	17	SENT_19	[p1l2029t1881r2120b1936, p1l11t1960r428b2034],
19	However	RB	O	however	advmod	17	SENT_19	[p1l459t1977r798b2044],
20	,	,	O	,	_	0	SENT_19	[p1l459t1977r798b2044],
21	drug	NN	O	drug	nn	22	SENT_19	[p1l830t1974r997b2054],
22	toxicity	NN	O	toxicity	prep_of	12	SENT_19	[p1l1026t1978r1282b2054],
23	and	CC	O	and	_	0	SENT_19	[p1l1312t1974r1441b2033],
24	adverse	JJ	O	adverse	amod	25	SENT_19	[p1l1472t1974r1738b2034],
25	effects	NNS	O	effect	conj_and	15	SENT_19	[p1l1769t1974r1984b2034],
26	are	VBP	O	be	cop	29	SENT_19	[p1l2016t1995r2119b2034],
27	still	RB	O	still	advmod	29	SENT_19	[p1l11t2072r134b2131],
28	major	JJ	O	major	amod	29	SENT_19	[p1l160t2075r358b2151],
29	challenges	NNS	O	challenge	_	0	SENT_19	[p1l385t2072r741b2151],
30	to	TO	O	to	_	0	SENT_19	[p1l769t2080r834b2131],
31	treatment	NN	O	treatment	nn	32	SENT_19	[p1l861t2080r1195b2131],
32	success	NN	O	success	prep_to	29	SENT_19	[p1l1221t2092r1486b2131],
33	.	.	O	.	_	0	SENT_19	[p1l1221t2092r1486b2131],

1	Nevertheless	RB	O	nevertheless	advmod	12	SENT_20	[p1l1516t2072r1980b2141],
2	,	,	O	,	_	0	SENT_20	[p1l1516t2072r1980b2141],
3	not	RB	O	not	neg	5	SENT_20	[p1l2007t2080r2121b2131],
4	all	DT	O	all	det	5	SENT_20	[p1l11t2168r93b2226],
5	people	NNS	O	people	nsubj	12	SENT_20	[p1l110t2168r341b2247],
6	exposed	VBN	O	expose	partmod	5	SENT_20	[p1l361t2168r642b2247],
7	to	TO	O	to	_	0	SENT_20	[p1l662t2176r727b2227],
8	the	DT	O	the	det	10	SENT_20	[p1l747t2168r852b2227],
9	same	JJ	O	same	amod	10	SENT_20	[p1l871t2188r1047b2227],
10	antiretrovirals	NNS	O	antiretroviral	prep_to	6	SENT_20	[p1l1067t2168r1554b2227],
11	may	MD	O	may	aux	12	SENT_20	[p1l1573t2188r1724b2247],
12	present	VB	DATE	present	_	0	SENT_20	[p1l1741t2176r1996b2247],
13	the	DT	O	the	det	16	SENT_20	[p1l2014t2168r2119b2227],
14	same	JJ	O	same	amod	16	SENT_20	[p1l11t2283r186b2322],
15	adverse	JJ	O	adverse	amod	16	SENT_20	[p1l214t2263r480b2322],
16	effect	NN	O	effect	dobj	12	SENT_20	[p1l506t2263r707b2332],
17	,	,	O	,	_	0	SENT_20	[p1l506t2263r707b2332],
18	and	CC	O	and	_	0	SENT_20	[p1l735t2263r863b2321],
19	genetic	JJ	O	genetic	amod	20	SENT_20	[p1l891t2266r1133b2342],
20	variations	NNS	O	variation	nsubj	25	SENT_20	[p1l1158t2266r1501b2322],
21	between	IN	O	between	_	0	SENT_20	[p1l1525t2263r1818b2322],
22	humans	NNS	O	human	prep_between	20	SENT_20	[p1l1841t2263r2119b2322],
23	might	MD	O	might	aux	25	SENT_20	[p1l10t2358r215b2439],
24	be	VB	O	be	cop	25	SENT_20	[p1l240t2358r321b2418],
25	responsible	JJ	O	responsible	conj_and	12	SENT_20	[p1l351t2358r742b2439],
26	for	IN	O	for	_	0	SENT_20	[p1l772t2358r869b2418],
27	the	DT	O	the	det	29	SENT_20	[p1l897t2358r1002b2418],
28	difference	NN	O	difference	nn	29	SENT_20	[p1l1033t2358r1372b2418],
29	rates	NNS	O	rate	prep_for	25	SENT_20	[p1l1402t2366r1564b2418],
30	and	CC	O	and	_	0	SENT_20	[p1l1595t2358r1724b2417],
31	expression	NN	O	expression	prep_for	25	SENT_20	[p1l1754t2361r2121b2439],
32	of	IN	O	of	_	0	SENT_20	[p1l11t2453r79b2513],
33	these	DT	O	these	det	36	SENT_20	[p1l101t2454r276b2513],
34	adverse	JJ	O	adverse	amod	36	SENT_20	[p1l302t2454r568b2513],
35	events	NNS	O	event	nn	36	SENT_20	[p1l594t2439r860b2513],
36	.1	NN	NUMBER	.1	prep_of	29	SENT_20	[p1l594t2439r860b2513],

1	Hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubj	3	SENT_21	[p1l98t2549r764b2628],
2	is	VBZ	O	be	cop	3	SENT_21	[p1l796t2552r847b2608],
3	one	CD	NUMBER	one	_	0	SENT_21	[p1l879t2569r999b2608],
4	of	IN	O	of	_	0	SENT_21	[p1l1031t2549r1098b2608],
5	these	DT	O	these	det	7	SENT_21	[p1l1126t2549r1296b2608],
6	adverse	JJ	O	adverse	amod	7	SENT_21	[p1l1328t2549r1588b2608],
7	effects	NNS	O	effect	prep_of	3	SENT_21	[p1l1619t2549r1826b2608],
8	and	CC	O	and	_	0	SENT_21	[p1l1858t2549r1985b2607],
9	the	DT	O	the	det	10	SENT_21	[p1l2016t2549r2119b2608],
10	development	NN	O	development	conj_and	3	SENT_21	[p1l11t2645r452b2725],
11	of	IN	O	of	_	0	SENT_21	[p1l491t2645r558b2705],
12	jaundice	NN	O	jaundice	prep_of	10	SENT_21	[p1l590t2645r875b2726],
13	could	MD	O	could	aux	14	SENT_21	[p1l914t2645r1101b2705],
14	lead	VB	O	lead	rcmod	12	SENT_21	[p1l1141t2645r1280b2705],
15	to	TO	O	to	_	0	SENT_21	[p1l1321t2653r1384b2705],
16	adherence	NN	O	adherence	nn	17	SENT_21	[p1l1425t2645r1766b2705],
17	problems	NNS	O	problem	prep_to	14	SENT_21	[p1l1804t2645r2119b2725],
18	and	CC	O	and	_	0	SENT_21	[p1l11t2743r138b2801],
19	treatment	NN	O	treatment	nn	21	SENT_21	[p1l175t2751r499b2802],
20	failure	NN	O	failure	nn	21	SENT_21	[p1l535t2728r838b2802],
21	.3	NN	NUMBER	.3	prep_to	14	SENT_21	[p1l535t2728r838b2802],
22	’	CD	NUMBER	’	number	23	SENT_21	[p1l535t2728r838b2802],
23	4	CD	NUMBER	4	dobj	14	SENT_21	[p1l535t2728r838b2802],
24	This	DT	O	this	nsubj	27	SENT_21	[p1l875t2743r1016b2802],
25	is	VBZ	O	be	cop	27	SENT_21	[p1l1054t2746r1105b2802],
26	particularly	RB	O	particularly	advmod	27	SENT_21	[p1l1141t2743r1532b2822],
27	true	JJ	O	true	rcmod	23	SENT_21	[p1l1568t2751r1702b2802],
28	in	IN	O	in	_	0	SENT_21	[p1l1739t2746r1804b2801],
29	HAART	NNP	O	HAART	nn	30	SENT_21	[p1l1839t2745r2120b2801],
30	regimens	NNS	O	regimen	prep_in	27	SENT_21	[p1l10t2841r317b2919],
31	containing	VBG	O	contain	xcomp	27	SENT_21	[p1l342t2841r696b2919],
32	indinavir	NN	O	indinavir	dobj	31	SENT_21	[p1l719t2838r1044b2908],
33	,	,	O	,	_	0	SENT_21	[p1l719t2838r1044b2908],
34	and	CC	O	and	_	0	SENT_21	[p1l1070t2838r1214b2908],
35	,	,	O	,	_	0	SENT_21	[p1l1070t2838r1214b2908],
36	mainly	RB	O	mainly	dep	23	SENT_21	[p1l1238t2838r1490b2919],
37	,	,	O	,	_	0	SENT_21	[p1l1238t2838r1490b2919],
38	atazanavir	NN	O	atazanavir	nn	41	SENT_21	[p1l1516t2841r1868b2897],
39	(	CD	NUMBER	(	num	41	SENT_21	[p1l1895t2838r2118b2913],
40	ATV	NN	O	atv	nn	41	SENT_21	[p1l1895t2838r2118b2913],
41	)	NN	O	)	conj_and	23	SENT_21	[p1l1895t2838r2118b2913],
42	,	,	O	,	_	0	SENT_21	[p1l1895t2838r2118b2913],
43	which	WDT	O	which	nsubj	44	SENT_21	[p1l9t2935r218b2995],
44	inhibit	VBP	O	inhibit	rcmod	10	SENT_21	[p1l251t2935r468b2994],
45	the	DT	O	the	det	50	SENT_21	[p1l502t2935r605b2995],
46	enzyme	NN	O	enzyme	nn	50	SENT_21	[p1l640t2955r902b3016],
47	uridine	NN	O	uridine	nn	50	SENT_21	[p1l936t2935r1178b2995],
48	diphosphateglucuronosyltransferase	NN	O	diphosphateglucuronosyltransferase	nn	50	SENT_21	[p1l1214t2935r2120b3016, p1l10t3032r373b3092],
49	A	NN	O	a	nn	50	SENT_21	[p1l396t3035r455b3091],
50	family	NN	O	family	dobj	44	SENT_21	[p1l479t3032r711b3112],
51	,	,	O	,	_	0	SENT_21	[p1l479t3032r711b3112],
52	polypeptide	NN	O	polypeptide	nn	53	SENT_21	[p1l735t3033r1141b3112],
53	A1	NN	O	a1	appos	50	SENT_21	[p1l1165t3035r1259b3091],
54	(	CD	NUMBER	(	num	55	SENT_21	[p1l1290t3018r1739b3107],
55	UGT1A1	NN	O	ugt1a1	dep	53	SENT_21	[p1l1290t3018r1739b3107],
56	)	CD	NUMBER	)	number	57	SENT_21	[p1l1290t3018r1739b3107],
57	.4	CD	NUMBER	.4	num	55	SENT_21	[p1l1290t3018r1739b3107],
58	"	``	O	"	punct	55	SENT_21	[p1l1290t3018r1739b3107],
59	6	CD	NUMBER	6	dep	55	SENT_21	[p1l1290t3018r1739b3107],
60	The	DT	O	the	det	61	SENT_21	[p1l1764t3033r1889b3092],
61	development	NN	O	development	dep	59	SENT_21	[p1l1915t3033r2120b3092, p1l11t3157r286b3230],
62	,	,	O	,	_	0	SENT_21	[p1l1915t3033r2120b3092, p1l11t3157r286b3230],

1	frequency	NN	O	frequency	nsubj	7	SENT_22	[p1l321t3149r670b3230],
2	,	,	O	,	_	0	SENT_22	[p1l321t3149r670b3230],
3	and	CC	O	and	_	0	SENT_22	[p1l705t3149r832b3208],
4	severity	NN	O	severity	conj_and	1	SENT_22	[p1l866t3152r1129b3230],
5	of	IN	O	of	_	0	SENT_22	[p1l1162t3149r1229b3209],
6	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	4	SENT_22	[p1l1258t3149r1906b3230],
7	differ	VBP	O	differ	_	0	SENT_22	[p1l1941t3149r2121b3209],
8	between	IN	O	between	_	0	SENT_22	[p1l8t3246r294b3306],
9	individuals	NNS	O	individual	nsubjpass	18	SENT_22	[p1l310t3246r688b3306],
10	and	CC	O	and	_	0	SENT_22	[p1l707t3246r834b3305],
11	one	CD	NUMBER	one	nsubjpass	18	SENT_22	[p1l853t3266r972b3306],
12	of	IN	O	of	_	0	SENT_22	[p1l990t3246r1057b3306],
13	the	DT	O	the	det	15	SENT_22	[p1l1072t3246r1174b3306],
14	possible	JJ	O	possible	amod	15	SENT_22	[p1l1192t3246r1462b3327],
15	explanations	NNS	O	explanation	prep_of	11	SENT_22	[p1l1481t3246r1903b3327],
16	might	MD	O	might	aux	18	SENT_22	[p1l1921t3246r2121b3327],
17	be	VB	O	be	auxpass	18	SENT_22	[p1l8t3344r87b3403],
18	related	VBN	O	relate	prepc_between	7	SENT_22	[p1l119t3344r348b3403],
19	to	TO	O	to	_	0	SENT_22	[p1l381t3352r444b3403],
20	genetics	NNS	O	genetics	prep_to	18	SENT_22	[p1l478t3329r848b3423],
21	.4	CD	NUMBER	.4	num	20	SENT_22	[p1l478t3329r848b3423],
22	"	``	O	"	punct	20	SENT_22	[p1l478t3329r848b3423],
23	6	CD	NUMBER	6	dep	20	SENT_22	[p1l478t3329r848b3423],
24	The	DT	O	the	det	25	SENT_22	[p1l880t3344r1005b3403],
25	combination	NN	O	combination	nsubj	29	SENT_22	[p1l1037t3344r1457b3403],
26	of	IN	O	of	_	0	SENT_22	[p1l1487t3343r1556b3403],
27	genetic	JJ	O	genetic	amod	28	SENT_22	[p1l1584t3347r1818b3423],
28	variants	NNS	O	variant	prep_of	25	SENT_22	[p1l1850t3347r2119b3403],
29	added	VBD	O	add	ccomp	18	SENT_22	[p1l11t3439r223b3499],
30	to	TO	O	to	_	0	SENT_22	[p1l259t3447r323b3499],
31	exposure	NN	O	exposure	prep_to	29	SENT_22	[p1l360t3459r662b3520],
32	to	TO	O	to	_	0	SENT_22	[p1l698t3447r763b3499],
33	xenobiotics	NNS	O	xenobiotic	prep_to	29	SENT_22	[p1l799t3439r1173b3499],
34	and	CC	O	and	_	0	SENT_22	[p1l1211t3439r1337b3498],
35	environmental	JJ	O	environmental	amod	36	SENT_22	[p1l1373t3439r1863b3499],
36	factors	NNS	O	factor	nsubj	38	SENT_22	[p1l1898t3439r2119b3499],
37	can	MD	O	can	aux	38	SENT_22	[p1l11t3556r127b3595],
38	inﬂuence	VB	O	inﬂuence	prepc_between	7	SENT_22	[p1l149t3536r454b3595],
39	the	DT	O	the	det	40	SENT_22	[p1l479t3536r582b3595],
40	activity	NN	O	activity	dobj	38	SENT_22	[p1l607t3539r854b3616],
41	of	IN	O	of	_	0	SENT_22	[p1l878t3536r944b3595],
42	glucuronidation	NN	O	glucuronidation	nn	43	SENT_22	[p1l966t3522r1551b3616],
43	.4	NN	NUMBER	.4	prep_of	40	SENT_22	[p1l966t3522r1551b3616],

1	LIGT1/11	NN	O	ligt1/11	dep	133	SENT_23	[p2l173t123r455b180],
2	gene	NN	O	gene	dep	133	SENT_23	[p2l510t142r667b200],
3	promoters	NNS	O	promoter	dep	133	SENT_23	[p2l714t130r1064b200],
4	containing	VBG	O	contain	dep	133	SENT_23	[p2l1113t125r1471b200],
5	seven	CD	NUMBER	seven	dep	133	SENT_23	[p2l1519t141r1710b180],
6	TA	NNP	O	TA	dep	133	SENT_23	[p2l1757t123r1862b179],
7	repeats	NNS	O	repeat	dep	133	SENT_23	[p2l1908t130r2151b200],
8	A	DT	O	a	dep	133	SENT_23	[p2l81t216r510b289],
9	(	CD	NUMBER	(	dep	133	SENT_23	[p2l81t216r510b289],
10	TA	NNP	O	TA	dep	133	SENT_23	[p2l81t216r510b289],
11	)	CD	NUMBER	)	dep	133	SENT_23	[p2l81t216r510b289],
12	7TAA	NNP	O	7TAA	dep	133	SENT_23	[p2l81t216r510b289],
13	,	,	O	,	_	0	SENT_23	[p2l81t216r510b289],
14	also	RB	O	also	dep	133	SENT_23	[p2l537t216r669b274],
15	known	VBN	O	know	dep	133	SENT_23	[p2l694t216r933b274],
16	as	IN	O	as	dep	133	SENT_23	[p2l958t236r1025b274],
17	LIGT1/l1	NN	O	ligt1/l1	dep	133	SENT_23	[p2l1056t217r1451b274],
18	*	CD	NUMBER	*	dep	133	SENT_23	[p2l1056t217r1451b274],
19	28	CD	NUMBER	28	dep	133	SENT_23	[p2l1056t217r1451b274],
20	(	CD	NUMBER	(	dep	133	SENT_23	[p2l1481t216r1878b289],
21	rs8175347	NN	O	rs8175347	dep	133	SENT_23	[p2l1481t216r1878b289],
22	)	NN	O	)	dep	133	SENT_23	[p2l1481t216r1878b289],
23	,	,	O	,	_	0	SENT_23	[p2l1481t216r1878b289],
24	cause	VB	O	cause	dep	133	SENT_23	[p2l1905t236r2089b274],
25	a	DT	O	a	dep	133	SENT_23	[p2l2116t236r2151b273],
26	reduction	NN	O	reduction	dep	133	SENT_23	[p2l81t309r414b367],
27	of	IN	O	of	dep	133	SENT_23	[p2l464t309r531b367],
28	approximately	RB	O	approximately	dep	133	SENT_23	[p2l579t309r1084b387],
29	50	CD	PERCENT	50	dep	133	SENT_23	[p2l1133t310r1274b367],
30	%	NN	PERCENT	%	dep	133	SENT_23	[p2l1133t310r1274b367],
31	in	IN	O	in	dep	133	SENT_23	[p2l1326t312r1392b366],
32	enzyme	NN	O	enzyme	dep	133	SENT_23	[p2l1441t329r1709b387],
33	activity	NN	O	activity	dep	133	SENT_23	[p2l1761t312r2035b387],
34	,	,	O	,	_	0	SENT_23	[p2l1761t312r2035b387],
35	in	IN	O	in	dep	133	SENT_23	[p2l2087t312r2153b366],
36	comparison	NN	O	comparison	dep	133	SENT_23	[p2l82t408r488b484],
37	with	IN	O	with	dep	133	SENT_23	[p2l523t405r682b463],
38	the	DT	O	the	dep	133	SENT_23	[p2l719t405r824b463],
39	wild-type	JJ	O	wild-type	dep	133	SENT_23	[p2l861t405r1197b484],
40	six	CD	NUMBER	six	dep	133	SENT_23	[p2l1236t408r1329b463],
41	TA	NNP	O	TA	dep	133	SENT_23	[p2l1367t406r1472b462],
42	repeats-containing	JJ	O	repeats-containing	dep	133	SENT_23	[p2l1510t408r2152b484],
43	allele	NN	O	allele	dep	133	SENT_23	[p2l82t500r260b558],
44	(	CD	NUMBER	(	dep	133	SENT_23	[p2l280t500r595b573],
45	LIGT1/l1	NN	O	ligt1/l1	dep	133	SENT_23	[p2l280t500r595b573],
46	*	NN	O	*	dep	133	SENT_23	[p2l608t486r749b573],
47	1	CD	NUMBER	1	dep	133	SENT_23	[p2l608t486r749b573],
48	)	CD	NUMBER	)	dep	133	SENT_23	[p2l608t486r749b573],
49	.7	CD	NUMBER	.7	dep	133	SENT_23	[p2l608t486r749b573],
50	Also	RB	O	also	dep	133	SENT_23	[p2l764t500r940b568],
51	,	,	O	,	_	0	SENT_23	[p2l764t500r940b568],
52	the	DT	O	the	dep	133	SENT_23	[p2l959t500r1064b558],
53	LIGTIAI	NNP	O	LIGTIAI	dep	133	SENT_23	[p2l1087t501r1373b558],
54	*	CD	NUMBER	*	dep	133	SENT_23	[p2l1387t501r1489b557],
55	28	CD	NUMBER	28	dep	133	SENT_23	[p2l1387t501r1489b557],
56	polymorphism	NN	O	polymorphism	dep	133	SENT_23	[p2l1506t500r2020b578],
57	has	VBZ	O	have	dep	133	SENT_23	[p2l2035t500r2150b558],
58	been	VBN	O	be	dep	133	SENT_23	[p2l79t593r243b651],
59	related	VBN	O	relate	dep	133	SENT_23	[p2l280t593r517b651],
60	to	TO	O	to	dep	133	SENT_23	[p2l556t601r621b651],
61	adverse	JJ	O	adverse	dep	133	SENT_23	[p2l661t593r927b651],
62	drug	NN	O	drug	dep	133	SENT_23	[p2l967t593r1132b671],
63	effects	NNS	O	effect	dep	133	SENT_23	[p2l1170t593r1385b651],
64	such	JJ	O	such	dep	133	SENT_23	[p2l1425t593r1583b651],
65	as	IN	O	as	dep	133	SENT_23	[p2l1621t613r1689b651],
66	toxicity	NN	O	toxicity	dep	133	SENT_23	[p2l1728t596r1984b671],
67	and	CC	O	and	dep	133	SENT_23	[p2l2023t593r2151b650],
68	predisposition	NN	O	predisposition	dep	133	SENT_23	[p2l80t688r580b767],
69	to	TO	O	to	dep	133	SENT_23	[p2l612t696r676b746],
70	cancer	NN	O	cancer	dep	133	SENT_23	[p2l710t674r980b746],
71	.4	CD	NUMBER	.4	dep	133	SENT_23	[p2l710t674r980b746],
72	Other	JJ	O	other	dep	133	SENT_23	[p2l1012t688r1210b746],
73	rarer	JJR	O	rarer	dep	133	SENT_23	[p2l1243t707r1409b746],
74	variants	NNS	O	variant	dep	133	SENT_23	[p2l1440t691r1719b746],
75	also	RB	O	also	dep	133	SENT_23	[p2l1753t688r1887b746],
76	reduce	VB	O	reduce	dep	133	SENT_23	[p2l1921t687r2151b746],
77	(	NN	O	(	dep	133	SENT_23	[p2l84t809r280b888],
78	eight	CD	NUMBER	eight	dep	133	SENT_23	[p2l84t809r280b888],
79	repeats	NNS	O	repeat	dep	133	SENT_23	[p2l345t817r611b888],
80	,	,	O	,	_	0	SENT_23	[p2l345t817r611b888],
81	UGT1A1	NN	O	ugt1a1	dep	133	SENT_23	[p2l678t809r1116b882],
82	*	NN	O	*	dep	133	SENT_23	[p2l678t809r1116b882],
83	37	CD	NUMBER	37	dep	133	SENT_23	[p2l678t809r1116b882],
84	)	CD	NUMBER	)	dep	133	SENT_23	[p2l678t809r1116b882],
85	or	CC	O	or	dep	133	SENT_23	[p2l1186t829r1256b867],
86	increase	VB	O	increase	dep	133	SENT_23	[p2l1322t812r1600b868],
87	(	CD	NUMBER	(	dep	133	SENT_23	[p2l1669t809r1818b882],
88	five	CD	NUMBER	five	dep	133	SENT_23	[p2l1669t809r1818b882],
89	repeats	NNS	O	repeat	dep	133	SENT_23	[p2l1884t817r2151b888],
90	,	,	O	,	_	0	SENT_23	[p2l1884t817r2151b888],
91	UGT1A1	NN	O	ugt1a1	dep	133	SENT_23	[p2l81t904r520b977],
92	*	CD	NUMBER	*	dep	133	SENT_23	[p2l81t904r520b977],
93	36	CD	NUMBER	36	dep	133	SENT_23	[p2l81t904r520b977],
94	)	NN	O	)	dep	133	SENT_23	[p2l81t904r520b977],
95	enzyme	NN	O	enzyme	dep	133	SENT_23	[p2l551t924r819b982],
96	activity	NN	O	activity	dep	133	SENT_23	[p2l848t890r1155b982],
97	.7	CD	NUMBER	.7	dep	133	SENT_23	[p2l848t890r1155b982],
98	Based	VBN	O	base	dep	133	SENT_23	[p2l1182t904r1383b962],
99	on	IN	O	on	dep	133	SENT_23	[p2l1413t924r1498b962],
100	this	DT	O	this	dep	133	SENT_23	[p2l1525t904r1648b962],
101	rationale	NN	O	rationale	dep	133	SENT_23	[p2l1676t904r1999b972],
102	,	,	O	,	_	0	SENT_23	[p2l1676t904r1999b972],
103	this	DT	O	this	dep	133	SENT_23	[p2l2028t904r2151b962],
104	study	NN	O	study	dep	133	SENT_23	[p2l82t998r276b1077],
105	aimed	VBN	O	aim	dep	133	SENT_23	[p2l341t998r552b1056],
106	to	TO	O	to	dep	133	SENT_23	[p2l618t1006r683b1056],
107	analyze	VB	O	analyze	dep	133	SENT_23	[p2l750t998r1013b1077],
108	the	DT	O	the	dep	133	SENT_23	[p2l1078t998r1183b1056],
109	association	NN	O	association	dep	133	SENT_23	[p2l1249t1001r1629b1056],
110	between	IN	O	between	dep	133	SENT_23	[p2l1690t998r1982b1056],
111	the	DT	O	the	dep	133	SENT_23	[p2l2046t998r2151b1056],
112	LIGT1A1	NN	O	ligt1a1	dep	133	SENT_23	[p2l87t1093r488b1150],
113	*	CD	NUMBER	*	dep	133	SENT_23	[p2l87t1093r488b1150],
114	28	CD	NUMBER	28	dep	133	SENT_23	[p2l87t1093r488b1150],
115	allele	NN	O	allele	dep	133	SENT_23	[p2l531t1092r709b1150],
116	and	CC	O	and	dep	133	SENT_23	[p2l751t1092r879b1149],
117	the	DT	O	the	dep	133	SENT_23	[p2l920t1092r1025b1150],
118	frequency	NN	O	frequency	dep	133	SENT_23	[p2l1067t1092r1409b1170],
119	and	CC	O	and	dep	133	SENT_23	[p2l1451t1092r1578b1149],
120	severity	NN	O	severity	dep	133	SENT_23	[p2l1621t1095r1892b1170],
121	of	IN	O	of	dep	133	SENT_23	[p2l1934t1092r2001b1150],
122	hyperbilirubinemia	NN	O	hyperbilirubinemia	dep	133	SENT_23	[p2l2038t1092r2151b1170, p2l80t1186r661b1265],
123	in	IN	O	in	dep	133	SENT_23	[p2l692t1189r758b1243],
124	HIV-infected	JJ	O	hiv-infected	dep	133	SENT_23	[p2l786t1186r1234b1244],
125	patients	NNS	O	patient	dep	133	SENT_23	[p2l1262t1189r1536b1265],
126	on	IN	O	on	dep	133	SENT_23	[p2l1567t1206r1653b1244],
127	HAART	NNP	LOCATION	HAART	dep	133	SENT_23	[p2l1681t1188r1983b1255],
128	,	,	O	,	_	0	SENT_23	[p2l1681t1188r1983b1255],
129	previously	RB	DATE	previously	dep	133	SENT_23	[p2l2013t1206r2151b1265, p2l80t1280r336b1359],
130	unexplored	JJ	O	unexplored	dep	133	SENT_23	[p2l360t1280r753b1359],
131	in	IN	O	in	dep	133	SENT_23	[p2l780t1283r846b1337],
132	Brazilian	JJ	MISC	brazilian	dep	133	SENT_23	[p2l869t1280r1177b1338],
133	patients	NNS	O	patient	_	0	SENT_23	[p2l1200t1283r1491b1359],
134	.	.	O	.	_	0	SENT_23	[p2l1200t1283r1491b1359],

1	We	PRP	O	we	nsubj	2	SENT_24	[p2l167t1376r279b1432],
2	developed	VBD	O	develop	dep	23	SENT_24	[p2l299t1374r646b1452],
3	a	DT	O	a	det	5	SENT_24	[p2l666t1394r701b1431],
4	cross-sectional	JJ	O	cross-sectional	amod	5	SENT_24	[p2l722t1374r1201b1432],
5	study	NN	O	study	dobj	2	SENT_24	[p2l1221t1374r1409b1452],
6	in	IN	O	in	_	0	SENT_24	[p2l1427t1377r1492b1431],
7	which	WDT	O	which	rel	9	SENT_24	[p2l1508t1374r1715b1432],
8	we	PRP	O	we	nsubj	9	SENT_24	[p2l1732t1394r1832b1432],
9	analyzed	VBD	O	analyze	rcmod	5	SENT_24	[p2l1851t1374r2152b1452],
10	consecutively	RB	O	consecutively	advmod	9	SENT_24	[p2l82t1468r532b1547],
11	375	CD	NUMBER	375	num	13	SENT_24	[p2l573t1471r684b1526],
12	HIV-infected	JJ	O	hiv-infected	amod	13	SENT_24	[p2l727t1468r1158b1526],
13	individuals	NNS	O	individual	dobj	9	SENT_24	[p2l1199t1468r1575b1526],
14	in	IN	O	in	_	0	SENT_24	[p2l1618t1471r1682b1525],
15	governmentsupported	VBN	O	governmentsupport	prepc_in	13	SENT_24	[p2l1724t1476r2152b1547, p2l82t1562r423b1641],
16	reference	NN	O	reference	nn	18	SENT_24	[p2l448t1562r749b1620],
17	treatment	NN	O	treatment	nn	18	SENT_24	[p2l773t1570r1095b1620],
18	services	NNS	O	service	dobj	15	SENT_24	[p2l1119t1565r1376b1620],
19	in	IN	O	in	_	0	SENT_24	[p2l1401t1565r1466b1619],
20	three	CD	NUMBER	three	num	22	SENT_24	[p2l1488t1562r1655b1620],
21	different	JJ	O	different	amod	22	SENT_24	[p2l1681t1562r1963b1620],
22	cities	NNS	O	city	prep_in	18	SENT_24	[p2l1986t1565r2151b1620],
23	(	VBP	O	(	_	0	SENT_24	[p2l84t1656r284b1729],
24	Porto	NNP	ORGANIZATION	Porto	nn	25	SENT_24	[p2l84t1656r284b1729],
25	Alegre	NNP	ORGANIZATION	Alegre	dobj	23	SENT_24	[p2l323t1656r562b1734],
26	,	,	O	,	_	0	SENT_24	[p2l323t1656r562b1734],
27	Pelotas	NNP	PERSON	Pelotas	conj_and	25	SENT_24	[p2l601t1656r854b1725],
28	,	,	O	,	_	0	SENT_24	[p2l601t1656r854b1725],
29	and	CC	O	and	_	0	SENT_24	[p2l894t1656r1019b1713],
30	Rio	NNP	LOCATION	Rio	nn	31	SENT_24	[p2l1057t1658r1168b1714],
31	Grande	NNP	LOCATION	Grande	dobj	23	SENT_24	[p2l1207t1656r1478b1729],
32	)	CD	NUMBER	)	nsubj	23	SENT_24	[p2l1207t1656r1478b1729],
33	from	IN	O	from	_	0	SENT_24	[p2l1518t1656r1681b1714],
34	the	DT	O	the	det	37	SENT_24	[p2l1717t1656r1819b1714],
35	Brazilian	JJ	MISC	brazilian	amod	37	SENT_24	[p2l1857t1656r2153b1713],
36	southernmost	JJ	O	southernmost	amod	37	SENT_24	[p2l82t1750r541b1808],
37	state	NN	O	state	prep_from	32	SENT_24	[p2l558t1758r724b1808],
38	.	.	O	.	_	0	SENT_24	[p2l558t1758r724b1808],

1	This	DT	O	this	det	2	SENT_25	[p2l746t1750r886b1808],
2	study	NN	O	study	nsubj	3	SENT_25	[p2l906t1750r1094b1829],
3	included	VBD	O	include	_	0	SENT_25	[p2l1111t1750r1402b1808],
4	only	RB	O	only	advmod	3	SENT_25	[p2l1421t1750r1568b1829],
5	people	NNS	O	people	dobj	3	SENT_25	[p2l1584t1750r1808b1829],
6	aged	VBN	O	age	partmod	5	SENT_25	[p2l1826t1750r1986b1829],
7	over	IN	O	over	_	0	SENT_25	[p2l2005t1770r2152b1808],
8	18	CD	DURATION	18	num	9	SENT_25	[p2l85t1847r154b1902],
9	years	NNS	NUMBER	year	prep_over	6	SENT_25	[p2l184t1864r377b1923],
10	,	,	O	,	_	0	SENT_25	[p2l184t1864r377b1923],
11	with	IN	O	with	_	0	SENT_25	[p2l405t1844r560b1902],
12	viral	JJ	O	viral	amod	13	SENT_25	[p2l585t1844r738b1902],
13	load	NN	O	load	prep_with	3	SENT_25	[p2l765t1844r910b1902],
14	below	IN	O	below	_	0	SENT_25	[p2l936t1844r1141b1902],
15	the	DT	O	the	det	17	SENT_25	[p2l1170t1844r1272b1902],
16	detection	NN	O	detection	nn	17	SENT_25	[p2l1302t1844r1606b1902],
17	limit	NN	O	limit	prep_below	3	SENT_25	[p2l1633t1844r1787b1902],
18	of	IN	O	of	_	0	SENT_25	[p2l1815t1844r1882b1902],
19	the	DT	O	the	det	20	SENT_25	[p2l1907t1844r2009b1902],
20	test	NN	O	test	prep_of	17	SENT_25	[p2l2037t1852r2152b1902],

1	1Universidade	NNP	O	1Universidade	nn	5	SENT_26	[p2l254t2070r461b2101],
2	Federal	NNP	O	Federal	nn	5	SENT_26	[p2l473t2076r580b2101],
3	de	IN	O	de	amod	5	SENT_26	[p2l592t2076r626b2101],
4	Ciencias	NNP	O	Ciencias	nn	5	SENT_26	[p2l639t2076r759b2101],
5	da	NNP	O	da	_	0	SENT_26	[p2l771t2076r806b2101],
6	Saﬁde	NNP	O	Saﬁde	nn	9	SENT_26	[p2l819t2076r907b2101],
7	de	IN	O	de	amod	9	SENT_26	[p2l919t2076r953b2101],
8	Porto	NNP	ORGANIZATION	Porto	nn	9	SENT_26	[p2l965t2077r1043b2101],
9	Alegre-UFCSPA	NNP	O	Alegre-UFCSPA	dep	5	SENT_26	[p2l1055t2076r1305b2110],
10	,	,	O	,	_	0	SENT_26	[p2l1055t2076r1305b2110],
11	Porto	NNP	ORGANIZATION	Porto	nn	12	SENT_26	[p2l1318t2077r1396b2101],
12	Alegre	NNP	ORGANIZATION	Alegre	appos	9	SENT_26	[p2l1408t2076r1512b2110],
13	,	,	O	,	_	0	SENT_26	[p2l1408t2076r1512b2110],
14	RS	NN	O	r	appos	9	SENT_26	[p2l1524t2076r1570b2105],
15	,	,	O	,	_	0	SENT_26	[p2l1524t2076r1570b2105],
16	Brazil	NNP	LOCATION	Brazil	appos	9	SENT_26	[p2l1583t2076r1673b2101],
17	.	.	O	.	_	0	SENT_26	[p2l1583t2076r1673b2101],

1	2Hospital	JJ	O	2hospital	_	0	SENT_27	[p2l253t2107r390b2147],
2	de	FW	O	de	dep	1	SENT_27	[p2l402t2114r436b2139],
3	Clinicas	FW	O	clinicas	nn	4	SENT_27	[p2l448t2113r562b2139],
4	de	FW	O	de	dep	2	SENT_27	[p2l575t2113r609b2139],
5	Porto	NNP	O	Porto	nn	6	SENT_27	[p2l621t2114r699b2139],
6	Alegre	NNP	O	Alegre	dep	2	SENT_27	[p2l711t2113r927b2147],
7	.	.	O	.	_	0	SENT_27	[p2l711t2113r927b2147],

1	—	NN	O	—	_	0	SENT_28	[p2l711t2113r927b2147],
2	.	.	O	.	_	0	SENT_28	[p2l711t2113r927b2147],

1	HCPA	NNP	O	HCPA	_	0	SENT_29	[p2l711t2113r927b2147],
2	,	,	O	,	_	0	SENT_29	[p2l711t2113r927b2147],
3	Porto	NNP	ORGANIZATION	Porto	nn	4	SENT_29	[p2l940t2114r1018b2139],
4	Alegre	NNP	ORGANIZATION	Alegre	appos	1	SENT_29	[p2l1029t2113r1134b2147],
5	,	,	O	,	_	0	SENT_29	[p2l1029t2113r1134b2147],
6	RS	NN	O	r	appos	1	SENT_29	[p2l1146t2114r1192b2143],
7	,	,	O	,	_	0	SENT_29	[p2l1146t2114r1192b2143],
8	Brazil	NNP	LOCATION	Brazil	appos	1	SENT_29	[p2l1205t2113r1295b2138],
9	.	.	O	.	_	0	SENT_29	[p2l1205t2113r1295b2138],

1	3Hospital	JJ	O	3hospital	amod	8	SENT_30	[p2l253t2145r390b2185],
2	Universitério	NNP	O	Universitério	nn	8	SENT_30	[p2l401t2152r591b2176],
3	Dr.	NNP	O	Dr.	nn	8	SENT_30	[p2l604t2152r648b2175],
4	Miguel	NNP	PERSON	Miguel	nn	8	SENT_30	[p2l661t2151r764b2185],
5	Riet	NNP	PERSON	Riet	nn	8	SENT_30	[p2l775t2152r832b2176],
6	Correa	NNP	PERSON	Correa	nn	8	SENT_30	[p2l844t2151r942b2176],
7	]	NNP	O	]	nn	8	SENT_30	[p2l953t2152r993b2182],
8	r.	NNP	O	r.	nsubj	12	SENT_30	[p2l953t2152r993b2182],
9	,	,	O	,	_	0	SENT_30	[p2l953t2152r993b2182],
10	Universidade	NNP	ORGANIZATION	Universidade	nn	11	SENT_30	[p2l1005t2151r1200b2176],
11	Federal	NNP	ORGANIZATION	Federal	nsubj	12	SENT_30	[p2l1212t2151r1320b2176],
12	do	VBP	O	do	_	0	SENT_30	[p2l1332t2151r1368b2176],
13	Rio	NNP	LOCATION	Rio	nn	14	SENT_30	[p2l1380t2152r1428b2176],
14	Grande	NNP	LOCATION	Grande	dobj	12	SENT_30	[p2l1441t2151r1557b2180],
15	,	,	O	,	_	0	SENT_30	[p2l1441t2151r1557b2180],
16	Rio	NNP	LOCATION	Rio	nn	17	SENT_30	[p2l1569t2152r1617b2176],
17	Grande	NNP	LOCATION	Grande	appos	14	SENT_30	[p2l1630t2151r1746b2180],
18	,	,	O	,	_	0	SENT_30	[p2l1630t2151r1746b2180],
19	RS	NN	O	r	appos	14	SENT_30	[p2l1758t2151r1804b2180],
20	,	,	O	,	_	0	SENT_30	[p2l1758t2151r1804b2180],
21	Brazil	NNP	LOCATION	Brazil	appos	14	SENT_30	[p2l1816t2151r1907b2176],
22	.	.	O	.	_	0	SENT_30	[p2l1816t2151r1907b2176],

1	4Servico	NNP	O	4Servico	nn	5	SENT_31	[p2l253t2182r371b2220],
2	de	NNP	O	de	nn	5	SENT_31	[p2l383t2188r417b2213],
3	Assisténcia	NNP	O	Assisténcia	nn	5	SENT_31	[p2l429t2189r590b2213],
4	Especializada	NNP	O	Especializada	nn	5	SENT_31	[p2l602t2188r799b2222],
5	em	NNP	O	em	_	0	SENT_31	[p2l811t2197r855b2213],
6	HIV	NN	O	hiv	dep	5	SENT_31	[p2l867t2188r945b2217],
7	/	:	O	/	punct	5	SENT_31	[p2l867t2188r945b2217],
8	AIDS	NNP	O	AIDS	dep	5	SENT_31	[p2l949t2189r1035b2218],
9	,	,	O	,	_	0	SENT_31	[p2l949t2189r1035b2218],
10	Universidade	NNP	ORGANIZATION	Universidade	nn	13	SENT_31	[p2l1047t2188r1242b2213],
11	Federal	NNP	ORGANIZATION	Federal	nn	13	SENT_31	[p2l1254t2188r1362b2213],
12	de	NNP	ORGANIZATION	de	nn	13	SENT_31	[p2l1374t2188r1408b2213],
13	Pelotas	NNP	ORGANIZATION	Pelotas	appos	8	SENT_31	[p2l1420t2188r1530b2218],
14	,	,	O	,	_	0	SENT_31	[p2l1420t2188r1530b2218],
15	Pelotas	NNP	PERSON	Pelotas	appos	8	SENT_31	[p2l1543t2188r1653b2217],
16	,	,	O	,	_	0	SENT_31	[p2l1543t2188r1653b2217],
17	RS	NN	O	r	appos	8	SENT_31	[p2l1666t2189r1712b2218],
18	,	,	O	,	_	0	SENT_31	[p2l1666t2189r1712b2218],
19	Brazil	NNP	LOCATION	Brazil	appos	8	SENT_31	[p2l1724t2188r1815b2213],
20	.	.	O	.	_	0	SENT_31	[p2l1724t2188r1815b2213],

1	1016	CD	DATE	1016	_	0	SENT_32	[p2l61t2336r140b2364],
2	TURATTI	NNP	O	TURATTI	nn	4	SENT_32	[p2l1809t2336r1966b2364],
3	ET	NNP	O	ET	nn	4	SENT_32	[p2l1983t2336r2028b2364],
4	AL.	NNP	O	AL.	dep	1	SENT_32	[p2l2042t2336r2099b2364],
5	.	.	O	.	_	0	SENT_32	[p2l2042t2336r2099b2364],

1	TABLE	NN	O	table	_	0	SENT_33	[p2l213t2437r313b2463],
2	1	CD	NUMBER	1	dep	1	SENT_33	[p2l329t2437r353b2463],
3	.	.	O	.	_	0	SENT_33	[p2l329t2437r353b2463],

1	MEDIAN	NNP	MISC	MEDIAN	nn	5	SENT_34	[p2l374t2436r510b2464],
2	BILIRUBIN	NNP	O	BILIRUBIN	nn	5	SENT_34	[p2l524t2437r689b2464],
3	LEVELS	NNP	O	LEVELS	nn	5	SENT_34	[p2l703t2436r817b2464],
4	COMPARED	NNP	O	COMPARED	nn	5	SENT_34	[p2l831t2436r1012b2464],
5	BETWEEN	NNP	O	BETWEEN	_	0	SENT_34	[p2l1027t2436r1177b2464],
6	THE	DT	O	the	det	8	SENT_34	[p2l1191t2444r1251b2463],
7	CoMMoN	NN	O	common	nn	8	SENT_34	[p2l1265t2436r1420b2464],
8	LIGT1/l1	NN	O	ligt1/l1	dep	5	SENT_34	[p2l1436t2436r1572b2464],
9	rs8175347	CD	NUMBER	rs8175347	num	10	SENT_34	[p2l1588t2437r1749b2464],
10	GENOTYPES	NNS	O	genotype	dep	5	SENT_34	[p2l1761t2436r1946b2464],

1	Genotypes	NNS	O	genotype	_	0	SENT_35	[p2l61t2522r214b2559],
2	Total	JJ	O	total	amod	4	SENT_35	[p2l699t2521r774b2549],
3	bilirubin	NN	O	bilirubin	nn	4	SENT_35	[p2l789t2521r916b2549],
4	p	NN	O	p	dep	1	SENT_35	[p2l1211t2531r1232b2559],
5	Indirect	JJ	MISC	indirect	amod	7	SENT_35	[p2l1507t2521r1624b2549],
6	bilirubin	NN	O	bilirubin	nn	7	SENT_35	[p2l1638t2521r1766b2549],
7	p	NN	O	p	dep	1	SENT_35	[p2l2041t2531r2062b2559],

1	TA6/TA6	NN	O	ta6/ta6	dep	127	SENT_36	[p2l59t2606r212b2641],
2	(	CD	NUMBER	(	dep	127	SENT_36	[p2l227t2607r256b2642],
3	n	NN	O	n	dep	127	SENT_36	[p2l227t2607r256b2642],
4	=	JJ	O	=	dep	127	SENT_36	[p2l264t2619r284b2629],
5	169	CD	NUMBER	169	dep	127	SENT_36	[p2l292t2606r357b2642],
6	)	CD	NUMBER	)	dep	127	SENT_36	[p2l292t2606r357b2642],
7	0.67	CD	NUMBER	0.67	dep	127	SENT_36	[p2l523t2608r588b2635],
8	mg	NN	O	mg	dep	127	SENT_36	[p2l595t2616r647b2644],
9	/	:	O	/	dep	127	SENT_36	[p2l651t2606r667b2638],
10	dl	NN	O	dl	dep	127	SENT_36	[p2l671t2606r703b2634],
11	(	CD	NUMBER	(	dep	127	SENT_36	[p2l718t2607r802b2642],
12	IQR	NN	O	iqr	dep	127	SENT_36	[p2l718t2607r802b2642],
13	,	,	O	,	_	0	SENT_36	[p2l718t2607r802b2642],
14	0.40-1	CD	NUMBER	0.40-1	dep	127	SENT_36	[p2l817t2608r964b2635],
15	.20	CD	NUMBER	.20	dep	127	SENT_36	[p2l817t2608r964b2635],
16	mg	NN	O	mg	dep	127	SENT_36	[p2l972t2606r1044b2644],
17	/	:	O	/	dep	127	SENT_36	[p2l972t2606r1044b2644],
18	dl	NN	O	dl	dep	127	SENT_36	[p2l1049t2606r1091b2642],
19	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1049t2606r1091b2642],
20	0.8483	CD	NUMBER	0.8483	dep	127	SENT_36	[p2l1174t2605r1271b2635],
21	0.47	CD	NUMBER	0.47	dep	127	SENT_36	[p2l1353t2607r1418b2635],
22	mg	NN	O	mg	dep	127	SENT_36	[p2l1424t2616r1477b2644],
23	/	:	O	/	dep	127	SENT_36	[p2l1480t2606r1496b2638],
24	dl	NN	O	dl	dep	127	SENT_36	[p2l1501t2606r1533b2634],
25	(	CD	NUMBER	(	dep	127	SENT_36	[p2l1547t2606r1632b2642],
26	IQR	NN	O	iqr	dep	127	SENT_36	[p2l1547t2606r1632b2642],
27	,	,	O	,	_	0	SENT_36	[p2l1547t2606r1632b2642],
28	0.30-0	CD	NUMBER	0.30-0	dep	127	SENT_36	[p2l1646t2608r1794b2635],
29	.89	CD	NUMBER	.89	dep	127	SENT_36	[p2l1646t2608r1794b2635],
30	mg	NN	O	mg	dep	127	SENT_36	[p2l1802t2616r1854b2644],
31	/	:	O	/	dep	127	SENT_36	[p2l1858t2606r1874b2638],
32	dl	NN	O	dl	dep	127	SENT_36	[p2l1878t2606r1921b2642],
33	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1878t2606r1921b2642],
34	0.6173	CD	NUMBER	0.6173	dep	127	SENT_36	[p2l2004t2605r2101b2635],
35	TA6/TA7	NN	O	ta6/ta7	dep	127	SENT_36	[p2l59t2647r212b2681],
36	(	CD	NUMBER	(	dep	127	SENT_36	[p2l227t2647r256b2682],
37	:1	NN	O	:1	dep	127	SENT_36	[p2l227t2647r256b2682],
38	=	JJ	O	=	dep	127	SENT_36	[p2l264t2659r284b2669],
39	145	CD	NUMBER	145	dep	127	SENT_36	[p2l292t2647r357b2682],
40	)	CD	NUMBER	)	dep	127	SENT_36	[p2l292t2647r357b2682],
41	0.61	CD	NUMBER	0.61	dep	127	SENT_36	[p2l523t2648r585b2675],
42	mg	NN	O	mg	dep	127	SENT_36	[p2l595t2656r647b2685],
43	/	:	O	/	dep	127	SENT_36	[p2l651t2647r667b2679],
44	dl	NN	O	dl	dep	127	SENT_36	[p2l671t2647r703b2675],
45	(	CD	NUMBER	(	dep	127	SENT_36	[p2l718t2647r802b2682],
46	IQR	NN	O	iqr	dep	127	SENT_36	[p2l718t2647r802b2682],
47	,	,	O	,	_	0	SENT_36	[p2l718t2647r802b2682],
48	0.40-1	CD	NUMBER	0.40-1	dep	127	SENT_36	[p2l817t2648r964b2675],
49	.23	CD	NUMBER	.23	dep	127	SENT_36	[p2l817t2648r964b2675],
50	mg	NN	O	mg	dep	127	SENT_36	[p2l972t2656r1025b2685],
51	/	:	O	/	dep	127	SENT_36	[p2l1028t2647r1044b2679],
52	d1	NN	O	d1	dep	127	SENT_36	[p2l1049t2647r1091b2682],
53	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1049t2647r1091b2682],
54	0.40	CD	NUMBER	0.40	dep	127	SENT_36	[p2l1353t2648r1416b2675],
55	mg	NN	O	mg	dep	127	SENT_36	[p2l1424t2656r1477b2685],
56	/	:	O	/	dep	127	SENT_36	[p2l1480t2647r1497b2679],
57	dl	NN	O	dl	dep	127	SENT_36	[p2l1501t2647r1533b2675],
58	(	CD	NUMBER	(	dep	127	SENT_36	[p2l1547t2647r1632b2682],
59	IQR	NN	O	iqr	dep	127	SENT_36	[p2l1547t2647r1632b2682],
60	,	,	O	,	_	0	SENT_36	[p2l1547t2647r1632b2682],
61	0.30-0	CD	NUMBER	0.30-0	dep	127	SENT_36	[p2l1646t2648r1795b2675],
62	.87	CD	NUMBER	.87	dep	127	SENT_36	[p2l1646t2648r1795b2675],
63	mg	NN	O	mg	dep	127	SENT_36	[p2l1802t2656r1854b2685],
64	/	:	O	/	dep	127	SENT_36	[p2l1858t2647r1874b2679],
65	dl	NN	O	dl	dep	127	SENT_36	[p2l1878t2647r1921b2682],
66	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1878t2647r1921b2682],
67	TA7/TA7	NN	O	ta7/ta7	dep	127	SENT_36	[p2l59t2688r212b2722],
68	(	NN	O	(	dep	127	SENT_36	[p2l227t2688r256b2723],
69	n	NN	O	n	dep	127	SENT_36	[p2l227t2688r256b2723],
70	=	JJ	O	=	dep	127	SENT_36	[p2l264t2700r284b2710],
71	39	CD	NUMBER	39	dep	127	SENT_36	[p2l291t2688r338b2723],
72	)	CD	NUMBER	)	dep	127	SENT_36	[p2l291t2688r338b2723],
73	0.80	CD	NUMBER	0.80	dep	127	SENT_36	[p2l523t2689r587b2716],
74	mg	NN	O	mg	dep	127	SENT_36	[p2l595t2697r647b2726],
75	/	:	O	/	dep	127	SENT_36	[p2l651t2688r667b2720],
76	dl	NN	O	dl	dep	127	SENT_36	[p2l671t2688r703b2716],
77	(	CD	NUMBER	(	dep	127	SENT_36	[p2l718t2688r802b2723],
78	IQR	NN	O	iqr	dep	127	SENT_36	[p2l718t2688r802b2723],
79	,	,	O	,	_	0	SENT_36	[p2l718t2688r802b2723],
80	0.40-1	CD	NUMBER	0.40-1	dep	127	SENT_36	[p2l817t2689r964b2716],
81	.30	CD	NUMBER	.30	dep	127	SENT_36	[p2l817t2689r964b2716],
82	mg	NN	O	mg	dep	127	SENT_36	[p2l972t2697r1025b2726],
83	/	:	O	/	dep	127	SENT_36	[p2l1028t2688r1044b2720],
84	d1	NN	O	d1	dep	127	SENT_36	[p2l1049t2688r1091b2723],
85	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1049t2688r1091b2723],
86	0.50	CD	NUMBER	0.50	dep	127	SENT_36	[p2l1353t2689r1416b2716],
87	mg/dl	NN	O	mg/dl	dep	127	SENT_36	[p2l1424t2688r1533b2726],
88	(	CD	NUMBER	(	dep	127	SENT_36	[p2l1547t2688r1632b2723],
89	IQR	NN	O	iqr	dep	127	SENT_36	[p2l1547t2688r1632b2723],
90	,	,	O	,	_	0	SENT_36	[p2l1547t2688r1632b2723],
91	0.30-1	CD	NUMBER	0.30-1	dep	127	SENT_36	[p2l1646t2689r1794b2716],
92	.00	CD	NUMBER	.00	dep	127	SENT_36	[p2l1646t2689r1794b2716],
93	mg/dl	NN	O	mg/dl	dep	127	SENT_36	[p2l1802t2688r1921b2726],
94	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1802t2688r1921b2726],
95	Whole	JJ	O	whole	dep	127	SENT_36	[p2l59t2729r165b2757],
96	sample	NN	O	sample	dep	127	SENT_36	[p2l179t2729r295b2767],
97	(	NN	O	(	dep	127	SENT_36	[p2l310t2729r339b2764],
98	n	NN	O	n	dep	127	SENT_36	[p2l310t2729r339b2764],
99	=	JJ	O	=	dep	127	SENT_36	[p2l347t2741r367b2751],
100	353	CD	NUMBER	353	dep	127	SENT_36	[p2l374t2729r440b2764],
101	)	CD	NUMBER	)	dep	127	SENT_36	[p2l374t2729r440b2764],
102	0.67	CD	NUMBER	0.67	dep	127	SENT_36	[p2l523t2730r588b2757],
103	mg	NN	O	mg	dep	127	SENT_36	[p2l594t2739r647b2767],
104	/	:	O	/	dep	127	SENT_36	[p2l651t2729r667b2761],
105	dl	NN	O	dl	dep	127	SENT_36	[p2l671t2729r703b2757],
106	(	CD	NUMBER	(	dep	127	SENT_36	[p2l718t2729r802b2764],
107	IQR	NN	O	iqr	dep	127	SENT_36	[p2l718t2729r802b2764],
108	,	,	O	,	_	0	SENT_36	[p2l718t2729r802b2764],
109	0.40-1	CD	NUMBER	0.40-1	dep	127	SENT_36	[p2l817t2730r964b2757],
110	.20	CD	NUMBER	.20	dep	127	SENT_36	[p2l817t2730r964b2757],
111	mg	NN	O	mg	dep	127	SENT_36	[p2l972t2729r1044b2767],
112	/	:	O	/	dep	127	SENT_36	[p2l972t2729r1044b2767],
113	dl	NN	O	dl	dep	127	SENT_36	[p2l1049t2729r1091b2764],
114	)	CD	NUMBER	)	dep	127	SENT_36	[p2l1049t2729r1091b2764],
115	0.40	CD	NUMBER	0.40	dep	127	SENT_36	[p2l1353t2730r1416b2757],
116	mg	NN	O	mg	dep	127	SENT_36	[p2l1424t2739r1477b2767],
117	/	:	O	/	dep	127	SENT_36	[p2l1480t2729r1497b2761],
118	dl	NN	O	dl	dep	127	SENT_36	[p2l1501t2729r1533b2757],
119	(	CD	NUMBER	(	dep	127	SENT_36	[p2l1547t2729r1632b2764],
120	IQR	NN	O	iqr	dep	127	SENT_36	[p2l1547t2729r1632b2764],
121	,	,	O	,	_	0	SENT_36	[p2l1547t2729r1632b2764],
122	0.30-0	CD	NUMBER	0.30-0	dep	127	SENT_36	[p2l1646t2730r1794b2757],
123	.85	CD	NUMBER	.85	dep	127	SENT_36	[p2l1646t2730r1794b2757],
124	mg	NN	O	mg	dep	127	SENT_36	[p2l1802t2739r1854b2767],
125	/	:	O	/	dep	127	SENT_36	[p2l1858t2729r1874b2761],
126	dl	NN	O	dl	dep	127	SENT_36	[p2l1878t2729r1921b2764],
127	)	NN	O	)	_	0	SENT_36	[p2l1878t2729r1921b2764],

1	aKrusl	NN	O	akrusl	_	0	SENT_37	[p2l81t2847r575b2902],
2	<	JJR	O	<	amod	4	SENT_37	[p2l81t2847r575b2902],
3	al-Wallis	JJ	O	al-wallis	amod	4	SENT_37	[p2l81t2847r575b2902],
4	test	NN	O	test	dep	1	SENT_37	[p2l601t2856r721b2902],
5	.	.	O	.	_	0	SENT_37	[p2l601t2856r721b2902],

1	IQR	NNP	O	IQR	_	0	SENT_38	[p2l81t2940r220b3003],
2	,	,	O	,	_	0	SENT_38	[p2l81t2940r220b3003],
3	interquartile	JJ	O	interquartile	amod	4	SENT_38	[p2l246t2939r624b3010],
4	range	NN	O	range	appos	1	SENT_38	[p2l650t2957r836b3010],
5	.	.	O	.	_	0	SENT_38	[p2l650t2957r836b3010],

1	(	NN	O	(	nn	2	SENT_39	[p2l13t3170r280b3244],
2	bDNA	NN	O	bdna	_	0	SENT_39	[p2l13t3170r280b3244],
3	,	,	O	,	_	0	SENT_39	[p2l13t3170r280b3244],
4	50	CD	NUMBER	50	num	5	SENT_39	[p2l307t3172r382b3229],
5	copies	NNS	O	copy	appos	2	SENT_39	[p2l411t3172r621b3250],
6	/	:	O	/	punct	8	SENT_39	[p2l629t3169r663b3237],
7	ml	NN	O	ml	nn	8	SENT_39	[p2l669t3169r780b3244],
8	)	NN	O	)	dep	5	SENT_39	[p2l669t3169r780b3244],
9	and	CC	O	and	_	0	SENT_39	[p2l811t3170r939b3229],
10	using	VBG	O	use	amod	12	SENT_39	[p2l966t3172r1153b3250],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_39	[p2l1180t3169r1625b3229],
12	therapy	NN	O	therapy	conj_and	5	SENT_39	[p2l1653t3169r1915b3250],
13	regularly	RB	O	regularly	advmod	12	SENT_39	[p2l1941t3190r2120b3250, p2l10t3266r164b3346],
14	for	IN	O	for	_	0	SENT_39	[p2l187t3265r282b3326],
15	at	IN	DURATION	at	quantmod	17	SENT_39	[p2l306t3274r368b3325],
16	least	JJS	DURATION	least	mwe	15	SENT_39	[p2l390t3266r544b3326],
17	1	CD	DURATION	1	prep_for	13	SENT_39	[p2l569t3268r598b3324],
18	year	NN	NUMBER	year	tmod	13	SENT_39	[p2l626t3286r788b3346],
19	.	.	O	.	_	0	SENT_39	[p2l626t3286r788b3346],

1	Indirect	JJ	O	indirect	nsubjpass	7	SENT_40	[p2l815t3266r1078b3326],
2	and	CC	O	and	_	0	SENT_40	[p2l1101t3266r1229b3325],
3	total	JJ	O	total	amod	5	SENT_40	[p2l1252t3266r1403b3326],
4	bilirubin	NN	O	bilirubin	nn	5	SENT_40	[p2l1424t3266r1719b3325],
5	levels	NNS	O	level	conj_and	1	SENT_40	[p2l1740t3266r1931b3326],
6	were	VBD	O	be	auxpass	7	SENT_40	[p2l1952t3286r2120b3326],
7	measured	VBN	O	measure	_	0	SENT_40	[p2l10t3361r343b3420],
8	through	IN	O	through	_	0	SENT_40	[p2l372t3361r647b3440],
9	standard	JJ	O	standard	amod	10	SENT_40	[p2l673t3361r973b3420],
10	methods	NNS	O	method	prep_through	7	SENT_40	[p2l1002t3361r1296b3420],
11	in	IN	O	in	_	0	SENT_40	[p2l1323t3364r1390b3419],
12	each	DT	O	each	det	13	SENT_40	[p2l1416t3361r1569b3420],
13	service	NN	O	service	prep_in	10	SENT_40	[p2l1596t3364r1843b3420],
14	.	.	O	.	_	0	SENT_40	[p2l1596t3364r1843b3420],

1	For	IN	O	for	_	0	SENT_41	[p2l1874t3363r1988b3420],
2	the	DT	O	the	det	3	SENT_41	[p2l2015t3361r2120b3420],
3	definition	NN	O	definition	prep_for	15	SENT_41	[p2l11t3456r340b3516],
4	of	IN	O	of	_	0	SENT_41	[p2l390t3456r458b3516],
5	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	3	SENT_41	[p2l504t3456r1179b3537],
6	,	,	O	,	_	0	SENT_41	[p2l504t3456r1179b3537],
7	the	DT	O	the	det	10	SENT_41	[p2l1231t3456r1336b3516],
8	AIDS	NNP	ORGANIZATION	AIDS	nn	10	SENT_41	[p2l1386t3458r1572b3516],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_41	[p2l1622t3456r1880b3516],
10	Trials	NNPS	ORGANIZATION	Trials	nsubjpass	15	SENT_41	[p2l1930t3456r2120b3516],
11	Group	NNP	ORGANIZATION	Group	nn	13	SENT_41	[p2l10t3555r230b3633],
12	guideline	NN	O	guideline	nn	13	SENT_41	[p2l264t3553r580b3633],
13	criterion	NN	O	criterion	dep	10	SENT_41	[p2l611t3557r895b3613],
14	was	VBD	O	be	auxpass	15	SENT_41	[p2l923t3574r1058b3613],
15	used	VBN	O	use	_	0	SENT_41	[p2l1090t3539r1297b3613],
16	.8	CD	NUMBER	.8	dobj	15	SENT_41	[p2l1090t3539r1297b3613],
17	All	DT	O	all	det	18	SENT_41	[p2l1329t3553r1432b3611],
18	patients	NNS	O	patient	nsubj	19	SENT_41	[p2l1462t3557r1729b3633],
19	signed	VBD	O	sign	rcmod	16	SENT_41	[p2l1762t3553r1984b3633],
20	the	DT	O	the	det	21	SENT_41	[p2l2015t3554r2120b3613],
21	Free	NNP	O	Free	dobj	19	SENT_41	[p2l10t3650r154b3707],
22	and	CC	O	and	_	0	SENT_41	[p2l172t3648r300b3706],
23	Informed	NNP	O	Informed	nn	25	SENT_41	[p2l318t3648r635b3707],
24	Consent	NNP	O	Consent	nn	25	SENT_41	[p2l652t3649r932b3707],
25	Form	NN	O	form	dobj	19	SENT_41	[p2l948t3650r1146b3707],
26	.	.	O	.	_	0	SENT_41	[p2l948t3650r1146b3707],

1	This	DT	O	this	det	2	SENT_42	[p2l1166t3648r1309b3707],
2	study	NN	O	study	nsubjpass	4	SENT_42	[p2l1329t3648r1520b3727],
3	was	VBD	O	be	auxpass	4	SENT_42	[p2l1535t3668r1671b3707],
4	approved	VBN	O	approve	_	0	SENT_42	[p2l1690t3648r2018b3727],
5	by	IN	O	by	_	0	SENT_42	[p2l2033t3648r2120b3727],
6	the	DT	O	the	det	9	SENT_42	[p2l10t3744r114b3802],
7	Research	NNP	O	Research	nn	9	SENT_42	[p2l132t3744r436b3802],
8	Ethics	NNPS	O	Ethics	nn	9	SENT_42	[p2l453t3743r655b3802],
9	Committees	NNS	O	committee	agent	4	SENT_42	[p2l674t3745r1082b3802],
10	from	IN	O	from	_	0	SENT_42	[p2l1100t3743r1265b3802],
11	the	DT	O	the	det	12	SENT_42	[p2l1282t3743r1386b3802],
12	institutions	NNS	O	institution	prep_from	4	SENT_42	[p2l1405t3746r1783b3802],
13	involved	VBN	O	involve	partmod	12	SENT_42	[p2l1802t3744r2116b3802],
14	.	.	O	.	_	0	SENT_42	[p2l1802t3744r2116b3802],

1	Genomic	JJ	O	genomic	amod	2	SENT_43	[p3l98t29r407b88],
2	DNA	NN	O	dna	nsubjpass	4	SENT_43	[p3l439t30r624b88],
3	was	VBD	O	be	auxpass	4	SENT_43	[p3l655t48r791b88],
4	extracted	VBN	O	extract	_	0	SENT_43	[p3l825t28r1139b88],
5	from	IN	O	from	_	0	SENT_43	[p3l1172t27r1339b88],
6	leukocytes	NNS	O	leukocyte	prep_from	4	SENT_43	[p3l1370t28r1734b108],
7	by	IN	O	by	_	0	SENT_43	[p3l1764t28r1852b108],
8	a	DT	O	a	det	9	SENT_43	[p3l1885t48r1920b87],
9	standard	JJ	O	standard	agent	4	SENT_43	[p3l1954t36r2119b88, p3l11t123r173b181],
10	salting	VBG	O	salt	partmod	9	SENT_43	[p3l204t123r433b202],
11	out	RP	O	out	prt	10	SENT_43	[p3l464t131r577b182],
12	methodology	NN	O	methodology	dobj	10	SENT_43	[p3l606t123r1083b202],
13	.	.	O	.	_	0	SENT_43	[p3l606t123r1083b202],

1	The	DT	O	the	det	2	SENT_44	[p3l1117t123r1245b182],
2	fragment	NN	O	fragment	nsubjpass	14	SENT_44	[p3l1275t123r1590b202],
3	containing	VBG	O	contain	partmod	2	SENT_44	[p3l1620t126r1984b202],
4	the	DT	O	the	det	6	SENT_44	[p3l2014t123r2119b182],
5	chromosomal	JJ	O	chromosomal	amod	6	SENT_44	[p3l11t218r481b278],
6	region	NN	O	region	dobj	3	SENT_44	[p3l522t221r743b299],
7	of	IN	O	of	_	0	SENT_44	[p3l784t218r852b278],
8	interest	NN	O	interest	prep_of	6	SENT_44	[p3l890t221r1144b278],
9	of	IN	O	of	_	0	SENT_44	[p3l1187t218r1255b278],
10	the	DT	O	the	det	12	SENT_44	[p3l1293t219r1398b278],
11	LIGT1/l1	NN	O	ligt1/l1	nn	12	SENT_44	[p3l1445t220r1733b278],
12	gene	NN	O	gene	prep_of	8	SENT_44	[p3l1782t239r1942b299],
13	was	VBD	O	be	auxpass	14	SENT_44	[p3l1982t239r2119b278],
14	amplified	VBN	O	amplify	_	0	SENT_44	[p3l11t315r340b396],
15	by	IN	O	by	_	0	SENT_44	[p3l383t316r471b396],
16	polymerase	NN	O	polymerase	nn	21	SENT_44	[p3l515t316r915b396],
17	chain	NN	O	chain	nn	21	SENT_44	[p3l961t316r1146b375],
18	reaction	NN	O	reaction	nn	21	SENT_44	[p3l1190t319r1467b375],
19	(	CD	NUMBER	(	num	21	SENT_44	[p3l1514t316r1734b391],
20	PCR	NN	O	pcr	nn	21	SENT_44	[p3l1514t316r1734b391],
21	)	NN	O	)	agent	14	SENT_44	[p3l1514t316r1734b391],
22	,	,	O	,	_	0	SENT_44	[p3l1514t316r1734b391],
23	using	VBG	O	use	partmod	21	SENT_44	[p3l1780t319r1970b396],
24	the	DT	O	the	det	25	SENT_44	[p3l2014t316r2119b375],
25	primers	NNS	O	primer	dobj	23	SENT_44	[p3l9t416r277b492],
26	described	VBN	O	describe	partmod	25	SENT_44	[p3l297t413r626b472],
27	by	IN	O	by	_	0	SENT_44	[p3l642t413r731b492],
28	Smiderle	NNP	O	Smiderle	agent	26	SENT_44	[p3l749t413r1053b472],
29	et	FW	O	et	nn	30	SENT_44	[p3l1071t419r1125b471],
30	al.	FW	O	al.	nsubjpass	38	SENT_44	[p3l1142t398r1245b471],
31	9	CD	NUMBER	9	dep	30	SENT_44	[p3l1142t398r1245b471],
32	The	DT	O	the	det	33	SENT_44	[p3l1264t412r1392b472],
33	size	NN	O	size	dep	30	SENT_44	[p3l1411t416r1540b472],
34	of	IN	O	of	_	0	SENT_44	[p3l1558t412r1627b472],
35	the	DT	O	the	det	36	SENT_44	[p3l1642t413r1747b472],
36	amplicons	NNS	O	amplicon	prep_of	33	SENT_44	[p3l1766t413r2118b492],
37	was	VBD	O	be	auxpass	38	SENT_44	[p3l9t529r146b568],
38	determined	VBN	O	determine	rcmod	25	SENT_44	[p3l197t509r592b568],
39	by	IN	O	by	_	0	SENT_44	[p3l641t509r729b589],
40	capillary	JJ	O	capillary	amod	41	SENT_44	[p3l778t509r1078b589],
41	electrophoresis	NN	O	electrophoresis	agent	38	SENT_44	[p3l1128t509r1645b589],
42	on	IN	O	on	_	0	SENT_44	[p3l1696t529r1782b568],
43	the	DT	O	the	det	45	SENT_44	[p3l1831t509r1936b568],
44	ABI	NNP	MISC	ABI	nn	45	SENT_44	[p3l1986t510r2119b567],
45	PRISM	NN	MISC	prism	prep_on	41	SENT_44	[p3l10t606r250b664],
46	310	CD	NUMBER	310	num	45	SENT_44	[p3l274t607r389b664],
47	Genetic	JJ	MISC	genetic	amod	51	SENT_44	[p3l415t606r674b664],
48	Analyzer	NNP	MISC	Analyzer	nn	51	SENT_44	[p3l699t605r1017b684],
49	(	NNP	O	(	nn	51	SENT_44	[p3l1044t605r1348b684],
50	Applied	NNP	MISC	Applied	nn	51	SENT_44	[p3l1044t605r1348b684],
51	Biosystems	NNP	MISC	Biosystems	tmod	23	SENT_44	[p3l1374t607r1776b684],
52	,	,	O	,	_	0	SENT_44	[p3l1374t607r1776b684],
53	USA	NNP	LOCATION	USA	appos	51	SENT_44	[p3l1802t605r2005b679],
54	)	CD	NUMBER	)	num	53	SENT_44	[p3l1802t605r2005b679],
55	.	.	O	.	_	0	SENT_44	[p3l1802t605r2005b679],

1	To	TO	O	to	aux	2	SENT_45	[p3l98t701r186b758],
2	check	VB	O	check	csubj	12	SENT_45	[p3l245t699r439b758],
3	whether	IN	O	whether	complm	7	SENT_45	[p3l494t699r780b758],
4	the	DT	O	the	det	6	SENT_45	[p3l838t699r943b758],
5	genotype	NN	O	genotype	nn	6	SENT_45	[p3l1002t707r1321b778],
6	frequencies	NNS	O	frequency	nsubj	7	SENT_45	[p3l1379t699r1769b778],
7	were	VBD	O	be	ccomp	2	SENT_45	[p3l1827t719r1996b758],
8	in	IN	O	in	_	0	SENT_45	[p3l2054t702r2121b757],
9	agreement	NN	O	agreement	prep_in	7	SENT_45	[p3l11t802r374b875],
10	with	IN	O	with	_	0	SENT_45	[p3l431t794r590b853],
11	those	DT	O	those	prep_with	9	SENT_45	[p3l648t794r829b854],
12	expected	VBN	O	expect	_	0	SENT_45	[p3l889t794r1192b875],
13	under	IN	O	under	_	0	SENT_45	[p3l1252t794r1458b854],
14	Hardy	NNP	PERSON	Hardy	prep_under	12	SENT_45	[p3l1517t794r2120b875],
15	.	.	O	.	_	0	SENT_45	[p3l1517t794r2120b875],

1	—	NN	O	—	_	0	SENT_46	[p3l1517t794r2120b875],
2	.	.	O	.	_	0	SENT_46	[p3l1517t794r2120b875],

1	Weinberg	NNP	PERSON	Weinberg	tmod	17	SENT_47	[p3l1517t794r2120b875],
2	equilibrium	NN	O	equilibrium	nn	5	SENT_47	[p3l11t892r416b972],
3	(	CD	NUMBER	(	num	5	SENT_47	[p3l450t892r707b967],
4	HWE	NN	O	hwe	nn	5	SENT_47	[p3l450t892r707b967],
5	)	NN	O	)	dep	1	SENT_47	[p3l450t892r707b967],
6	,	,	O	,	_	0	SENT_47	[p3l450t892r707b967],
7	the	DT	O	the	det	8	SENT_47	[p3l740t892r845b951],
8	Roff	NNP	PERSON	Roff	nsubjpass	17	SENT_47	[p3l878t891r1025b951],
9	and	CC	O	and	_	0	SENT_47	[p3l1055t892r1184b951],
10	Bentzen	NNP	PERSON	Bentzen	nn	15	SENT_47	[p3l1217t894r1493b951],
11	(	CD	NUMBER	(	num	15	SENT_47	[p3l1527t892r1729b967],
12	1989	CD	DATE	1989	num	15	SENT_47	[p3l1527t892r1729b967],
13	)	CD	NUMBER	)	num	15	SENT_47	[p3l1527t892r1729b967],
14	chi-square	JJ	O	chi-square	amod	15	SENT_47	[p3l1764t892r2119b972],
15	test	NN	O	test	nsubjpass	17	SENT_47	[p3l10t997r130b1048],
16	was	VBD	O	be	auxpass	17	SENT_47	[p3l156t1009r293b1048],
17	used	VBN	O	use	_	0	SENT_47	[p3l322t974r563b1048],
18	.10	CD	NUMBER	.10	dobj	17	SENT_47	[p3l322t974r563b1048],
19	Due	JJ	O	due	_	0	SENT_47	[p3l593t991r735b1048],
20	to	TO	O	to	_	0	SENT_47	[p3l764t997r829b1048],
21	their	PRP$	O	they	poss	23	SENT_47	[p3l858t988r1017b1048],
22	asymmetric	JJ	O	asymmetric	amod	23	SENT_47	[p3l1047t992r1447b1068],
23	distribution	NN	O	distribution	prep_due_to	18	SENT_47	[p3l1477t988r1900b1058],
24	,	,	O	,	_	0	SENT_47	[p3l1477t988r1900b1058],
25	mean	VB	O	mean	dep	17	SENT_47	[p3l1930t1009r2120b1048],
26	bilirubin	NN	O	bilirubin	nn	27	SENT_47	[p3l8t1085r308b1144],
27	levels	NNS	O	level	nsubjpass	29	SENT_47	[p3l324t1085r517b1145],
28	were	VBD	O	be	auxpass	29	SENT_47	[p3l533t1105r702b1145],
29	compared	VBN	O	compare	ccomp	25	SENT_47	[p3l720t1085r1065b1165],
30	among	IN	O	among	_	0	SENT_47	[p3l1084t1105r1321b1166],
31	genotypes	NNS	O	genotype	prep_among	29	SENT_47	[p3l1339t1093r1690b1166],
32	by	IN	O	by	_	0	SENT_47	[p3l1705t1085r1793b1166],
33	Kruskal	NNP	PERSON	Kruskal	nn	36	SENT_47	[p3l1809t1085r2120b1145],
34	—	NNP	O	—	nn	36	SENT_47	[p3l1809t1085r2120b1145],
35	Wallis	NNP	LOCATION	Wallis	nn	36	SENT_47	[p3l9t1182r226b1241],
36	tests	NNS	O	test	agent	29	SENT_47	[p3l253t1190r420b1241],
37	.	.	O	.	_	0	SENT_47	[p3l253t1190r420b1241],

1	Poisson	NNP	PERSON	Poisson	nn	3	SENT_48	[p3l451t1184r716b1241],
2	regression	NN	O	regression	nn	3	SENT_48	[p3l741t1185r1096b1261],
3	models	NNS	O	model	nsubjpass	8	SENT_48	[p3l1121t1182r1370b1241],
4	with	IN	O	with	_	0	SENT_48	[p3l1397t1182r1556b1240],
5	robust	JJ	O	robust	amod	6	SENT_48	[p3l1581t1182r1802b1241],
6	variance	NN	O	variance	prep_with	3	SENT_48	[p3l1827t1185r2119b1241],
7	were	VBD	O	be	auxpass	8	SENT_48	[p3l9t1296r178b1335],
8	used	VBN	O	use	_	0	SENT_48	[p3l208t1276r370b1335],
9	to	TO	O	to	aux	10	SENT_48	[p3l401t1284r466b1335],
10	assess	VB	O	assess	xcomp	8	SENT_48	[p3l498t1296r703b1335],
11	the	DT	O	the	det	13	SENT_48	[p3l734t1276r839b1335],
12	predictor	NN	O	predictor	nn	13	SENT_48	[p3l868t1276r1186b1355],
13	variables	NNS	O	variable	dobj	10	SENT_48	[p3l1214t1276r1525b1335],
14	for	IN	O	for	_	0	SENT_48	[p3l1555t1276r1652b1335],
15	the	DT	O	the	det	16	SENT_48	[p3l1682t1276r1787b1335],
16	development	NN	O	development	prep_for	10	SENT_48	[p3l1819t1276r2119b1355, p3l10t1379r186b1431],
17	of	IN	O	of	_	0	SENT_48	[p3l239t1371r307b1431],
18	severe	JJ	O	severe	amod	19	SENT_48	[p3l358t1391r573b1431],
19	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	16	SENT_48	[p3l626t1371r1311b1452],
20	.	.	O	.	_	0	SENT_48	[p3l626t1371r1311b1452],

1	The	DT	O	the	det	2	SENT_49	[p3l1368t1371r1495b1431],
2	variables	NNS	O	variable	nsubjpass	31	SENT_49	[p3l1548t1371r1858b1431],
3	ethnic	JJ	O	ethnic	amod	4	SENT_49	[p3l1912t1371r2119b1431],
4	group	NN	O	group	dep	2	SENT_49	[p3l11t1489r237b1548],
5	,	,	O	,	_	0	SENT_49	[p3l11t1489r237b1548],
6	gender	NN	O	gender	dep	2	SENT_49	[p3l269t1469r525b1548],
7	,	,	O	,	_	0	SENT_49	[p3l269t1469r525b1548],
8	indinavir	NN	O	indinavir	nn	9	SENT_49	[p3l556t1469r874b1527],
9	use	NN	O	use	dep	2	SENT_49	[p3l902t1489r1035b1538],
10	,	,	O	,	_	0	SENT_49	[p3l902t1489r1035b1538],
11	atazanavir	NN	O	atazanavir	nn	12	SENT_49	[p3l1067t1472r1430b1527],
12	use	NN	O	use	dep	2	SENT_49	[p3l1459t1489r1592b1538],
13	,	,	O	,	_	0	SENT_49	[p3l1459t1489r1592b1538],
14	age	NN	O	age	conj_and	4	SENT_49	[p3l1623t1489r1759b1548],
15	,	,	O	,	_	0	SENT_49	[p3l1623t1489r1759b1548],
16	and	CC	O	and	_	0	SENT_49	[p3l1790t1469r1919b1527],
17	presence	NN	O	presence	conj_and	4	SENT_49	[p3l1948t1489r2120b1548, p3l11t1583r162b1622],
18	of	IN	O	of	_	0	SENT_49	[p3l186t1563r254b1622],
19	the	DT	O	the	det	20	SENT_49	[p3l274t1563r379b1622],
20	LIGTIAI	NNP	O	LIGTIAI	prep_of	17	SENT_49	[p3l407t1564r694b1622],
21	*	CD	NUMBER	*	num	20	SENT_49	[p3l708t1564r809b1621],
22	28	CD	NUMBER	28	num	23	SENT_49	[p3l708t1564r809b1621],
23	allele	NN	O	allele	dep	2	SENT_49	[p3l835t1563r1012b1622],
24	were	VBD	O	be	auxpass	25	SENT_49	[p3l1034t1583r1203b1622],
25	included	VBN	O	include	_	0	SENT_49	[p3l1225t1563r1527b1622],
26	in	IN	O	in	_	0	SENT_49	[p3l1550t1566r1617b1621],
27	the	DT	O	the	det	29	SENT_49	[p3l1638t1563r1743b1622],
28	regression	NN	O	regression	nn	29	SENT_49	[p3l1766t1566r2121b1642],
29	model	NN	O	model	prep_in	25	SENT_49	[p3l10t1658r228b1718],
30	and	CC	O	and	_	0	SENT_49	[p3l259t1658r388b1717],
31	removed	VBD	O	remove	conj_and	25	SENT_49	[p3l419t1658r725b1718],
32	stepwise	JJ	O	stepwise	acomp	31	SENT_49	[p3l757t1661r1070b1739],
33	.	.	O	.	_	0	SENT_49	[p3l757t1661r1070b1739],

1	Only	RB	O	only	advmod	2	SENT_50	[p3l1105t1658r1277b1739],
2	those	DT	O	those	nsubjpass	8	SENT_50	[p3l1307t1658r1488b1718],
3	that	WDT	O	that	nsubj	6	SENT_50	[p3l1519t1658r1653b1717],
4	were	VBD	O	be	cop	6	SENT_50	[p3l1682t1678r1851b1718],
5	significant	JJ	O	significant	amod	6	SENT_50	[p3l1883t1658r2119b1739, p3l11t1763r154b1814],
6	predictors	NNS	O	predictor	rcmod	2	SENT_50	[p3l181t1754r530b1835],
7	were	VBD	O	be	auxpass	8	SENT_50	[p3l559t1774r728b1814],
8	kept	VBN	O	keep	_	0	SENT_50	[p3l757t1754r909b1835],
9	in	IN	O	in	_	0	SENT_50	[p3l937t1757r1004b1813],
10	the	DT	O	the	det	12	SENT_50	[p3l1032t1754r1137b1814],
11	final	JJ	O	final	amod	12	SENT_50	[p3l1166t1754r1319b1813],
12	model	NN	O	model	prep_in	8	SENT_50	[p3l1348t1754r1581b1814],
13	.	.	O	.	_	0	SENT_50	[p3l1348t1754r1581b1814],

1	Statistical	JJ	O	statistical	amod	2	SENT_51	[p3l1614t1754r1943b1814],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_51	[p3l1973t1774r2120b1813, p3l10t1850r176b1929],
3	were	VBD	O	be	auxpass	4	SENT_51	[p3l225t1870r394b1909],
4	performed	VBN	O	perform	_	0	SENT_51	[p3l442t1850r808b1929],
5	with	IN	O	with	_	0	SENT_51	[p3l857t1850r1016b1908],
6	Statistical	JJ	O	statistical	amod	7	SENT_51	[p3l1063t1850r1392b1909],
7	Package	NN	O	package	prep_with	4	SENT_51	[p3l1442t1850r1724b1929],
8	for	IN	O	for	_	0	SENT_51	[p3l1774t1850r1870b1909],
9	Social	NNP	O	Social	nn	11	SENT_51	[p3l1919t1850r2120b1909],
10	Sciences	NNPS	O	Sciences	nn	11	SENT_51	[p3l10t1946r292b2005],
11	Version	NNP	O	Version	prep_for	7	SENT_51	[p3l326t1948r594b2005],
12	16.0	CD	NUMBER	16.0	number	13	SENT_51	[p3l630t1948r762b2005],
13	(	CD	NUMBER	(	num	14	SENT_51	[p3l799t1945r1009b2020],
14	SPSS	NNS	ORGANIZATION	spss	dep	11	SENT_51	[p3l799t1945r1009b2020],
15	,	,	O	,	_	0	SENT_51	[p3l799t1945r1009b2020],
16	Chicago	NNP	LOCATION	Chicago	appos	11	SENT_51	[p3l1043t1945r1344b2026],
17	,	,	O	,	_	0	SENT_51	[p3l1043t1945r1344b2026],
18	IL	NN	LOCATION	il	nn	19	SENT_51	[p3l1379t1945r1493b2020],
19	)	NN	O	)	appos	16	SENT_51	[p3l1379t1945r1493b2020],
20	.	.	O	.	_	0	SENT_51	[p3l1379t1945r1493b2020],

1	Differences	NNS	O	difference	nsubjpass	3	SENT_52	[p3l1530t1945r1916b2005],
2	were	VBD	O	be	auxpass	3	SENT_52	[p3l1950t1965r2119b2005],
3	considered	VBN	O	consider	_	0	SENT_52	[p3l11t2041r385b2101],
4	significant	JJ	O	significant	dobj	3	SENT_52	[p3l412t2041r768b2122],
5	when	WRB	O	when	advmod	7	SENT_52	[p3l792t2041r985b2101],
6	p	NN	O	p	dep	7	SENT_52	[p3l1006t2060r1044b2121],
7	<	JJR	O	<	dep	4	SENT_52	[p3l1062t2058r1102b2099],
8	0.05	CD	NUMBER	0.05	advmod	3	SENT_52	[p3l1119t2044r1270b2101],
9	.	.	O	.	_	0	SENT_52	[p3l1119t2044r1270b2101],

1	We	PRP	O	we	nsubj	2	SENT_53	[p3l97t2139r212b2196],
2	analyzed	VBD	O	analyze	_	0	SENT_53	[p3l233t2137r544b2216],
3	a	DT	O	a	det	4	SENT_53	[p3l566t2157r601b2195],
4	total	NN	O	total	dobj	2	SENT_53	[p3l622t2137r776b2196],
5	of	IN	O	of	_	0	SENT_53	[p3l797t2137r865b2196],
6	375	CD	NUMBER	375	num	8	SENT_53	[p3l881t2140r996b2196],
7	HIV-infected	JJ	O	hiv-infected	amod	8	SENT_53	[p3l1019t2137r1464b2196],
8	individuals	NNS	O	individual	prep_of	4	SENT_53	[p3l1486t2137r1893b2196],
9	:	:	O	:	_	0	SENT_53	[p3l1486t2137r1893b2196],
10	60.3	CD	PERCENT	60.3	num	11	SENT_53	[p3l1918t2138r2118b2196],
11	%	NN	PERCENT	%	nsubj	13	SENT_53	[p3l1918t2138r2118b2196],
12	were	VBD	O	be	cop	13	SENT_53	[p3l9t2253r178b2293],
13	Euro	NNP	O	Euro	parataxis	2	SENT_53	[p3l222t2233r754b2293],
14	.	.	O	.	_	0	SENT_53	[p3l222t2233r754b2293],

1	—	NN	O	—	_	0	SENT_54	[p3l222t2233r754b2293],
2	.	.	O	.	_	0	SENT_54	[p3l222t2233r754b2293],

1	Brazilians	NNS	MISC	brazilian	nsubj	7	SENT_55	[p3l222t2233r754b2293],
2	and	CC	O	and	_	0	SENT_55	[p3l799t2233r927b2292],
3	39.7	CD	PERCENT	39.7	number	4	SENT_55	[p3l971t2234r1172b2293],
4	%	NN	PERCENT	%	num	5	SENT_55	[p3l971t2234r1172b2293],
5	Afro-Brazilians	NNS	MISC	afro-brazilian	conj_and	1	SENT_55	[p3l1216t2233r1760b2303],
6	,	,	O	,	_	0	SENT_55	[p3l1216t2233r1760b2303],
7	classified	VBN	O	classify	_	0	SENT_55	[p3l1805t2233r2118b2293],
8	according	VBG	O	accord	_	0	SENT_55	[p3l11t2330r350b2410],
9	to	TO	O	to	prepc_according_to	7	SENT_55	[p3l379t2338r444b2389],
10	the	DT	O	the	det	12	SENT_55	[p3l475t2330r580b2389],
11	phenotypic	JJ	O	phenotypic	amod	12	SENT_55	[p3l610t2330r998b2410],
12	definition	NN	O	definition	pobj	7	SENT_55	[p3l1031t2330r1365b2389],
13	by	IN	O	by	_	0	SENT_55	[p3l1391t2330r1479b2410],
14	the	DT	O	the	det	15	SENT_55	[p3l1509t2330r1614b2389],
15	interviewer	NN	O	interviewer	prep_by	12	SENT_55	[p3l1644t2316r2116b2389],
16	.	.	O	.	_	0	SENT_55	[p3l1644t2316r2116b2389],

1	“	NN	O	“	nn	2	SENT_56	[p3l1644t2316r2116b2389],
2	Males	NNS	O	male	nsubj	3	SENT_56	[p3l10t2425r213b2484],
3	comprised	VBN	O	comprise	_	0	SENT_56	[p3l250t2425r611b2504],
4	54.4	CD	NUMBER	54.4	number	5	SENT_56	[p3l647t2426r849b2484],
5	°	CD	NUMBER	°	dobj	3	SENT_56	[p3l647t2426r849b2484],
6	/	:	O	/	punct	7	SENT_56	[p3l647t2426r849b2484],
7	o	NN	O	o	dep	5	SENT_56	[p3l647t2426r849b2484],
8	of	IN	O	of	_	0	SENT_56	[p3l886t2425r954b2484],
9	our	PRP$	O	we	poss	10	SENT_56	[p3l987t2445r1105b2484],
10	sample	NN	O	sample	prep_of	5	SENT_56	[p3l1141t2425r1402b2504],
11	.	.	O	.	_	0	SENT_56	[p3l1141t2425r1402b2504],

1	The	DT	O	the	det	3	SENT_57	[p3l1442t2425r1569b2484],
2	mean	NN	O	mean	nn	3	SENT_57	[p3l1605t2445r1796b2484],
3	age	NN	O	age	nsubj	5	SENT_57	[p3l1831t2445r1948b2504],
4	was	VBD	O	be	cop	5	SENT_57	[p3l1982t2445r2119b2484],
5	43.2	CD	NUMBER	43.2	_	0	SENT_57	[p3l9t2522r145b2580],
6	i	FW	O	i	dep	5	SENT_57	[p3l161t2526r203b2578],
7	9.6	CD	DURATION	9.6	num	8	SENT_57	[p3l219t2523r314b2580],
8	years	NNS	NUMBER	year	tmod	5	SENT_57	[p3l342t2540r540b2601],
9	.	.	O	.	_	0	SENT_57	[p3l342t2540r540b2601],

1	The	DT	O	the	det	3	SENT_58	[p3l571t2520r698b2580],
2	median	JJ	O	median	amod	3	SENT_58	[p3l726t2520r986b2580],
3	time	NN	O	time	nsubj	8	SENT_58	[p3l1012t2523r1163b2580],
4	on	IN	O	on	_	0	SENT_58	[p3l1192t2540r1278b2580],
5	antiretrovirals	NNS	O	antiretroviral	prep_on	3	SENT_58	[p3l1305t2520r1792b2580],
6	was	VBD	O	be	cop	8	SENT_58	[p3l1819t2540r1956b2580],
7	58.0	CD	DURATION	58.0	num	8	SENT_58	[p3l1983t2523r2118b2580],
8	months	NNS	NUMBER	month	_	0	SENT_58	[p3l10t2616r268b2676],
9	(	RB	O	(	advmod	10	SENT_58	[p3l316t2616r764b2697],
10	interquartile	JJ	O	interquartile	amod	11	SENT_58	[p3l316t2616r764b2697],
11	range	NN	O	range	attr	8	SENT_58	[p3l809t2636r1021b2697],
12	,	,	O	,	_	0	SENT_58	[p3l809t2636r1021b2697],
13	IQR	NN	O	iqr	appos	11	SENT_58	[p3l1066t2617r1223b2688],
14	,	,	O	,	_	0	SENT_58	[p3l1066t2617r1223b2688],
15	34	CD	DURATION	34	number	17	SENT_58	[p3l1268t2619r1344b2676],
16	to	TO	DURATION	to	dep	17	SENT_58	[p3l1389t2625r1454b2676],
17	105	CD	DURATION	105	num	18	SENT_58	[p3l1501t2619r1613b2676],
18	months	NNS	NUMBER	month	tmod	19	SENT_58	[p3l1658t2616r1958b2691],
19	)	RB	O	)	amod	11	SENT_58	[p3l1658t2616r1958b2691],
20	.	.	O	.	_	0	SENT_58	[p3l1658t2616r1958b2691],

1	Regarding	VBG	O	regard	_	0	SENT_59	[p3l2007t2619r2119b2676, p3l11t2712r281b2791],
2	treatment	NN	O	treatment	prep_regarding	12	SENT_59	[p3l311t2720r662b2781],
3	,	,	O	,	_	0	SENT_59	[p3l311t2720r662b2781],
4	51.7	CD	PERCENT	51.7	num	5	SENT_59	[p3l693t2713r894b2771],
5	%	NN	PERCENT	%	nsubj	12	SENT_59	[p3l693t2713r894b2771],
6	were	VBD	O	be	cop	12	SENT_59	[p3l923t2732r1092b2771],
7	protease	NN	O	protease	nn	12	SENT_59	[p3l1122t2720r1412b2791],
8	inhibitor	NN	O	inhibitor	nn	12	SENT_59	[p3l1443t2712r1741b2771],
9	(	NN	O	(	nn	12	SENT_59	[p3l1773t2712r1889b2786],
10	PI	NN	O	pi	nn	12	SENT_59	[p3l1773t2712r1889b2786],
11	)	NN	O	)	nn	12	SENT_59	[p3l1773t2712r1889b2786],
12	users	NNS	O	user	_	0	SENT_59	[p3l1921t2732r2115b2771],
13	.	.	O	.	_	0	SENT_59	[p3l1921t2732r2115b2771],

1	ATV	NN	O	atv	nn	2	SENT_60	[p3l10t2809r174b2866],
2	users	NNS	O	user	nsubj	15	SENT_60	[p3l193t2827r371b2867],
3	comprised	VBN	O	comprise	partmod	2	SENT_60	[p3l391t2807r752b2888],
4	25.1	CD	PERCENT	25.1	num	5	SENT_60	[p3l772t2808r973b2867],
5	%	NN	PERCENT	%	dobj	3	SENT_60	[p3l772t2808r973b2867],
6	(	CD	NUMBER	(	number	7	SENT_60	[p3l997t2807r1119b2882],
7	94	CD	NUMBER	94	num	8	SENT_60	[p3l997t2807r1119b2882],
8	)	NN	O	)	tmod	3	SENT_60	[p3l997t2807r1119b2882],
9	of	IN	O	of	_	0	SENT_60	[p3l1143t2807r1211b2867],
10	our	PRP$	O	we	poss	11	SENT_60	[p3l1228t2827r1345b2867],
11	sample	NN	O	sample	prep_of	8	SENT_60	[p3l1365t2807r1610b2887],
12	and	CC	O	and	_	0	SENT_60	[p3l1631t2807r1760b2866],
13	IDV	NN	ORGANIZATION	idv	nn	14	SENT_60	[p3l1780t2809r1922b2866],
14	users	NNS	O	user	conj_and	11	SENT_60	[p3l1941t2827r2119b2867],
15	comprised	VBN	O	comprise	_	0	SENT_60	[p3l11t2903r372b2984],
16	1.6	CD	PERCENT	1.6	num	17	SENT_60	[p3l400t2904r558b2963],
17	%	NN	PERCENT	%	dobj	15	SENT_60	[p3l400t2904r558b2963],
18	(	CD	NUMBER	(	number	19	SENT_60	[p3l587t2903r688b2978],
19	6	CD	NUMBER	6	num	20	SENT_60	[p3l587t2903r688b2978],
20	)	NN	O	)	dep	17	SENT_60	[p3l587t2903r688b2978],
21	.	.	O	.	_	0	SENT_60	[p3l587t2903r688b2978],

1	UGT1/l1	NN	O	ugt1/l1	nn	3	SENT_61	[p3l103t3001r391b3059],
2	allele	NN	O	allele	nn	3	SENT_61	[p3l437t2999r613b3059],
3	frequencies	NNS	O	frequency	nsubj	5	SENT_61	[p3l652t2999r1042b3080],
4	were	VBD	O	be	cop	5	SENT_61	[p3l1080t3020r1250b3059],
5	0.015	CD	NUMBER	0.015	_	0	SENT_61	[p3l1288t3002r1482b3070],
6	,	,	O	,	_	0	SENT_61	[p3l1288t3002r1482b3070],
7	0.665	CD	NUMBER	0.665	appos	5	SENT_61	[p3l1522t3002r1716b3070],
8	,	,	O	,	_	0	SENT_61	[p3l1522t3002r1716b3070],
9	0.306	CD	NUMBER	0.306	num	7	SENT_61	[p3l1756t3002r1950b3070],
10	,	,	O	,	_	0	SENT_61	[p3l1756t3002r1950b3070],
11	and	CC	O	and	_	0	SENT_61	[p3l1990t3000r2119b3059],
12	0.014	CD	NUMBER	0.014	conj_and	7	SENT_61	[p3l11t3097r185b3154],
13	for	IN	O	for	_	0	SENT_61	[p3l211t3095r308b3154],
14	alleles	NNS	O	allele	nn	15	SENT_61	[p3l334t3095r543b3154],
15	TA5	NN	O	ta5	prep_for	7	SENT_61	[p3l569t3097r704b3167],
16	(	CD	NUMBER	(	number	17	SENT_61	[p3l734t3095r907b3169],
17	*	CD	NUMBER	*	dep	15	SENT_61	[p3l734t3095r907b3169],
18	36	CD	NUMBER	36	num	19	SENT_61	[p3l734t3095r907b3169],
19	)	NN	O	)	dep	17	SENT_61	[p3l734t3095r907b3169],
20	,	,	O	,	_	0	SENT_61	[p3l734t3095r907b3169],
21	TA6	NN	O	ta6	nn	23	SENT_61	[p3l934t3097r1070b3167],
22	(	CD	NUMBER	(	num	23	SENT_61	[p3l1099t3095r1149b3169],
23	*	NN	O	*	prep_for	7	SENT_61	[p3l1099t3095r1149b3169],
24	1	CD	NUMBER	1	num	25	SENT_61	[p3l1155t3095r1233b3169],
25	)	NN	O	)	dep	23	SENT_61	[p3l1155t3095r1233b3169],
26	,	,	O	,	_	0	SENT_61	[p3l1155t3095r1233b3169],
27	TA7	NN	O	ta7	prep_for	7	SENT_61	[p3l1259t3097r1397b3166],
28	(	CD	NUMBER	(	num	27	SENT_61	[p3l1424t3095r1597b3169],
29	*	CD	NUMBER	*	number	30	SENT_61	[p3l1424t3095r1597b3169],
30	28	CD	NUMBER	28	num	31	SENT_61	[p3l1424t3095r1597b3169],
31	)	NN	O	)	dep	27	SENT_61	[p3l1424t3095r1597b3169],
32	,	,	O	,	_	0	SENT_61	[p3l1424t3095r1597b3169],
33	and	CC	O	and	_	0	SENT_61	[p3l1625t3095r1754b3154],
34	TA8	NN	O	ta8	nn	36	SENT_61	[p3l1780t3097r1915b3167],
35	(	CD	NUMBER	(	num	36	SENT_61	[p3l1944t3095r2118b3169],
36	*	NN	O	*	prep_for	7	SENT_61	[p3l1944t3095r2118b3169],
37	37	CD	NUMBER	37	num	38	SENT_61	[p3l1944t3095r2118b3169],
38	)	NN	O	)	dep	36	SENT_61	[p3l1944t3095r2118b3169],
39	,	,	O	,	_	0	SENT_61	[p3l1944t3095r2118b3169],

1	respectively	RB	O	respectively	_	0	SENT_62	[p4l80t86r500b164],
2	.	.	O	.	_	0	SENT_62	[p4l80t86r500b164],

1	Genotype	NN	O	genotype	nn	2	SENT_63	[p4l533t87r863b164],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_63	[p4l893t85r1275b164],
3	were	VBD	O	be	auxpass	4	SENT_63	[p4l1304t105r1470b144],
4	distributed	VBN	O	distribute	_	0	SENT_63	[p4l1501t85r1872b144],
5	according	VBG	O	accord	_	0	SENT_63	[p4l1902t86r2150b144, p4l80t183r187b258],
6	to	TO	O	to	prepc_according_to	4	SENT_63	[p4l219t188r283b238],
7	those	DT	O	those	pobj	4	SENT_63	[p4l317t180r494b238],
8	expected	VBN	O	expect	partmod	7	SENT_63	[p4l527t180r825b258],
9	under	IN	O	under	_	0	SENT_63	[p4l858t180r1060b238],
10	HWE	NNP	O	HWE	prep_under	8	SENT_63	[p4l1092t181r1294b237],
11	.	.	O	.	_	0	SENT_63	[p4l1092t181r1294b237],

1	The	DT	O	the	det	4	SENT_64	[p4l1330t180r1455b238],
2	observed	VBN	O	observe	amod	4	SENT_64	[p4l1489t180r1795b238],
3	allele	NN	O	allele	nn	4	SENT_64	[p4l1830t180r2003b238],
4	frequencies	NNS	O	frequency	nsubj	8	SENT_64	[p4l2036t179r2151b238, p4l81t277r371b352],
5	were	VBD	O	be	cop	8	SENT_64	[p4l423t294r589b332],
6	not	RB	O	not	neg	8	SENT_64	[p4l640t282r751b332],
7	significantly	RB	O	significantly	advmod	8	SENT_64	[p4l803t273r1218b352],
8	different	JJ	O	different	_	0	SENT_64	[p4l1271t273r1559b332],
9	between	IN	O	between	_	0	SENT_64	[p4l1608t274r1895b332],
10	ethnic	JJ	O	ethnic	amod	11	SENT_64	[p4l1947t274r2150b332],
11	groups	NNS	O	group	prep_between	8	SENT_64	[p4l81t387r332b446],
12	.	.	O	.	_	0	SENT_64	[p4l81t387r332b446],

1	On	IN	O	on	_	0	SENT_65	[p4l363t369r467b426],
2	the	DT	O	the	det	4	SENT_65	[p4l491t368r595b426],
3	375	CD	NUMBER	375	num	4	SENT_65	[p4l620t370r733b426],
4	patients	NNS	O	patient	prep_on	12	SENT_65	[p4l759t370r1028b446],
5	evaluated	VBD	O	evaluate	partmod	4	SENT_65	[p4l1055t367r1404b436],
6	,	,	O	,	_	0	SENT_65	[p4l1055t367r1404b436],
7	the	DT	O	the	det	8	SENT_65	[p4l1432t368r1535b426],
8	majority	NN	O	majority	nsubj	12	SENT_65	[p4l1561t370r1846b446],
9	of	IN	O	of	_	0	SENT_65	[p4l1872t367r1939b426],
10	genotypes	NNS	O	genotype	prep_of	8	SENT_65	[p4l1963t387r2150b446, p4l80t470r260b540],
11	were	VBD	O	be	cop	12	SENT_65	[p4l276t482r442b520],
12	TA6	NN	O	ta6	_	0	SENT_65	[p4l460t464r593b532],
13	/	:	O	/	punct	14	SENT_65	[p4l601t462r634b528],
14	TA6	NN	O	ta6	dep	12	SENT_65	[p4l642t463r795b532],
15	,	,	O	,	_	0	SENT_65	[p4l642t463r795b532],
16	TA6	NN	O	ta6	appos	14	SENT_65	[p4l812t464r945b532],
17	/	:	O	/	punct	14	SENT_65	[p4l954t462r1147b531],
18	TA7	NN	O	ta7	dep	12	SENT_65	[p4l954t462r1147b531],
19	,	,	O	,	_	0	SENT_65	[p4l954t462r1147b531],
20	and	CC	O	and	_	0	SENT_65	[p4l1167t462r1293b519],
21	TA7	NN	O	ta7	conj_and	12	SENT_65	[p4l1310t462r1485b531],
22	/	:	O	/	punct	26	SENT_65	[p4l1310t462r1485b531],
23	TA7	NN	O	ta7	dep	26	SENT_65	[p4l1493t464r1628b531],
24	(	CD	NUMBER	(	number	25	SENT_65	[p4l1646t462r1708b535],
25	11	CD	NUMBER	11	npadvmod	26	SENT_65	[p4l1646t462r1708b535],
26	=	JJ	O	=	dep	21	SENT_65	[p4l1724t488r1765b508],
27	353	CD	NUMBER	353	num	28	SENT_65	[p4l1780t462r1936b535],
28	)	NN	O	)	dep	21	SENT_65	[p4l1780t462r1936b535],
29	.	.	O	.	_	0	SENT_65	[p4l1780t462r1936b535],

1	Other	JJ	O	other	amod	3	SENT_66	[p4l1956t462r2151b520],
2	genotypic	JJ	O	genotypic	amod	3	SENT_66	[p4l81t558r412b633],
3	combinations	NNS	O	combination	nsubj	11	SENT_66	[p4l453t555r908b613],
4	of	IN	O	of	_	0	SENT_66	[p4l949t555r1016b613],
5	TA5	NN	O	ta5	nn	8	SENT_66	[p4l1052t557r1185b626],
6	and	CC	O	and	_	0	SENT_66	[p4l1227t555r1353b612],
7	TA8	NN	O	ta8	nn	8	SENT_66	[p4l1393t557r1526b626],
8	alleles	NNS	O	allele	prep_of	3	SENT_66	[p4l1567t555r1772b613],
9	were	VBD	O	be	cop	11	SENT_66	[p4l1812t575r1978b613],
10	also	RB	O	also	advmod	11	SENT_66	[p4l2019t555r2150b613],
11	present	JJ	DATE	present	_	0	SENT_66	[p4l79t658r346b728],
12	,	,	O	,	_	0	SENT_66	[p4l79t658r346b728],
13	but	CC	O	but	_	0	SENT_66	[p4l364t650r479b707],
14	the	DT	O	the	det	16	SENT_66	[p4l498t650r601b708],
15	rarer	JJR	O	rarer	amod	16	SENT_66	[p4l620t669r783b708],
16	TA5	NN	O	ta5	nsubjpass	26	SENT_66	[p4l802t651r934b720],
17	/	:	O	/	punct	18	SENT_66	[p4l943t649r977b716],
18	TA5	NN	O	ta5	dep	16	SENT_66	[p4l985t651r1117b720],
19	and	CC	O	and	_	0	SENT_66	[p4l1138t650r1265b707],
20	TA8	NN	O	ta8	conj_and	18	SENT_66	[p4l1284t651r1417b720],
21	/	:	O	/	punct	18	SENT_66	[p4l1426t649r1459b716],
22	TA8	NN	O	ta8	nn	23	SENT_66	[p4l1467t651r1600b720],
23	genotypes	NNS	O	genotype	dep	16	SENT_66	[p4l1621t658r1966b728],
24	were	VBD	O	be	auxpass	26	SENT_66	[p4l1984t669r2150b708],
25	not	RB	O	not	neg	26	SENT_66	[p4l79t752r190b802],
26	observed	VBN	O	observe	conj_but	11	SENT_66	[p4l210t744r532b802],
27	.	.	O	.	_	0	SENT_66	[p4l210t744r532b802],

1	Due	JJ	O	due	_	0	SENT_67	[p4l556t746r696b802],
2	to	TO	O	to	_	0	SENT_67	[p4l715t752r779b802],
3	the	DT	O	the	det	5	SENT_67	[p4l799t744r903b802],
4	small	JJ	O	small	amod	5	SENT_67	[p4l923t744r1104b802],
5	number	NN	O	number	prep_due_to	19	SENT_67	[p4l1121t744r1388b802],
6	of	IN	O	of	_	0	SENT_67	[p4l1408t743r1475b802],
7	individuals	NNS	O	individual	prep_of	5	SENT_67	[p4l1491t744r1875b802],
8	bearing	VBG	O	bear	partmod	7	SENT_67	[p4l1893t744r2151b822],
9	TA5	NN	O	ta5	nn	12	SENT_67	[p4l80t839r213b908],
10	and	CC	O	and	_	0	SENT_67	[p4l258t837r385b895],
11	TA8	NN	O	ta8	nn	12	SENT_67	[p4l428t839r561b908],
12	alleles	NNS	O	allele	dobj	8	SENT_67	[p4l606t837r831b906],
13	,	,	O	,	_	0	SENT_67	[p4l606t837r831b906],
14	these	DT	O	these	det	17	SENT_67	[p4l875t837r1047b895],
15	rare	JJ	O	rare	amod	17	SENT_67	[p4l1092t857r1224b895],
16	allele	NN	O	allele	nn	17	SENT_67	[p4l1269t837r1442b895],
17	combinations	NNS	O	combination	nsubjpass	19	SENT_67	[p4l1486t837r1941b896],
18	were	VBD	O	be	auxpass	19	SENT_67	[p4l1984t857r2150b895],
19	excluded	VBN	O	exclude	_	0	SENT_67	[p4l80t932r385b990],
20	from	IN	O	from	_	0	SENT_67	[p4l415t931r578b990],
21	the	DT	O	the	det	23	SENT_67	[p4l605t932r708b990],
22	association	NN	O	association	nn	23	SENT_67	[p4l738t934r1110b990],
23	analysis	NN	O	analysis	prep_from	19	SENT_67	[p4l1138t931r1424b1010],
24	.	.	O	.	_	0	SENT_67	[p4l1138t931r1424b1010],

1	A	DT	O	a	det	3	SENT_68	[p4l1455t933r1514b988],
2	previous	JJ	O	previous	amod	3	SENT_68	[p4l1541t934r1837b1010],
3	study	NN	O	study	ccomp	27	SENT_68	[p4l1867t932r2058b1010],
4	of	IN	O	of	_	0	SENT_68	[p4l2086t931r2153b990],
5	UGTIAI	NNP	O	UGTIAI	prep_of	3	SENT_68	[p4l85t1027r367b1084],
6	(	CD	NUMBER	(	num	5	SENT_68	[p4l412t1026r594b1099],
7	TA	NNP	O	TA	nn	8	SENT_68	[p4l412t1026r594b1099],
8	)	NNP	O	)	dep	3	SENT_68	[p4l412t1026r594b1099],
9	,	,	O	,	_	0	SENT_68	[p4l412t1026r594b1099],
10	,	,	O	,	_	0	SENT_68	[p4l412t1026r594b1099],
11	polymorphism	NN	O	polymorphism	nsubj	27	SENT_68	[p4l629t1026r1135b1104],
12	performed	VBN	O	perform	dep	11	SENT_68	[p4l1167t1025r1526b1104],
13	in	IN	O	in	_	0	SENT_68	[p4l1562t1029r1627b1083],
14	the	DT	O	the	det	17	SENT_68	[p4l1660t1026r1763b1084],
15	same	JJ	O	same	amod	17	SENT_68	[p4l1799t1046r1971b1084],
16	geographic	JJ	O	geographic	amod	17	SENT_68	[p4l2007t1046r2151b1104, p4l81t1121r335b1199],
17	region	NN	O	region	prep_in	12	SENT_68	[p4l361t1124r578b1199],
18	but	CC	O	but	_	0	SENT_68	[p4l600t1121r715b1178],
19	regarding	VBG	O	regard	dep	11	SENT_68	[p4l740t1121r1072b1199],
20	hemolytic	JJ	O	hemolytic	amod	22	SENT_68	[p4l1096t1121r1430b1199],
21	anemia	NN	O	anemia	nn	22	SENT_68	[p4l1458t1124r1703b1179],
22	patients	NNS	O	patient	dobj	19	SENT_68	[p4l1727t1124r1996b1199],
23	and	CC	O	and	_	0	SENT_68	[p4l2023t1121r2150b1178],
24	healthy	JJ	O	healthy	amod	25	SENT_68	[p4l79t1247r332b1326],
25	controls	NNS	O	control	dobj	19	SENT_68	[p4l374t1234r701b1305],
26	”	RB	O	”	advmod	27	SENT_68	[p4l374t1234r701b1305],
27	found	VBD	O	find	_	0	SENT_68	[p4l743t1247r944b1305],
28	allelic	JJ	O	allelic	amod	31	SENT_68	[p4l988t1247r1180b1305],
29	and	CC	O	and	_	0	SENT_68	[p4l1223t1247r1350b1305],
30	genotypic	JJ	O	genotypic	conj_and	28	SENT_68	[p4l1392t1250r1724b1326],
31	frequencies	NNS	O	frequency	dobj	27	SENT_68	[p4l1767t1247r2149b1326],
32	similar	JJ	O	similar	amod	31	SENT_68	[p4l81t1341r313b1399],
33	to	TO	O	to	_	0	SENT_68	[p4l337t1349r400b1399],
34	those	DT	O	those	prep_to	32	SENT_68	[p4l425t1341r603b1399],
35	found	VBN	O	find	partmod	34	SENT_68	[p4l628t1340r829b1399],
36	herein	RB	O	herein	advmod	35	SENT_68	[p4l853t1341r1081b1399],
37	.	.	O	.	_	0	SENT_68	[p4l853t1341r1081b1399],

1	The	DT	O	the	det	2	SENT_69	[p4l166t1433r291b1491],
2	medians	NNS	O	median	nsubjpass	19	SENT_69	[p4l327t1433r613b1491],
3	of	IN	O	of	_	0	SENT_69	[p4l651t1433r718b1491],
4	total	JJ	O	total	amod	8	SENT_69	[p4l750t1433r901b1491],
5	and	CC	O	and	_	0	SENT_69	[p4l937t1433r1064b1490],
6	indirect	JJ	O	indirect	amod	8	SENT_69	[p4l1100t1433r1359b1491],
7	bilirubin	NN	O	bilirubin	nn	8	SENT_69	[p4l1391t1433r1687b1490],
8	levels	NNS	O	level	prep_of	2	SENT_69	[p4l1721t1433r1911b1491],
9	in	IN	O	in	_	0	SENT_69	[p4l1947t1436r2012b1490],
10	the	DT	O	the	det	12	SENT_69	[p4l2047t1433r2150b1491],
11	whole	JJ	O	whole	amod	12	SENT_69	[p4l79t1527r287b1585],
12	sample	NN	O	sample	prep_in	8	SENT_69	[p4l311t1527r551b1606],
13	and	CC	O	and	_	0	SENT_69	[p4l576t1527r702b1585],
14	among	IN	O	among	_	0	SENT_69	[p4l727t1547r960b1606],
15	the	DT	O	the	det	17	SENT_69	[p4l983t1527r1086b1585],
16	common	JJ	O	common	amod	17	SENT_69	[p4l1110t1547r1407b1585],
17	genotypes	NNS	O	genotype	prep_among	8	SENT_69	[p4l1430t1535r1774b1606],
18	are	VBP	O	be	auxpass	19	SENT_69	[p4l1799t1547r1901b1585],
19	shown	VBN	O	show	_	0	SENT_69	[p4l1925t1527r2152b1585],
20	in	IN	O	in	_	0	SENT_69	[p4l80t1625r145b1679],
21	Table	NNP	O	Table	prep_in	19	SENT_69	[p4l165t1622r349b1680],
22	1	CD	NUMBER	1	num	21	SENT_69	[p4l373t1624r422b1679],
23	.	.	O	.	_	0	SENT_69	[p4l373t1624r422b1679],

1	Bilirubin	NN	O	bilirubin	nn	2	SENT_70	[p4l448t1622r744b1679],
2	levels	NNS	O	level	nsubj	5	SENT_70	[p4l763t1622r953b1680],
3	were	VBD	O	be	cop	5	SENT_70	[p4l973t1642r1140b1680],
4	not	RB	O	not	neg	5	SENT_70	[p4l1160t1630r1271b1680],
5	different	JJ	O	different	_	0	SENT_70	[p4l1293t1621r1581b1680],
6	among	IN	O	among	_	0	SENT_70	[p4l1602t1642r1836b1700],
7	the	DT	O	the	det	9	SENT_70	[p4l1856t1622r1959b1680],
8	three	CD	NUMBER	three	num	9	SENT_70	[p4l1980t1622r2150b1680],
9	genotypes	NNS	O	genotype	prep_among	5	SENT_70	[p4l81t1723r442b1793],
10	.	.	O	.	_	0	SENT_70	[p4l81t1723r442b1793],

1	According	VBG	O	accord	_	0	SENT_71	[p4l166t1809r520b1888],
2	to	TO	O	to	prepc_according_to	12	SENT_71	[p4l574t1817r638b1867],
3	the	DT	O	the	det	6	SENT_71	[p4l692t1809r796b1867],
4	AIDS	NNP	MISC	AIDS	nn	6	SENT_71	[p4l850t1810r1034b1867],
5	Clinical	JJ	MISC	clinical	amod	6	SENT_71	[p4l1089t1809r1346b1867],
6	Trials	NNPS	MISC	Trials	pobj	12	SENT_71	[p4l1400t1809r1588b1867],
7	Group	NNP	MISC	Group	dep	6	SENT_71	[p4l1643t1810r1882b1888],
8	,	,	O	,	_	0	SENT_71	[p4l1643t1810r1882b1888],
9	severe	JJ	O	severe	amod	10	SENT_71	[p4l1938t1829r2150b1867],
10	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubjpass	12	SENT_71	[p4l79t1904r735b1982],
11	was	VBD	O	be	auxpass	12	SENT_71	[p4l789t1924r923b1962],
12	defined	VBN	O	define	_	0	SENT_71	[p4l979t1903r1233b1962],
13	as	IN	O	as	_	0	SENT_71	[p4l1289t1924r1356b1962],
14	total	JJ	O	total	amod	16	SENT_71	[p4l1410t1904r1561b1962],
15	bilirubin	NN	O	bilirubin	nn	16	SENT_71	[p4l1612t1904r1908b1961],
16	levels	NNS	O	level	prep_as	12	SENT_71	[p4l1960t1904r2150b1962],
17	>	JJR	O	>	dep	34	SENT_71	[p4l80t2013r120b2053],
18	3.1	CD	NUMBER	3.1	num	19	SENT_71	[p4l136t1999r226b2055],
19	mg	NN	O	mg	nsubj	34	SENT_71	[p4l245t2017r355b2075],
20	/	:	O	/	punct	30	SENT_71	[p4l362t1997r396b2063],
21	dl	NN	O	dl	dep	30	SENT_71	[p4l405t1997r488b2066],
22	,	,	O	,	_	0	SENT_71	[p4l405t1997r488b2066],
23	and	CC	O	and	_	0	SENT_71	[p4l514t1997r641b2054],
24	6.7	CD	PERCENT	6.7	num	25	SENT_71	[p4l665t1998r823b2055],
25	%	NN	PERCENT	%	conj_and	21	SENT_71	[p4l665t1998r823b2055],
26	(	CD	NUMBER	(	number	27	SENT_71	[p4l850t1997r911b2070],
27	71	CD	NUMBER	71	num	25	SENT_71	[p4l850t1997r911b2070],
28	=	JJ	O	=	amod	30	SENT_71	[p4l928t2023r969b2043],
29	25	CD	NUMBER	25	num	30	SENT_71	[p4l984t1997r1083b2070],
30	)	NN	O	)	dep	19	SENT_71	[p4l984t1997r1083b2070],
31	of	IN	O	of	_	0	SENT_71	[p4l1109t1997r1176b2055],
32	patients	NNS	O	patient	prep_of	19	SENT_71	[p4l1196t2000r1464b2075],
33	analyzed	VBN	O	analyze	partmod	32	SENT_71	[p4l1489t1997r1794b2075],
34	presented	VBD	O	present	dep	12	SENT_71	[p4l1818t1997r2149b2075],
35	this	DT	O	this	det	36	SENT_71	[p4l80t2091r201b2149],
36	outcome	NN	O	outcome	dobj	34	SENT_71	[p4l235t2099r541b2149],
37	.	.	O	.	_	0	SENT_71	[p4l235t2099r541b2149],

1	From	IN	O	from	_	0	SENT_72	[p4l577t2094r758b2149],
2	these	DT	O	these	det	4	SENT_72	[p4l790t2091r962b2149],
3	25	CD	NUMBER	25	num	4	SENT_72	[p4l995t2094r1069b2149],
4	patients	NNS	O	patient	prep_from	10	SENT_72	[p4l1102t2094r1389b2170],
5	,	,	O	,	_	0	SENT_72	[p4l1102t2094r1389b2170],
6	72	CD	PERCENT	72	num	7	SENT_72	[p4l1425t2092r1562b2149],
7	%	NN	PERCENT	%	nsubj	10	SENT_72	[p4l1425t2092r1562b2149],
8	were	VBD	O	be	cop	10	SENT_72	[p4l1594t2111r1760b2149],
9	atazanavir	JJ	O	atazanavir	amod	10	SENT_72	[p4l1794t2094r2151b2149],
10	users	NNS	O	user	dep	14	SENT_72	[p4l80t2204r254b2243],
11	and	CC	O	and	_	0	SENT_72	[p4l280t2185r406b2242],
12	60	CD	PERCENT	60	num	13	SENT_72	[p4l432t2186r570b2243],
13	%	NN	PERCENT	%	conj_and	10	SENT_72	[p4l432t2186r570b2243],
14	carried	VBD	O	carry	_	0	SENT_72	[p4l596t2185r830b2243],
15	at	IN	O	at	quantmod	17	SENT_72	[p4l856t2193r918b2242],
16	least	JJS	O	least	mwe	15	SENT_72	[p4l941t2185r1094b2243],
17	one	CD	NUMBER	one	num	18	SENT_72	[p4l1118t2204r1238b2243],
18	LIGT1/l1	NN	O	ligt1/l1	dobj	14	SENT_72	[p4l1268t2186r1662b2242],
19	*	CD	NUMBER	*	num	21	SENT_72	[p4l1268t2186r1662b2242],
20	28	CD	NUMBER	28	amod	21	SENT_72	[p4l1268t2186r1662b2242],
21	allele	NN	O	allele	nsubj	14	SENT_72	[p4l1689t2185r1878b2243],
22	.	.	O	.	_	0	SENT_72	[p4l1689t2185r1878b2243],

1	The	DT	O	the	det	3	SENT_73	[p4l166t2278r291b2336],
2	predicting	VBG	O	predict	amod	3	SENT_73	[p4l322t2278r671b2356],
3	variables	NNS	O	variable	nsubjpass	13	SENT_73	[p4l700t2278r1005b2336],
4	that	WDT	O	that	nsubj	5	SENT_73	[p4l1037t2278r1169b2335],
5	contributed	VBD	O	contribute	rcmod	3	SENT_73	[p4l1200t2278r1591b2336],
6	to	TO	O	to	_	0	SENT_73	[p4l1623t2286r1687b2336],
7	the	DT	O	the	det	8	SENT_73	[p4l1719t2278r1822b2336],
8	development	NN	O	development	prep_to	5	SENT_73	[p4l1855t2278r2150b2356, p4l80t2380r253b2430],
9	of	IN	O	of	_	0	SENT_73	[p4l285t2372r352b2430],
10	severe	JJ	O	severe	amod	11	SENT_73	[p4l382t2392r594b2430],
11	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	8	SENT_73	[p4l626t2372r1282b2451],
12	were	VBD	O	be	auxpass	13	SENT_73	[p4l1315t2392r1480b2430],
13	evaluated	VBN	O	evaluate	_	0	SENT_73	[p4l1514t2372r1844b2430],
14	through	IN	O	through	_	0	SENT_73	[p4l1877t2372r2151b2451],
15	multivariate	JJ	O	multivariate	amod	18	SENT_73	[p4l80t2466r495b2524],
16	Poisson	NNP	PERSON	Poisson	nn	18	SENT_73	[p4l514t2469r774b2524],
17	regression	NN	O	regression	nn	18	SENT_73	[p4l791t2469r1139b2545],
18	analyses	NNS	O	analysis	prep_through	13	SENT_73	[p4l1157t2466r1457b2545],
19	.	.	O	.	_	0	SENT_73	[p4l1157t2466r1457b2545],

1	The	DT	O	the	det	2	SENT_74	[p4l1479t2466r1605b2524],
2	variables	NNS	O	variable	nsubj	14	SENT_74	[p4l1622t2466r1927b2524],
3	ethnic	JJ	O	ethnic	amod	4	SENT_74	[p4l1947t2466r2150b2524],
4	group	NN	O	group	dep	2	SENT_74	[p4l81t2582r307b2640],
5	,	,	O	,	_	0	SENT_74	[p4l81t2582r307b2640],
6	gender	NN	O	gender	conj_and	2	SENT_74	[p4l339t2562r596b2640],
7	,	,	O	,	_	0	SENT_74	[p4l339t2562r596b2640],
8	and	CC	O	and	_	0	SENT_74	[p4l628t2562r756b2619],
9	indinavir	NN	O	indinavir	nn	10	SENT_74	[p4l786t2562r1105b2619],
10	use	NN	O	use	conj_and	2	SENT_74	[p4l1134t2582r1248b2620],
11	were	VBD	O	be	cop	14	SENT_74	[p4l1278t2582r1446b2620],
12	not	RB	O	not	neg	14	SENT_74	[p4l1475t2570r1588b2620],
13	significant	JJ	O	significant	amod	14	SENT_74	[p4l1618t2562r1975b2640],
14	contributors	NNS	O	contributor	_	0	SENT_74	[p4l2005t2582r2151b2620, p4l80t2656r379b2714],
15	to	TO	O	to	_	0	SENT_74	[p4l426t2664r491b2714],
16	this	DT	O	this	det	17	SENT_74	[p4l539t2656r663b2714],
17	outcome	NN	O	outcome	prep_to	14	SENT_74	[p4l711t2664r1025b2725],
18	,	,	O	,	_	0	SENT_74	[p4l711t2664r1025b2725],
19	while	IN	O	while	mark	24	SENT_74	[p4l1072t2656r1264b2714],
20	the	DT	O	the	det	23	SENT_74	[p4l1311t2656r1416b2714],
21	most	RBS	O	most	advmod	22	SENT_74	[p4l1463t2664r1632b2714],
22	parsimonious	JJ	O	parsimonious	amod	23	SENT_74	[p4l1676t2659r2150b2735],
23	model	NN	O	model	nsubj	24	SENT_74	[p4l80t2750r296b2808],
24	included	VBD	O	include	advcl	14	SENT_74	[p4l315t2750r616b2808],
25	only	RB	O	only	advmod	27	SENT_74	[p4l636t2750r787b2829],
26	atazanavir	JJ	O	atazanavir	amod	27	SENT_74	[p4l806t2753r1169b2808],
27	use	NN	O	use	dobj	24	SENT_74	[p4l1187t2770r1319b2819],
28	,	,	O	,	_	0	SENT_74	[p4l1187t2770r1319b2819],
29	age	NN	O	age	conj_and	27	SENT_74	[p4l1340t2770r1476b2829],
30	,	,	O	,	_	0	SENT_74	[p4l1340t2770r1476b2829],
31	and	CC	O	and	_	0	SENT_74	[p4l1497t2750r1625b2808],
32	presence	NN	O	presence	conj_and	27	SENT_74	[p4l1642t2770r1942b2829],
33	of	IN	O	of	_	0	SENT_74	[p4l1962t2750r2029b2808],
34	the	DT	O	the	det	35	SENT_74	[p4l2045t2750r2150b2808],
35	UGT1/l1	NN	O	ugt1/l1	prep_of	32	SENT_74	[p4l85t2845r487b2902],
36	*	CD	NUMBER	*	number	37	SENT_74	[p4l85t2845r487b2902],
37	28	CD	NUMBER	28	num	35	SENT_74	[p4l85t2845r487b2902],
38	allele	NN	O	allele	nn	40	SENT_74	[p4l514t2844r691b2902],
39	(	CD	NUMBER	(	num	40	SENT_74	[p4l719t2844r930b2917],
40	Table	NNP	O	Table	dep	32	SENT_74	[p4l719t2844r930b2917],
41	2	CD	NUMBER	2	number	42	SENT_74	[p4l955t2844r1034b2917],
42	)	CD	NUMBER	)	dep	40	SENT_74	[p4l955t2844r1034b2917],
43	.	.	O	.	_	0	SENT_74	[p4l955t2844r1034b2917],

1	Hepatic	JJ	O	hepatic	amod	3	SENT_75	[p4l166t2941r430b3018],
2	uridine	NN	O	uridine	nn	3	SENT_75	[p4l460t2939r705b2997],
3	diphosphate-glucuronosyltransferase	NN	O	diphosphate-glucuronosyltransferase	nsubj	4	SENT_75	[p4l737t2939r1998b3018],
4	catalyzes	VBZ	O	catalyze	_	0	SENT_75	[p4l2030t2947r2151b2997, p4l81t3033r288b3112],
5	the	DT	O	the	det	6	SENT_75	[p4l324t3033r428b3091],
6	conjugation	NN	O	conjugation	dobj	4	SENT_75	[p4l464t3036r862b3112],
7	of	IN	O	of	_	0	SENT_75	[p4l898t3033r965b3091],
8	bilirubin	NN	O	bilirubin	prep_of	6	SENT_75	[p4l995t3033r1290b3091],
9	with	IN	O	with	_	0	SENT_75	[p4l1324t3033r1480b3091],
10	glucuronic	JJ	O	glucuronic	amod	11	SENT_75	[p4l1515t3033r1874b3112],
11	acid	NN	O	acid	prep_with	4	SENT_75	[p4l1911t3033r2049b3091],
12	to	TO	O	to	aux	13	SENT_75	[p4l2085t3041r2149b3091],
13	form	VB	O	form	infmod	11	SENT_75	[p4l80t3127r243b3185],
14	the	DT	O	the	det	18	SENT_75	[p4l260t3127r363b3185],
15	more	RBR	O	more	advmod	16	SENT_75	[p4l380t3147r554b3185],
16	water-soluble	JJ	O	water-soluble	amod	18	SENT_75	[p4l571t3127r1033b3185],
17	bilirubin	NN	O	bilirubin	nn	18	SENT_75	[p4l1047t3127r1343b3184],
18	diglucuronide	NN	O	diglucuronide	dobj	13	SENT_75	[p4l1360t3127r1856b3205],
19	,	,	O	,	_	0	SENT_75	[p4l1360t3127r1856b3205],
20	which	WDT	O	which	nsubjpass	22	SENT_75	[p4l1873t3127r2082b3185],
21	is	VBZ	O	be	auxpass	22	SENT_75	[p4l2099t3130r2150b3185],
22	excreted	VBN	O	excrete	rcmod	18	SENT_75	[p4l80t3220r362b3279],
23	into	IN	O	into	_	0	SENT_75	[p4l386t3224r516b3279],
24	the	DT	O	the	det	26	SENT_75	[p4l540t3220r644b3279],
25	bile	NN	O	bile	nn	26	SENT_75	[p4l664t3207r835b3279],
26	.3	NN	NUMBER	.3	prep_into	22	SENT_75	[p4l664t3207r835b3279],
27	It	PRP	O	it	nsubjpass	30	SENT_75	[p4l860t3223r909b3278],
28	is	VBZ	O	be	auxpass	30	SENT_75	[p4l932t3224r983b3279],
29	well	RB	O	well	advmod	30	SENT_75	[p4l1005t3220r1150b3279],
30	established	VBN	O	establish	dep	13	SENT_75	[p4l1173t3220r1549b3279],
31	that	IN	O	that	complm	46	SENT_75	[p4l1573t3220r1705b3278],
32	the	DT	O	the	det	33	SENT_75	[p4l1727t3220r1831b3279],
33	insertion	NN	O	insertion	nsubj	46	SENT_75	[p4l1854t3224r2151b3279],
34	of	IN	O	of	_	0	SENT_75	[p5l81t25r148b83],
35	a	DT	O	a	det	37	SENT_75	[p5l176t45r211b83],
36	TA	NNP	O	TA	nn	37	SENT_75	[p5l241t27r346b82],
37	dinucleotide	NN	O	dinucleotide	prep_of	33	SENT_75	[p5l377t25r797b83],
38	in	IN	O	in	_	0	SENT_75	[p5l828t28r893b82],
39	the	DT	O	the	det	41	SENT_75	[p5l922t25r1025b83],
40	TATA	NN	O	ta	nn	41	SENT_75	[p5l1055t27r1267b82],
41	box	NN	O	box	prep_in	37	SENT_75	[p5l1295t25r1420b83],
42	of	IN	O	of	_	0	SENT_75	[p5l1450t25r1517b83],
43	the	DT	O	the	det	45	SENT_75	[p5l1544t25r1648b83],
44	UGT1A1	NN	O	ugt1a1	nn	45	SENT_75	[p5l1677t26r1974b83],
45	promoter	NN	O	promoter	prep_of	41	SENT_75	[p5l2008t45r2150b104, p5l80t127r280b177],
46	results	VBZ	O	result	ccomp	13	SENT_75	[p5l304t119r525b177],
47	in	IN	O	in	_	0	SENT_75	[p5l551t122r617b176],
48	an	DT	O	a	det	49	SENT_75	[p5l641t139r722b176],
49	enzyme	NN	O	enzyme	prep_in	46	SENT_75	[p5l747t139r1011b197],
50	with	IN	O	with	_	0	SENT_75	[p5l1035t119r1191b176],
51	reduced	VBN	O	reduce	amod	52	SENT_75	[p5l1215t119r1488b177],
52	activity	NN	O	activity	prep_with	49	SENT_75	[p5l1515t122r1783b197],
53	,	,	O	,	_	0	SENT_75	[p5l1515t122r1783b197],
54	leading	VBG	O	lead	partmod	4	SENT_75	[p5l1810t119r2062b197],
55	to	TO	O	to	_	0	SENT_75	[p5l2085t127r2149b177],
56	elevation	NN	O	elevation	prep_to	54	SENT_75	[p5l80t213r389b271],
57	of	IN	O	of	_	0	SENT_75	[p5l423t213r490b271],
58	unconjugated	JJ	O	unconjugated	amod	60	SENT_75	[p5l521t213r983b292],
59	bilirubin	NN	O	bilirubin	nn	60	SENT_75	[p5l1015t213r1311b271],
60	levels	NNS	O	level	prep_of	56	SENT_75	[p5l1343t213r1549b271],
61	.	.	O	.	_	0	SENT_75	[p5l1343t213r1549b271],

1	However	RB	O	however	advmod	19	SENT_76	[p5l1587t215r1920b282],
2	,	,	O	,	_	0	SENT_76	[p5l1587t215r1920b282],
3	correlation	NN	O	correlation	nsubj	19	SENT_76	[p5l1955t233r2150b271, p5l80t307r273b365],
4	of	IN	O	of	_	0	SENT_76	[p5l296t307r363b365],
5	bilirubin	NN	O	bilirubin	nn	6	SENT_76	[p5l381t307r676b365],
6	levels	NNS	O	level	prep_of	3	SENT_76	[p5l699t307r888b365],
7	with	IN	O	with	_	0	SENT_76	[p5l911t307r1067b365],
8	the	DT	O	the	det	9	SENT_76	[p5l1089t307r1193b365],
9	presence	NN	O	presence	prep_with	6	SENT_76	[p5l1216t327r1510b386],
10	of	IN	O	of	_	0	SENT_76	[p5l1534t307r1601b365],
11	the	DT	O	the	det	12	SENT_76	[p5l1622t307r1725b365],
12	lIGT1A1	NN	O	ligt1a1	prep_of	9	SENT_76	[p5l1754t309r2149b365],
13	*	CD	NUMBER	*	number	14	SENT_76	[p5l1754t309r2149b365],
14	28	CD	NUMBER	28	num	15	SENT_76	[p5l1754t309r2149b365],
15	allele	NN	O	allele	dep	12	SENT_76	[p5l81t402r254b460],
16	is	VBZ	O	be	cop	19	SENT_76	[p5l273t405r324b460],
17	not	RB	O	not	neg	19	SENT_76	[p5l342t410r453b460],
18	necessarily	RB	O	necessarily	advmod	19	SENT_76	[p5l469t402r839b481],
19	obvious	JJ	O	obvious	_	0	SENT_76	[p5l858t402r1125b460],
20	in	IN	O	in	_	0	SENT_76	[p5l1144t405r1209b459],
21	all	PDT	O	all	predet	24	SENT_76	[p5l1226t402r1306b460],
22	the	DT	O	the	det	24	SENT_76	[p5l1324t402r1427b460],
23	populations	NNS	O	population	nn	24	SENT_76	[p5l1444t402r1849b481],
24	studied3	NN	O	studied3	prep_in	19	SENT_76	[p5l1869t388r2150b460],
25	due	JJ	O	due	_	0	SENT_76	[p5l81t495r207b553],
26	to	TO	O	to	_	0	SENT_76	[p5l234t503r297b553],
27	several	JJ	O	several	amod	29	SENT_76	[p5l326t495r563b553],
28	environmental	JJ	O	environmental	amod	29	SENT_76	[p5l589t495r1084b553],
29	factors	NNS	O	factor	prep_due_to	19	SENT_76	[p5l1111t495r1335b553],
30	that	WDT	O	that	nsubj	33	SENT_76	[p5l1362t495r1494b552],
31	can	MD	O	can	aux	33	SENT_76	[p5l1520t515r1636b553],
32	also	RB	O	also	advmod	33	SENT_76	[p5l1662t495r1793b553],
33	affect	VB	O	affect	rcmod	29	SENT_76	[p5l1821t495r2003b553],
34	this	DT	O	this	dobj	33	SENT_76	[p5l2029t495r2150b553],

1	TABLE	NN	O	table	_	0	SENT_77	[p5l75t628r175b655],
2	2	CD	NUMBER	2	dep	1	SENT_77	[p5l189t629r214b655],
3	.	.	O	.	_	0	SENT_77	[p5l189t629r214b655],

1	PoIssoN	NNP	O	PoIssoN	nn	3	SENT_78	[p5l236t629r374b656],
2	REcREssIoN	NNP	O	REcREssIoN	nn	3	SENT_78	[p5l388t629r584b656],
3	MoDELs	NNPS	O	MoDELs	_	0	SENT_78	[p5l597t629r731b656],
4	AND	CC	O	and	nsubj	5	SENT_78	[p5l745t636r814b656],
5	PREDICTING	VBG	O	predict	rcmod	3	SENT_78	[p5l829t629r1022b656],
6	VARIABLES	NNS	O	variable	dobj	5	SENT_78	[p5l1035t629r1212b656],
7	FOR	IN	O	for	_	0	SENT_78	[p5l1227t636r1287b656],
8	DEVELOPMENT	NNP	O	DEVELOPMENT	prep_for	6	SENT_78	[p5l1300t629r1537b656],
9	OF	IN	O	of	_	0	SENT_78	[p5l1551t636r1589b656],
10	SEVERE	JJ	O	severe	amod	11	SENT_78	[p5l1603t628r1718b656],
11	HYPERBILIRUBINEMIA	NN	O	hyperbilirubinemia	prep_of	8	SENT_78	[p5l1732t629r2084b656],

1	IN	IN	O	in	dep	2	SENT_79	[p5l721t678r757b697],
2	HIV-INFECTED	JJ	O	hiv-infected	amod	3	SENT_79	[p5l771t670r1005b697],
3	INDIVIDUALS	NNS	O	individual	nsubj	4	SENT_79	[p5l1020t670r1228b697],
4	oN	VBP	O	on	_	0	SENT_79	[p5l1243t677r1290b697],
5	HAART	NN	O	haart	dobj	4	SENT_79	[p5l1303t670r1438b697],

1	Outcome	NNP	O	Outcome	_	0	SENT_80	[p5l60t749r194b776],
2	Predicting	VBG	O	predict	dep	1	SENT_80	[p5l740t748r896b786],
3	variable	JJ	O	variable	amod	4	SENT_80	[p5l910t748r1026b776],
4	PR	NN	O	pr	dobj	2	SENT_80	[p5l1281t749r1327b776],
5	95	CD	PERCENT	95	num	8	SENT_80	[p5l1604t749r1671b776],
6	%	NN	PERCENT	%	nn	8	SENT_80	[p5l1604t749r1671b776],
7	CI	NN	O	ci	nn	8	SENT_80	[p5l1688t749r1725b776],
8	p	NN	O	p	dep	4	SENT_80	[p5l2034t758r2055b786],

1	Severe	JJ	O	severe	amod	4	SENT_81	[p5l59t859r165b886],
2	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	4	SENT_81	[p5l178t858r493b896],
3	ATV	NN	O	atv	nn	4	SENT_81	[p5l737t859r815b886],
4	use	NN	O	use	dep	13	SENT_81	[p5l828t867r882b886],
5	7.72	CD	NUMBER	7.72	num	7	SENT_81	[p5l1273t859r1336b886],
6	3.14	CD	NUMBER	3.14	num	7	SENT_81	[p5l1580t859r1746b886],
7	—	NN	O	—	dep	4	SENT_81	[p5l1580t859r1746b886],
8	18.98	CD	NUMBER	18.98	num	9	SENT_81	[p5l1580t859r1746b886],
9	<	JJR	O	<	dep	7	SENT_81	[p5l1997t859r2098b886],
10	0.001	CD	NUMBER	0.001	num	11	SENT_81	[p5l1997t859r2098b886],
11	Age	NN	O	age	dep	13	SENT_81	[p5l737t900r803b937],
12	1.04	CD	NUMBER	1.04	num	13	SENT_81	[p5l1273t900r1336b927],
13	1.01-1	CD	NUMBER	1.01-1	dep	19	SENT_81	[p5l1581t900r1728b927],
14	.08	CD	NUMBER	.08	number	15	SENT_81	[p5l1581t900r1728b927],
15	0.029	CD	NUMBER	0.029	num	16	SENT_81	[p5l2017t900r2099b927],
16	llGT1A1	NN	O	llgt1a1	dep	13	SENT_81	[p5l740t941r930b968],
17	*	CD	NUMBER	*	num	18	SENT_81	[p5l740t941r930b968],
18	28	CD	NUMBER	28	dep	16	SENT_81	[p5l740t941r930b968],
19	allele	NN	O	allele	dep	21	SENT_81	[p5l945t940r1028b968],
20	2.43	CD	NUMBER	2.43	num	19	SENT_81	[p5l1272t941r1336b968],
21	1.08-5	CD	NUMBER	1.08-5	dep	23	SENT_81	[p5l1581t941r1727b968],
22	.45	CD	NUMBER	.45	num	23	SENT_81	[p5l1581t941r1727b968],
23	0.032	CD	NUMBER	0.032	_	0	SENT_81	[p5l2017t941r2100b968],

1	PR	NN	O	pr	_	0	SENT_82	[p5l92t1019r140b1048],
2	,	,	O	,	_	0	SENT_82	[p5l92t1019r140b1048],
3	prevalence	NN	O	prevalence	nn	4	SENT_82	[p5l152t1018r309b1052],
4	ratio	NN	O	ratio	appos	1	SENT_82	[p5l321t1019r395b1048],
5	;	:	O	;	_	0	SENT_82	[p5l321t1019r395b1048],
6	95	CD	PERCENT	95	number	7	SENT_82	[p5l407t1018r467b1043],
7	%	NN	PERCENT	%	amod	8	SENT_82	[p5l407t1018r467b1043],
8	CI	NN	O	ci	dep	1	SENT_82	[p5l479t1018r521b1048],
9	,	,	O	,	_	0	SENT_82	[p5l479t1018r521b1048],
10	confidence	NN	O	confidence	nn	11	SENT_82	[p5l533t1018r688b1043],
11	interval	NN	O	interval	appos	8	SENT_82	[p5l700t1018r819b1048],
12	;	:	O	;	_	0	SENT_82	[p5l700t1018r819b1048],
13	ATV	NNP	O	ATV	dep	1	SENT_82	[p5l831t1019r907b1048],
14	,	,	O	,	_	0	SENT_82	[p5l831t1019r907b1048],
15	atazanavir	NN	O	atazanavir	appos	13	SENT_82	[p5l920t1019r1079b1043],
16	.	.	O	.	_	0	SENT_82	[p5l920t1019r1079b1043],

1	UGT1A1	NN	O	ugt1a1	_	0	SENT_83	[p5l10t1214r305b1275],
2	AND	CC	O	and	cc	3	SENT_83	[p5l344t1216r513b1274],
3	HYPERBILIRUBINEMIA	NN	O	hyperbilirubinemia	dep	1	SENT_83	[p5l548t1216r1424b1275],
4	IN	IN	O	in	_	0	SENT_83	[p5l1458t1216r1529b1274],
5	HIV	NN	O	hiv	nn	6	SENT_83	[p5l1566t1216r1693b1274],
6	THERAPY	NN	O	therapy	prep_in	3	SENT_83	[p5l1722t1216r2103b1274],

1	phenotype	NN	O	phenotype	_	0	SENT_84	[p5l6t1429r400b1510],
2	,	,	O	,	_	0	SENT_84	[p5l6t1429r400b1510],
3	such	JJ	O	such	_	0	SENT_84	[p5l424t1429r584b1489],
4	as	IN	O	as	_	0	SENT_84	[p5l604t1449r674b1489],
5	alcohol	NN	O	alcohol	prep_such_as	1	SENT_84	[p5l696t1429r965b1500],
6	,	,	O	,	_	0	SENT_84	[p5l696t1429r965b1500],
7	drugs	NNS	O	drug	prep_such_as	1	SENT_84	[p5l988t1429r1209b1510],
8	,	,	O	,	_	0	SENT_84	[p5l988t1429r1209b1510],
9	smoking	NN	O	smoking	prep_such_as	1	SENT_84	[p5l1231t1429r1551b1510],
10	,	,	O	,	_	0	SENT_84	[p5l1231t1429r1551b1510],
11	age	NN	O	age	conj_and	5	SENT_84	[p5l1575t1449r1713b1510],
12	,	,	O	,	_	0	SENT_84	[p5l1575t1449r1713b1510],
13	and	CC	O	and	_	0	SENT_84	[p5l1735t1429r1866b1488],
14	gender	NN	O	gender	conj_and	5	SENT_84	[p5l1888t1428r2146b1510],
15	.	.	O	.	_	0	SENT_84	[p5l1888t1428r2146b1510],

1	Our	PRP$	O	we	poss	2	SENT_85	[p5l7t1527r147b1586],
2	results	NNS	O	result	nsubj	14	SENT_85	[p5l173t1526r401b1586],
3	in	IN	O	in	_	0	SENT_85	[p5l429t1528r497b1585],
4	a	DT	O	a	det	5	SENT_85	[p5l524t1546r559b1585],
5	sample	NN	O	sample	prep_in	2	SENT_85	[p5l588t1525r836b1607],
6	of	IN	O	of	_	0	SENT_85	[p5l864t1525r933b1586],
7	HIV	NN	MISC	hiv	nn	10	SENT_85	[p5l958t1525r1410b1586],
8	—	NN	O	—	nn	10	SENT_85	[p5l958t1525r1410b1586],
9	infected	JJ	O	infected	amod	10	SENT_85	[p5l958t1525r1410b1586],
10	individuals	NNS	O	individual	prep_of	5	SENT_85	[p5l1438t1526r1835b1586],
11	exposed	VBN	O	expose	partmod	2	SENT_85	[p5l1863t1525r2150b1607],
12	to	TO	O	to	_	0	SENT_85	[p5l7t1631r74b1683],
13	HAART	NNP	O	HAART	prep_to	11	SENT_85	[p5l101t1624r391b1682],
14	are	VBP	O	be	_	0	SENT_85	[p5l418t1643r523b1683],
15	in	IN	O	in	_	0	SENT_85	[p5l551t1625r618b1682],
16	line	NN	O	line	prep_in	14	SENT_85	[p5l643t1622r769b1683],
17	with	IN	O	with	_	0	SENT_85	[p5l795t1622r957b1682],
18	these	DT	O	these	det	19	SENT_85	[p5l982t1622r1160b1683],
19	findings	NNS	O	finding	prep_with	16	SENT_85	[p5l1187t1622r1474b1704],
20	in	IN	O	in	_	0	SENT_85	[p5l1501t1625r1568b1681],
21	general	JJ	O	general	amod	22	SENT_85	[p5l1594t1622r1851b1704],
22	populations	NNS	O	population	prep_in	19	SENT_85	[p5l1876t1622r2150b1704, p5l7t1722r195b1790],
23	,	,	O	,	_	0	SENT_85	[p5l1876t1622r2150b1704, p5l7t1722r195b1790],
24	as	IN	O	as	mark	33	SENT_85	[p5l229t1740r298b1780],
25	total	JJ	O	total	nsubj	33	SENT_85	[p5l329t1720r485b1780],
26	and	CC	O	and	_	0	SENT_85	[p5l516t1719r647b1779],
27	indirect	JJ	O	indirect	amod	29	SENT_85	[p5l678t1720r946b1780],
28	bilirubin	NN	O	bilirubin	nn	29	SENT_85	[p5l973t1719r1279b1779],
29	levels	NNS	O	level	nsubj	33	SENT_85	[p5l1308t1720r1504b1780],
30	were	VBD	O	be	cop	33	SENT_85	[p5l1534t1740r1706b1780],
31	only	RB	O	only	advmod	33	SENT_85	[p5l1738t1720r1892b1801],
32	mildly	RB	O	mildly	advmod	33	SENT_85	[p5l1921t1719r2151b1801],
33	elevated	JJ	O	elevated	advcl	14	SENT_85	[p5l8t1817r300b1877],
34	in	IN	O	in	_	0	SENT_85	[p5l335t1820r402b1876],
35	TA7	NN	O	ta7	nn	37	SENT_85	[p5l434t1819r574b1889],
36	allele	NN	O	allele	nn	37	SENT_85	[p5l608t1817r788b1877],
37	homozygotes	NNS	O	homozygote	prep_in	33	SENT_85	[p5l820t1817r1311b1898],
38	,	,	O	,	_	0	SENT_85	[p5l820t1817r1311b1898],
39	being	VBG	O	be	cop	42	SENT_85	[p5l1344t1817r1540b1898],
40	not	RB	O	not	neg	42	SENT_85	[p5l1572t1825r1687b1877],
41	significantly	RB	O	significantly	advmod	42	SENT_85	[p5l1721t1816r2151b1898],
42	different	JJ	O	different	xcomp	33	SENT_85	[p5l8t1915r307b1976],
43	among	IN	O	among	_	0	SENT_85	[p5l332t1936r575b1997],
44	genotypes	NNS	O	genotype	prep_among	42	SENT_85	[p5l599t1924r973b1997],
45	.	.	O	.	_	0	SENT_85	[p5l599t1924r973b1997],

1	Moreover	RB	O	moreover	advmod	11	SENT_86	[p5l96t2015r458b2084],
2	,	,	O	,	_	0	SENT_86	[p5l96t2015r458b2084],
3	the	DT	O	the	det	4	SENT_86	[p5l477t2012r584b2073],
4	results	NNS	O	result	nsubj	11	SENT_86	[p5l602t2012r831b2073],
5	of	IN	O	of	_	0	SENT_86	[p5l850t2012r919b2073],
6	the	DT	O	the	det	10	SENT_86	[p5l934t2013r1041b2073],
7	multivariate	JJ	O	multivariate	amod	10	SENT_86	[p5l1058t2013r1488b2073],
8	Poisson	NNP	PERSON	Poisson	nn	10	SENT_86	[p5l1506t2015r1775b2073],
9	regression	NN	O	regression	nn	10	SENT_86	[p5l1792t2015r2151b2094],
10	analysis	NN	O	analysis	prep_of	4	SENT_86	[p5l8t2110r287b2191],
11	showed	VBD	O	show	_	0	SENT_86	[p5l306t2110r579b2170],
12	that	IN	O	that	complm	25	SENT_86	[p5l598t2110r734b2170],
13	the	DT	O	the	det	14	SENT_86	[p5l751t2110r858b2170],
14	presence	NN	O	presence	nsubj	25	SENT_86	[p5l876t2130r1180b2191],
15	of	IN	O	of	_	0	SENT_86	[p5l1200t2109r1268b2170],
16	the	DT	O	the	det	17	SENT_86	[p5l1284t2110r1391b2170],
17	UGT1A1	NN	O	ugt1a1	prep_of	14	SENT_86	[p5l1414t2111r1706b2170],
18	*	CD	NUMBER	*	number	19	SENT_86	[p5l1720t2111r1823b2170],
19	28	CD	NUMBER	28	num	20	SENT_86	[p5l1720t2111r1823b2170],
20	allele	NN	O	allele	dep	17	SENT_86	[p5l1843t2110r2023b2170],
21	is	VBZ	O	be	cop	25	SENT_86	[p5l2041t2113r2094b2170],
22	a	DT	O	a	det	25	SENT_86	[p5l2113t2130r2150b2170],
23	significant	JJ	O	significant	amod	25	SENT_86	[p5l8t2206r371b2288],
24	risk	NN	O	risk	nn	25	SENT_86	[p5l406t2206r537b2267],
25	factor	NN	O	factor	ccomp	11	SENT_86	[p5l572t2206r772b2267],
26	for	IN	O	for	_	0	SENT_86	[p5l809t2206r907b2267],
27	the	DT	O	the	det	28	SENT_86	[p5l943t2206r1049b2267],
28	development	NN	O	development	prep_for	25	SENT_86	[p5l1088t2206r1548b2288],
29	of	IN	O	of	_	0	SENT_86	[p5l1585t2206r1654b2267],
30	the	DT	O	the	det	33	SENT_86	[p5l1688t2206r1794b2267],
31	more	RBR	O	more	advmod	32	SENT_86	[p5l1831t2227r2011b2267],
32	extreme	JJ	O	extreme	amod	33	SENT_86	[p5l2048t2227r2151b2267, p5l7t2312r207b2364],
33	phenotype	NN	O	phenotype	prep_of	28	SENT_86	[p5l261t2304r655b2385],
34	,	,	O	,	_	0	SENT_86	[p5l261t2304r655b2385],
35	severe	JJ	O	severe	amod	36	SENT_86	[p5l712t2324r931b2364],
36	hyperbilirubinemia	NN	O	hyperbilirubinemia	appos	33	SENT_86	[p5l985t2303r1684b2385],
37	,	,	O	,	_	0	SENT_86	[p5l985t2303r1684b2385],
38	in	IN	O	in	_	0	SENT_86	[p5l1739t2306r1807b2362],
39	HAART	NNP	O	HAART	nn	40	SENT_86	[p5l1860t2305r2151b2362],
40	users	NNS	O	user	prep_in	33	SENT_86	[p5l7t2422r204b2462],
41	.	.	O	.	_	0	SENT_86	[p5l7t2422r204b2462],

1	These	DT	O	these	det	2	SENT_87	[p5l228t2402r428b2462],
2	results	NNS	O	result	nsubj	12	SENT_87	[p5l448t2402r677b2462],
3	are	VBP	O	be	_	0	SENT_87	[p5l698t2422r803b2462],
4	in	IN	O	in	_	0	SENT_87	[p5l823t2405r890b2461],
5	agreement	NN	O	agreement	prep_in	3	SENT_87	[p5l909t2410r1278b2483],
6	with	IN	O	with	_	0	SENT_87	[p5l1295t2402r1457b2462],
7	other	JJ	O	other	amod	9	SENT_87	[p5l1476t2402r1657b2462],
8	studies5	NN	O	studies5	nn	9	SENT_87	[p5l1677t2387r1998b2462],
9	’	NN	O	’	prep_with	3	SENT_87	[p5l1677t2387r1998b2462],
10	6	CD	NUMBER	6	tmod	3	SENT_87	[p5l1677t2387r1998b2462],
11	and	CC	O	and	_	0	SENT_87	[p5l2019t2402r2150b2462],
12	demonstrate	VBP	O	demonstrate	conj_and	3	SENT_87	[p5l8t2498r445b2558],
13	that	IN	O	that	complm	45	SENT_87	[p5l482t2498r618b2557],
14	when	WRB	O	when	advmod	16	SENT_87	[p5l653t2498r849b2558],
15	we	PRP	O	we	nsubj	16	SENT_87	[p5l883t2518r986b2558],
16	control	VBP	O	control	advcl	45	SENT_87	[p5l1023t2498r1268b2558],
17	for	IN	O	for	_	0	SENT_87	[p5l1304t2498r1403b2558],
18	environmental	JJ	O	environmental	amod	19	SENT_87	[p5l1439t2498r1952b2558],
19	variables	NNS	O	variable	prep_for	16	SENT_87	[p5l1986t2501r2150b2557, p5l8t2595r183b2656],
20	that	WDT	O	that	nsubj	23	SENT_87	[p5l222t2595r358b2655],
21	can	MD	O	can	aux	23	SENT_87	[p5l396t2616r516b2656],
22	also	RB	O	also	advmod	23	SENT_87	[p5l554t2596r690b2656],
23	affect	VB	O	affect	rcmod	19	SENT_87	[p5l730t2595r918b2656],
24	bilirubin	NN	O	bilirubin	nn	25	SENT_87	[p5l953t2595r1259b2655],
25	levels	NNS	O	level	dobj	23	SENT_87	[p5l1296t2595r1511b2667],
26	,	,	O	,	_	0	SENT_87	[p5l1296t2595r1511b2667],
27	such	JJ	O	such	_	0	SENT_87	[p5l1552t2596r1713b2656],
28	as	IN	O	as	_	0	SENT_87	[p5l1751t2616r1820b2656],
29	age	NN	O	age	nn	32	SENT_87	[p5l1861t2616r1979b2677],
30	and	CC	O	and	_	0	SENT_87	[p5l2019t2595r2150b2655],
31	atazanavir	NN	O	atazanavir	nn	32	SENT_87	[p5l8t2696r377b2753],
32	use	NN	O	use	prep_such_as	19	SENT_87	[p5l404t2713r540b2764],
33	,	,	O	,	_	0	SENT_87	[p5l404t2713r540b2764],
34	the	DT	O	the	det	35	SENT_87	[p5l570t2693r677b2753],
35	consequences	NNS	O	consequence	nsubjpass	45	SENT_87	[p5l706t2713r1180b2774],
36	of	IN	O	of	_	0	SENT_87	[p5l1210t2692r1279b2753],
37	the	DT	O	the	det	38	SENT_87	[p5l1304t2693r1411b2753],
38	presence	NN	O	presence	prep_of	35	SENT_87	[p5l1439t2713r1743b2774],
39	of	IN	O	of	_	0	SENT_87	[p5l1773t2692r1842b2753],
40	this	DT	O	this	det	42	SENT_87	[p5l1867t2693r1993b2753],
41	risk	NN	O	risk	nn	42	SENT_87	[p5l2021t2693r2151b2753],
42	allele	NN	O	allele	prep_of	38	SENT_87	[p5l8t2789r188b2850],
43	can	MD	O	can	aux	45	SENT_87	[p5l212t2809r332b2850],
44	be	VB	O	be	auxpass	45	SENT_87	[p5l351t2789r434b2849],
45	highlighted	VBN	O	highlight	ccomp	12	SENT_87	[p5l456t2789r878b2870],
46	.	.	O	.	_	0	SENT_87	[p5l456t2789r878b2870],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_88	[p5l906t2789r1368b2860],
2	,	,	O	,	_	0	SENT_88	[p5l906t2789r1368b2860],
3	it	PRP	O	it	nsubj	5	SENT_88	[p5l1393t2792r1440b2849],
4	is	VBZ	O	be	cop	5	SENT_88	[p5l1463t2792r1516b2849],
5	important	JJ	O	important	_	0	SENT_88	[p5l1539t2792r1891b2870],
6	to	TO	O	to	aux	7	SENT_88	[p5l1914t2797r1980b2850],
7	take	VB	O	take	xcomp	5	SENT_88	[p5l2004t2789r2150b2850],
8	into	IN	O	into	_	0	SENT_88	[p5l7t2889r142b2947],
9	consideration	NN	O	consideration	prep_into	7	SENT_88	[p5l176t2887r650b2947],
10	that	WDT	O	that	dobj	14	SENT_88	[p5l681t2887r818b2946],
11	atazanavir	NN	O	atazanavir	nsubjpass	14	SENT_88	[p5l850t2889r1219b2946],
12	is	VBZ	O	be	auxpass	14	SENT_88	[p5l1250t2889r1303b2947],
13	widely	RB	O	widely	advmod	14	SENT_88	[p5l1335t2886r1577b2968],
14	used	VBN	O	use	rcmod	9	SENT_88	[p5l1608t2887r1773b2947],
15	as	IN	O	as	_	0	SENT_88	[p5l1806t2907r1876b2947],
16	part	NN	O	part	prep_as	14	SENT_88	[p5l1907t2895r2052b2968],
17	of	IN	O	of	_	0	SENT_88	[p5l2084t2886r2153b2947],
18	HAART	NNP	LOCATION	HAART	prep_of	16	SENT_88	[p5l7t2986r315b3055],
19	,	,	O	,	_	0	SENT_88	[p5l7t2986r315b3055],
20	being	VBG	O	be	auxpass	21	SENT_88	[p5l369t2984r565b3065],
21	associated	VBN	O	associate	partmod	16	SENT_88	[p5l619t2984r975b3044],
22	with	IN	O	with	_	0	SENT_88	[p5l1029t2984r1191b3044],
23	unconjugated	JJ	O	unconjugated	amod	24	SENT_88	[p5l1243t2984r1721b3065],
24	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	21	SENT_88	[p5l1775t2984r2150b3065, p5l7t3080r336b3141],
25	due	JJ	O	due	_	0	SENT_88	[p5l367t3080r497b3141],
26	to	TO	O	to	_	0	SENT_88	[p5l526t3088r592b3140],
27	the	DT	O	the	det	28	SENT_88	[p5l622t3080r729b3141],
28	competition	NN	O	competition	prep_due_to	24	SENT_88	[p5l758t3083r1178b3161],
29	between	IN	O	between	_	0	SENT_88	[p5l1203t3080r1502b3141],
30	this	DT	O	this	det	31	SENT_88	[p5l1529t3080r1654b3141],
31	drug	NN	O	drug	prep_between	28	SENT_88	[p5l1684t3080r1853b3161],
32	and	CC	O	and	_	0	SENT_88	[p5l1883t3080r2013b3140],
33	the	DT	O	the	det	35	SENT_88	[p5l2043t3080r2150b3140],
34	physiologic	JJ	O	physiologic	amod	35	SENT_88	[p5l6t3178r410b3260],
35	binding	NN	O	binding	conj_and	28	SENT_88	[p5l434t3179r709b3260],
36	of	IN	O	of	_	0	SENT_88	[p5l735t3178r804b3239],
37	bilirubin	NN	O	bilirubin	prep_of	35	SENT_88	[p5l823t3178r1129b3238],
38	to	TO	O	to	_	0	SENT_88	[p5l1152t3187r1218b3239],
39	the	DT	O	the	det	41	SENT_88	[p5l1244t3178r1351b3239],
40	UGT1A1	NN	O	ugt1a1	nn	41	SENT_88	[p5l1376t3180r1683b3239],
41	enzyme	NN	O	enzyme	prep_to	37	SENT_88	[p5l1714t3164r2067b3260],
42	.13	CD	NUMBER	.13	tmod	28	SENT_88	[p5l1714t3164r2067b3260],

1	This	DT	O	this	nsubj	5	SENT_89	[p5l96t3276r243b3336],
2	is	VBZ	O	be	cop	5	SENT_89	[p5l282t3279r334b3336],
3	the	DT	O	the	det	5	SENT_89	[p5l374t3276r480b3336],
4	first	JJ	ORDINAL	first	amod	5	SENT_89	[p5l519t3275r656b3336],
5	description	NN	O	description	_	0	SENT_89	[p5l695t3276r1079b3357],
6	of	IN	O	of	_	0	SENT_89	[p5l1117t3275r1186b3336],
7	the	DT	O	the	det	8	SENT_89	[p5l1222t3276r1328b3336],
8	inﬂuence	NN	O	inﬂuence	prep_of	5	SENT_89	[p5l1368t3275r1681b3336],
9	of	IN	O	of	_	0	SENT_89	[p5l1722t3275r1791b3336],
10	this	DT	O	this	det	12	SENT_89	[p5l1827t3276r1949b3336],
11	gene	NN	O	gene	nn	12	SENT_89	[p5l1990t3296r2150b3357],
12	variant	NN	O	variant	prep_of	8	SENT_89	[p5l6t3375r252b3432],
13	on	IN	O	on	_	0	SENT_89	[p5l287t3392r374b3432],
14	the	DT	O	the	det	15	SENT_89	[p5l406t3372r512b3432],
15	development	NN	O	development	prep_on	12	SENT_89	[p5l547t3372r1000b3453],
16	of	IN	O	of	_	0	SENT_89	[p5l1034t3372r1103b3432],
17	severe	JJ	O	severe	amod	18	SENT_89	[p5l1135t3392r1351b3433],
18	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	15	SENT_89	[p5l1383t3372r2050b3453],
19	in	IN	O	in	_	0	SENT_89	[p5l2085t3375r2152b3431],
20	HIV-infected	JJ	O	hiv-infected	amod	21	SENT_89	[p5l7t3469r452b3530],
21	individuals	NNS	O	individual	prep_in	18	SENT_89	[p5l485t3469r875b3530],
22	in	IN	O	in	_	0	SENT_89	[p5l907t3472r975b3528],
23	Brazil	NNP	LOCATION	Brazil	prep_in	21	SENT_89	[p5l1006t3469r1219b3529],
24	.	.	O	.	_	0	SENT_89	[p5l1006t3469r1219b3529],

1	This	DT	O	this	det	2	SENT_90	[p5l1256t3469r1401b3530],
2	study	NN	O	study	nsubj	4	SENT_90	[p5l1435t3469r1630b3551],
3	is	VBZ	O	be	cop	4	SENT_90	[p5l1661t3472r1714b3530],
4	relevant	JJ	O	relevant	_	0	SENT_90	[p5l1747t3469r2027b3530],
5	especially	RB	O	especially	advmod	4	SENT_90	[p5l2058t3489r2151b3530, p5l6t3567r273b3648],
6	because	IN	O	because	mark	15	SENT_90	[p5l300t3567r572b3627],
7	the	DT	O	the	det	9	SENT_90	[p5l602t3567r707b3627],
8	Brazilian	JJ	LOCATION	brazilian	amod	9	SENT_90	[p5l738t3567r1045b3627],
9	population	NN	O	population	nsubj	15	SENT_90	[p5l1073t3567r1454b3648],
10	is	VBZ	O	be	cop	15	SENT_90	[p5l1482t3570r1535b3627],
11	a	DT	O	a	det	15	SENT_90	[p5l1566t3587r1602b3627],
12	very	RB	O	very	advmod	14	SENT_90	[p5l1632t3587r1788b3648],
13	ethnically	RB	O	ethnically	advmod	14	SENT_90	[p5l1817t3567r2152b3648],
14	admixed	JJ	O	admixed	amod	15	SENT_90	[p5l8t3663r309b3724],
15	population	NN	O	population	ccomp	4	SENT_90	[p5l343t3663r741b3744],
16	,	,	O	,	_	0	SENT_90	[p5l343t3663r741b3744],
17	which	WDT	O	which	nsubj	20	SENT_90	[p5l775t3663r989b3723],
18	is	VBZ	O	be	cop	20	SENT_90	[p5l1022t3666r1075b3724],
19	the	DT	O	the	det	20	SENT_90	[p5l1110t3663r1216b3724],
20	result	NN	O	result	rcmod	15	SENT_90	[p5l1250t3663r1445b3724],
21	of	IN	O	of	_	0	SENT_90	[p5l1478t3663r1547b3723],
22	five	CD	DURATION	five	num	23	SENT_90	[p5l1579t3663r1705b3724],
23	centuries	NNS	DURATION	century	prep_of	20	SENT_90	[p5l1741t3666r2048b3724],
24	of	IN	O	of	_	0	SENT_90	[p5l2085t3663r2154b3723],
25	interethnic	JJ	O	interethnic	amod	26	SENT_90	[p6l7t15r373b76],
26	crosses	NNS	O	cross	prep_of	23	SENT_90	[p6l399t35r639b76],
27	of	IN	O	of	_	0	SENT_90	[p6l665t15r734b76],
28	peoples	NNS	O	people	prep_of	26	SENT_90	[p6l754t15r1018b97],
29	from	IN	O	from	_	0	SENT_90	[p6l1044t15r1210b76],
30	three	CD	NUMBER	three	num	31	SENT_90	[p6l1234t15r1407b76],
31	continents	NNS	O	continent	prep_from	28	SENT_90	[p6l1432t18r1801b76],
32	:	:	O	:	_	0	SENT_90	[p6l1432t18r1801b76],
33	the	DT	O	the	det	35	SENT_90	[p6l1829t15r1935b76],
34	European	JJ	MISC	european	amod	35	SENT_90	[p6l1959t18r2151b76, p6l6t133r176b194],
35	colonizers	NNS	O	colonizer	dep	20	SENT_90	[p6l212t113r577b183],
36	,	,	O	,	_	0	SENT_90	[p6l212t113r577b183],
37	mainly	RB	O	mainly	advmod	38	SENT_90	[p6l614t113r856b194],
38	represented	VBN	O	represent	partmod	35	SENT_90	[p6l892t113r1296b194],
39	by	IN	O	by	_	0	SENT_90	[p6l1331t113r1420b194],
40	the	DT	O	the	det	41	SENT_90	[p6l1457t113r1563b173],
41	Portuguese	NNP	MISC	Portuguese	agent	38	SENT_90	[p6l1600t115r2006b194],
42	,	,	O	,	_	0	SENT_90	[p6l1600t115r2006b194],
43	the	DT	O	the	det	45	SENT_90	[p6l2044t113r2150b173],
44	African	NNP	MISC	African	nn	45	SENT_90	[p6l7t211r265b271],
45	slaves	NNS	O	slave	conj_and	41	SENT_90	[p6l316t211r540b282],
46	,	,	O	,	_	0	SENT_90	[p6l316t211r540b282],
47	and	CC	O	and	_	0	SENT_90	[p6l594t211r724b270],
48	the	DT	O	the	det	50	SENT_90	[p6l777t211r882b271],
49	autochthonous	JJ	O	autochthonous	amod	50	SENT_90	[p6l935t211r1448b271],
50	Amerindians	NNPS	MISC	Amerindians	conj_and	41	SENT_90	[p6l1499t196r2029b271],
51	.	.	O	.	_	0	SENT_90	[p6l1499t196r2029b271],

1	”	NN	O	”	npadvmod	19	SENT_91	[p6l1499t196r2029b271],
2	In	IN	O	in	_	0	SENT_91	[p6l2081t213r2152b270],
3	the	DT	O	the	det	4	SENT_91	[p6l7t308r113b369],
4	South	NNP	LOCATION	South	prep_in	19	SENT_91	[p6l138t308r339b369],
5	of	IN	LOCATION	of	_	0	SENT_91	[p6l363t308r432b369],
6	Brazil	NNP	LOCATION	Brazil	prep_of	4	SENT_91	[p6l453t308r669b379],
7	,	,	O	,	_	0	SENT_91	[p6l453t308r669b379],
8	where	WRB	O	where	advmod	12	SENT_91	[p6l694t308r909b369],
9	our	PRP$	O	we	poss	10	SENT_91	[p6l935t328r1053b369],
10	study	NN	O	study	nsubjpass	12	SENT_91	[p6l1077t308r1272b390],
11	was	VBD	O	be	auxpass	12	SENT_91	[p6l1295t328r1432b369],
12	performed	VBN	O	perform	advcl	19	SENT_91	[p6l1456t308r1841b389],
13	,	,	O	,	_	0	SENT_91	[p6l1456t308r1841b389],
14	the	DT	O	the	det	16	SENT_91	[p6l1866t308r1972b369],
15	Amerindian	NNP	MISC	Amerindian	nn	16	SENT_91	[p6l1996t310r2151b367, p6l8t406r296b466],
16	contribution	NN	O	contribution	nsubj	19	SENT_91	[p6l320t406r745b466],
17	is	VBZ	O	be	cop	19	SENT_91	[p6l769t409r822b466],
18	very	RB	O	very	advmod	19	SENT_91	[p6l847t426r1003b487],
19	low	JJ	O	low	_	0	SENT_91	[p6l1028t406r1176b477],
20	,	,	O	,	_	0	SENT_91	[p6l1028t406r1176b477],
21	and	CC	O	and	_	0	SENT_91	[p6l1203t406r1334b466],
22	African	JJ	MISC	african	amod	23	SENT_91	[p6l1359t405r1616b466],
23	inﬂuence	NN	O	inﬂuence	nsubjpass	25	SENT_91	[p6l1641t405r1954b466],
24	is	VBZ	O	be	auxpass	25	SENT_91	[p6l1981t409r2034b466],
25	reduced	VBN	O	reduce	conj_and	19	SENT_91	[p6l2060t426r2151b466, p6l8t502r219b563],
26	in	IN	O	in	_	0	SENT_91	[p6l237t505r304b561],
27	comparison	NN	O	comparison	prep_in	25	SENT_91	[p6l320t505r725b583],
28	to	TO	O	to	_	0	SENT_91	[p6l741t510r806b563],
29	all	DT	O	all	det	32	SENT_91	[p6l825t502r906b562],
30	other	JJ	O	other	amod	32	SENT_91	[p6l924t502r1102b563],
31	geographic	JJ	O	geographic	amod	32	SENT_91	[p6l1120t502r1502b583],
32	regions	NNS	O	region	prep_to	25	SENT_91	[p6l1520t505r1787b583],
33	.	.	O	.	_	0	SENT_91	[p6l1520t505r1787b583],

1	Published	VBN	O	publish	_	0	SENT_92	[p6l1808t502r2150b563],
2	studies	NNS	O	study	dobj	1	SENT_92	[p6l8t599r249b660],
3	on	IN	O	on	_	0	SENT_92	[p6l294t619r382b660],
4	this	DT	O	this	det	6	SENT_92	[p6l423t599r545b660],
5	same	JJ	O	same	amod	6	SENT_92	[p6l590t619r766b660],
6	gene	NN	O	gene	prep_on	1	SENT_92	[p6l811t619r971b681],
7	evaluated	VBD	O	evaluate	dep	1	SENT_92	[p6l1015t599r1351b660],
8	a	DT	O	a	det	10	SENT_92	[p6l1395t619r1431b659],
9	smaller	JJR	O	smaller	amod	10	SENT_92	[p6l1477t599r1728b660],
10	number	NN	O	number	dobj	7	SENT_92	[p6l1768t599r2041b660],
11	of	IN	O	of	_	0	SENT_92	[p6l2085t599r2154b660],
12	patients	NNS	O	patient	prep_of	10	SENT_92	[p6l6t700r279b778],
13	and	CC	O	and	_	0	SENT_92	[p6l316t697r446b757],
14	more	JJR	O	more	dep	16	SENT_92	[p6l481t717r659b757],
15	ethnically	RB	O	ethnically	advmod	16	SENT_92	[p6l696t697r1030b778],
16	restricted	JJ	O	restricted	amod	17	SENT_92	[p6l1064t697r1384b757],
17	populations	NNS	O	population	conj_and	10	SENT_92	[p6l1419t697r1850b778],
18	,	,	O	,	_	0	SENT_92	[p6l1419t697r1850b778],
19	such	JJ	O	such	_	0	SENT_92	[p6l1887t697r2045b757],
20	as	IN	O	as	_	0	SENT_92	[p6l2081t717r2150b757],
21	Rodrigues-Novoa	NNP	O	Rodrigues-Novoa	prep_such_as	17	SENT_92	[p6l7t793r621b874],
22	et	FW	O	et	nn	23	SENT_92	[p6l656t799r711b853],
23	al.	FW	O	al.	nsubj	1	SENT_92	[p6l743t792r836b864],
24	,	,	O	,	_	0	SENT_92	[p6l743t792r836b864],
25	which	WDT	O	which	nsubj	26	SENT_92	[p6l871t793r1085b854],
26	analyzed	VBD	O	analyze	rcmod	23	SENT_92	[p6l1119t793r1430b874],
27	a	DT	O	a	det	28	SENT_92	[p6l1466t813r1502b853],
28	total	NN	O	total	dobj	26	SENT_92	[p6l1538t793r1692b854],
29	of	IN	O	of	_	0	SENT_92	[p6l1726t793r1796b854],
30	118	CD	NUMBER	118	num	32	SENT_92	[p6l1830t795r1942b854],
31	HIVinfected	JJ	O	hivinfected	amod	32	SENT_92	[p6l1978t795r2151b853, p6l7t890r279b951],
32	patients	NNS	O	patient	prep_of	28	SENT_92	[p6l316t893r608b971],
33	,	,	O	,	_	0	SENT_92	[p6l316t893r608b971],
34	all	DT	O	all	det	35	SENT_92	[p6l648t890r729b950],
35	white	JJ	O	white	appos	32	SENT_92	[p6l765t890r978b961],
36	;	:	O	;	_	0	SENT_92	[p6l765t890r978b961],
37	Rotger	NNP	O	Rotger	dep	28	SENT_92	[p6l1017t893r1248b972],
38	et	FW	O	et	tmod	37	SENT_92	[p6l1285t896r1340b950],
39	all	DT	O	all	advmod	38	SENT_92	[p6l1375t890r1446b950],
40	.	.	O	.	_	0	SENT_92	[p6l1375t890r1446b950],

1	evaluated	VBN	O	evaluate	partmod	37	SENT_93	[p6l1488t890r1825b951],
2	96	CD	NUMBER	96	num	4	SENT_93	[p6l1863t893r1940b951],
3	HIVinfected	JJ	O	hivinfected	amod	4	SENT_93	[p6l1978t892r2151b950, p6l7t987r279b1048],
4	individuals	NNS	O	individual	dobj	1	SENT_93	[p6l313t987r720b1058],
5	,	,	O	,	_	0	SENT_93	[p6l313t987r720b1058],
6	with	IN	O	with	_	0	SENT_93	[p6l753t987r913b1047],
7	96	CD	PERCENT	96	num	9	SENT_93	[p6l944t988r1086b1048],
8	%	NN	PERCENT	%	nn	9	SENT_93	[p6l944t988r1086b1048],
9	being	NN	O	being	prep_with	1	SENT_93	[p6l1118t987r1311b1069],
10	of	IN	O	of	_	0	SENT_93	[p6l1344t987r1413b1048],
11	white	JJ	O	white	amod	12	SENT_93	[p6l1441t987r1636b1048],
12	ethnicity	NN	O	ethnicity	prep_of	9	SENT_93	[p6l1670t987r1985b1069],
13	,	,	O	,	_	0	SENT_93	[p6l1670t987r1985b1069],
14	and	CC	O	and	_	0	SENT_93	[p6l2020t987r2150b1047],
15	Anderson	NNP	PERSON	Anderson	prep_with	1	SENT_93	[p6l7t1084r350b1145],
16	et	FW	O	et	nn	17	SENT_93	[p6l390t1090r445b1144],
17	al.	FW	O	al.	dep	15	SENT_93	[p6l486t1083r554b1144],
18	analyzed	VBN	O	analyze	partmod	9	SENT_93	[p6l604t1084r916b1165],
19	33	CD	NUMBER	33	num	21	SENT_93	[p6l958t1087r1035b1145],
20	HIV	NN	O	hiv	nn	21	SENT_93	[p6l1078t1084r1523b1145],
21	—	NN	O	—	nsubj	23	SENT_93	[p6l1078t1084r1523b1145],
22	infected	JJ	O	infected	amod	23	SENT_93	[p6l1078t1084r1523b1145],
23	subjects	NNS	O	subject	xcomp	18	SENT_93	[p6l1568t1084r1853b1165],
24	,	,	O	,	_	0	SENT_93	[p6l1568t1084r1853b1165],
25	79	CD	PERCENT	79	num	26	SENT_93	[p6l1899t1085r2040b1145],
26	%	NN	PERCENT	%	nsubj	37	SENT_93	[p6l1899t1085r2040b1145],
27	of	IN	O	of	_	0	SENT_93	[p6l2085t1084r2154b1145],
28	whom	WP	O	whom	nsubj	31	SENT_93	[p6l6t1182r231b1243],
29	were	VBD	O	be	cop	31	SENT_93	[p6l254t1202r424b1243],
30	white	JJ	O	white	amod	31	SENT_93	[p6l447t1168r808b1243],
31	.5	NN	NUMBER	.5	prepc_of	26	SENT_93	[p6l447t1168r808b1243],
32	'	''	O	'	_	0	SENT_93	[p6l447t1168r808b1243],
33	6	CD	NUMBER	6	number	34	SENT_93	[p6l447t1168r808b1243],
34	'15	CD	NUMBER	'15	dep	31	SENT_93	[p6l447t1168r808b1243],
35	Our	PRP$	O	we	poss	36	SENT_93	[p6l833t1183r971b1243],
36	data	NNS	O	datum	dep	34	SENT_93	[p6l997t1182r1145b1242],
37	suggest	VBP	O	suggest	_	0	SENT_93	[p6l1172t1190r1433b1264],
38	that	IN	O	that	complm	50	SENT_93	[p6l1456t1182r1591b1242],
39	the	DT	O	the	det	40	SENT_93	[p6l1615t1182r1721b1243],
40	effect	NN	O	effect	nsubjpass	50	SENT_93	[p6l1747t1182r1930b1243],
41	of	IN	O	of	_	0	SENT_93	[p6l1954t1182r2023b1243],
42	the	DT	O	the	det	43	SENT_93	[p6l2044t1182r2150b1243],
43	UGT1/l1	NN	O	ugt1/l1	prep_of	40	SENT_93	[p6l12t1281r416b1340],
44	*	CD	NUMBER	*	number	45	SENT_93	[p6l12t1281r416b1340],
45	28	CD	NUMBER	28	num	46	SENT_93	[p6l12t1281r416b1340],
46	allele	NN	O	allele	dep	43	SENT_93	[p6l443t1279r620b1340],
47	may	MD	O	may	aux	50	SENT_93	[p6l645t1300r798b1361],
48	also	RB	O	also	advmod	50	SENT_93	[p6l823t1279r958b1340],
49	be	VB	O	be	auxpass	50	SENT_93	[p6l981t1279r1063b1340],
50	observed	VBN	O	observe	ccomp	37	SENT_93	[p6l1090t1279r1402b1340],
51	in	IN	O	in	_	0	SENT_93	[p6l1428t1282r1496b1338],
52	African	NNP	MISC	African	nn	55	SENT_93	[p6l1520t1279r1777b1340],
53	and	CC	O	and	_	0	SENT_93	[p6l1803t1279r1933b1339],
54	Euroamerican	NNP	O	Euroamerican	nn	55	SENT_93	[p6l1959t1282r2151b1340, p6l8t1381r324b1439],
55	populations	NNS	O	population	prep_in	50	SENT_93	[p6l349t1378r777b1459],
56	.	.	O	.	_	0	SENT_93	[p6l349t1378r777b1459],

1	This	DT	O	this	nsubj	5	SENT_94	[p6l808t1378r953b1439],
2	is	VBZ	O	be	cop	5	SENT_94	[p6l982t1381r1035b1438],
3	even	RB	O	even	advmod	5	SENT_94	[p6l1062t1398r1225b1439],
4	more	RBR	O	more	advmod	5	SENT_94	[p6l1251t1398r1430b1439],
5	important	JJ	O	important	_	0	SENT_94	[p6l1457t1381r1803b1459],
6	when	WRB	O	when	advmod	8	SENT_94	[p6l1828t1378r2023b1439],
7	we	PRP	O	we	nsubj	8	SENT_94	[p6l2048t1398r2151b1439],
8	take	VBP	O	take	advcl	5	SENT_94	[p6l7t1475r151b1536],
9	into	IN	O	into	_	0	SENT_94	[p6l176t1478r309b1536],
10	consideration	NN	O	consideration	prep_into	8	SENT_94	[p6l334t1475r801b1536],
11	the	DT	O	the	det	13	SENT_94	[p6l823t1475r929b1536],
12	high	JJ	O	high	amod	13	SENT_94	[p6l952t1475r1110b1557],
13	number	NN	O	number	dobj	8	SENT_94	[p6l1132t1475r1405b1536],
14	of	IN	O	of	_	0	SENT_94	[p6l1430t1475r1499b1536],
15	HIV-infected	JJ	MISC	hiv-infected	amod	16	SENT_94	[p6l1520t1475r1966b1536],
16	individuals	NNS	O	individual	prep_of	13	SENT_94	[p6l1990t1475r2151b1535, p6l6t1572r260b1633],
17	in	IN	O	in	_	0	SENT_94	[p6l278t1575r345b1632],
18	these	DT	O	these	det	19	SENT_94	[p6l360t1572r536b1633],
19	populations	NNS	O	population	prep_in	8	SENT_94	[p6l551t1572r978b1654],
20	.	.	O	.	_	0	SENT_94	[p6l551t1572r978b1654],

1	In	IN	O	in	_	0	SENT_95	[p6l1000t1575r1071b1632],
2	Brazil	NNP	LOCATION	Brazil	prep_in	6	SENT_95	[p6l1087t1572r1304b1643],
3	,	,	O	,	_	0	SENT_95	[p6l1087t1572r1304b1643],
4	it	PRP	O	it	nsubjpass	6	SENT_95	[p6l1321t1575r1368b1632],
5	is	VBZ	O	be	auxpass	6	SENT_95	[p6l1383t1575r1436b1633],
6	estimated	VBN	O	estimate	_	0	SENT_95	[p6l1453t1572r1787b1633],
7	that	IN	O	that	complm	12	SENT_95	[p6l1804t1572r1938b1632],
8	about	IN	O	about	dep	12	SENT_95	[p6l1955t1572r2152b1633],
9	630,000	CD	NUMBER	630,000	num	10	SENT_95	[p6l8t1674r261b1742],
10	people	NNS	O	people	nsubjpass	12	SENT_95	[p6l285t1671r517b1752],
11	are	VBP	O	be	auxpass	12	SENT_95	[p6l541t1691r645b1732],
12	infected	VBN	O	infect	ccomp	6	SENT_95	[p6l669t1671r942b1732],
13	with	IN	O	with	_	0	SENT_95	[p6l964t1671r1124b1731],
14	the	DT	O	the	det	15	SENT_95	[p6l1147t1671r1253b1732],
15	virus	NN	O	virus	prep_with	12	SENT_95	[p6l1275t1656r1529b1732],
16	.16	CD	NUMBER	.16	num	15	SENT_95	[p6l1275t1656r1529b1732],

1	There	EX	O	there	expl	2	SENT_96	[p6l96t1768r295b1829],
2	are	VBP	O	be	_	0	SENT_96	[p6l320t1788r425b1829],
3	other	JJ	O	other	amod	6	SENT_96	[p6l450t1768r632b1829],
4	UGT1A1	NN	O	ugt1a1	nn	6	SENT_96	[p6l660t1769r952b1828],
5	gene	NN	O	gene	nn	6	SENT_96	[p6l984t1788r1146b1850],
6	variants	NNS	O	variant	nsubj	2	SENT_96	[p6l1168t1771r1451b1829],
7	that	WDT	O	that	nsubjpass	11	SENT_96	[p6l1476t1768r1613b1828],
8	have	VBP	O	have	aux	11	SENT_96	[p6l1634t1768r1802b1829],
9	also	RB	O	also	advmod	11	SENT_96	[p6l1827t1768r1962b1829],
10	been	VBN	O	be	auxpass	11	SENT_96	[p6l1984t1768r2152b1829],
11	related	VBN	O	relate	rcmod	6	SENT_96	[p6l7t1865r240b1926],
12	to	TO	O	to	_	0	SENT_96	[p6l258t1874r322b1926],
13	decreased	VBN	O	decrease	amod	15	SENT_96	[p6l342t1865r676b1926],
14	enzymatic	JJ	O	enzymatic	amod	15	SENT_96	[p6l694t1868r1043b1947],
15	activity	NN	O	activity	prep_to	11	SENT_96	[p6l1061t1868r1325b1947],
16	:	:	O	:	_	0	SENT_96	[p6l1061t1868r1325b1947],
17	LlGT1A1	NN	O	llgt1a1	conj_and	6	SENT_96	[p6l1352t1867r1637b1926],
18	*	CD	NUMBER	*	number	19	SENT_96	[p6l1649t1867r1711b1925],
19	6	CD	NUMBER	6	num	20	SENT_96	[p6l1649t1867r1711b1925],
20	(	NN	O	(	dep	17	SENT_96	[p6l1732t1866r1864b1941],
21	211	CD	NUMBER	211	num	22	SENT_96	[p6l1732t1866r1864b1941],
22	G	NN	O	g	npadvmod	23	SENT_96	[p6l1886t1866r1943b1926],
23	>	JJR	O	>	amod	20	SENT_96	[p6l1976t1882r2016b1924],
24	A	DT	O	a	det	25	SENT_96	[p6l2047t1865r2149b1941],
25	)	NN	O	)	dep	17	SENT_96	[p6l2047t1865r2149b1941],
26	,	,	O	,	_	0	SENT_96	[p6l2047t1865r2149b1941],
27	LIGT1A1	NN	O	ligt1a1	conj_and	6	SENT_96	[p6l12t1964r414b2023],
28	*	CD	NUMBER	*	number	29	SENT_96	[p6l12t1964r414b2023],
29	27	CD	NUMBER	27	num	31	SENT_96	[p6l12t1964r414b2023],
30	(	NN	O	(	nn	31	SENT_96	[p6l441t1963r632b2039],
31	686C	NN	O	686c	npadvmod	32	SENT_96	[p6l441t1963r632b2039],
32	>	JJR	O	>	amod	34	SENT_96	[p6l673t1979r714b2021],
33	A	DT	O	a	det	34	SENT_96	[p6l753t1963r855b2039],
34	)	NN	O	)	dep	27	SENT_96	[p6l753t1963r855b2039],
35	,	,	O	,	_	0	SENT_96	[p6l753t1963r855b2039],
36	and	CC	O	and	_	0	SENT_96	[p6l883t1962r1011b2022],
37	UGT1A1	NN	O	ugt1a1	nn	38	SENT_96	[p6l1043t1964r1444b2023],
38	*	NN	O	*	nsubj	2	SENT_96	[p6l1043t1964r1444b2023],
39	37	CD	NUMBER	37	number	40	SENT_96	[p6l1043t1964r1444b2023],
40	(	CD	NUMBER	(	num	42	SENT_96	[p6l1471t1963r1667b2039],
41	TA8	NN	O	ta8	nn	42	SENT_96	[p6l1471t1963r1667b2039],
42	)	NN	O	)	dep	38	SENT_96	[p6l1471t1963r1667b2039],
43	.	.	O	.	_	0	SENT_96	[p6l1471t1963r1667b2039],

1	Although	IN	O	although	mark	5	SENT_97	[p6l1696t1962r2025b2044],
2	we	PRP	O	we	nsubj	5	SENT_97	[p6l2048t1983r2150b2023],
3	have	VBP	O	have	aux	5	SENT_97	[p6l6t2059r170b2120],
4	not	RB	O	not	neg	5	SENT_97	[p6l192t2068r304b2120],
5	analyzed	VBN	O	analyze	advcl	23	SENT_97	[p6l328t2059r634b2141],
6	the	DT	O	the	det	7	SENT_97	[p6l658t2059r762b2120],
7	*	NN	O	*	dobj	5	SENT_97	[p6l787t2062r852b2120],
8	6	CD	NUMBER	6	dep	7	SENT_97	[p6l787t2062r852b2120],
9	and	CC	O	and	_	0	SENT_97	[p6l877t2059r1005b2119],
10	*	CD	NUMBER	*	number	11	SENT_97	[p6l1030t2062r1137b2118],
11	27	CD	NUMBER	27	num	12	SENT_97	[p6l1030t2062r1137b2118],
12	alleles	NNS	O	allele	dobj	5	SENT_97	[p6l1159t2059r1382b2130],
13	,	,	O	,	_	0	SENT_97	[p6l1159t2059r1382b2130],
14	according	VBG	O	accord	_	0	SENT_97	[p6l1408t2059r1742b2141],
15	to	TO	O	to	prepc_according_to	5	SENT_97	[p6l1764t2068r1829b2120],
16	previous	JJ	O	previous	amod	17	SENT_97	[p6l1852t2062r2150b2141],
17	studies	NNS	O	study	pobj	5	SENT_97	[p6l8t2143r324b2228],
18	,	,	O	,	_	0	SENT_97	[p6l8t2143r324b2228],
19	”	IN	O	”	_	0	SENT_97	[p6l8t2143r324b2228],
20	they	PRP	O	they	prep_”	23	SENT_97	[p6l355t2157r503b2239],
21	have	VBP	O	have	aux	23	SENT_97	[p6l533t2157r698b2218],
22	been	VBN	O	be	auxpass	23	SENT_97	[p6l726t2157r889b2218],
23	found	VBN	O	find	_	0	SENT_97	[p6l920t2157r1123b2218],
24	exclusively	RB	O	exclusively	advmod	23	SENT_97	[p6l1156t2157r1530b2239],
25	in	IN	O	in	_	0	SENT_97	[p6l1561t2160r1627b2216],
26	Asian	JJ	LOCATION	asian	amod	27	SENT_97	[p6l1657t2159r1856b2218],
27	populations	NNS	O	population	prep_in	23	SENT_97	[p6l1885t2157r2151b2239, p6l7t2257r187b2315],
28	.	.	O	.	_	0	SENT_97	[p6l1885t2157r2151b2239, p6l7t2257r187b2315],

1	Regarding	VBG	O	regard	_	0	SENT_98	[p6l206t2254r562b2336],
2	the	DT	O	the	det	5	SENT_98	[p6l577t2255r681b2315],
3	*	NN	O	*	nn	5	SENT_98	[p6l699t2257r805b2315],
4	37	CD	NUMBER	37	num	5	SENT_98	[p6l699t2257r805b2315],
5	variant	NN	O	variant	prep_regarding	11	SENT_98	[p6l820t2257r1079b2325],
6	,	,	O	,	_	0	SENT_98	[p6l820t2257r1079b2325],
7	in	IN	O	in	_	0	SENT_98	[p6l1096t2257r1163b2314],
8	our	PRP$	O	we	poss	9	SENT_98	[p6l1178t2275r1295b2315],
9	sample	NN	O	sample	prep_in	5	SENT_98	[p6l1312t2254r1553b2336],
10	we	PRP	O	we	nsubj	11	SENT_98	[p6l1568t2275r1670b2315],
11	found	VBD	O	find	_	0	SENT_98	[p6l1687t2254r1890b2315],
12	only	RB	O	only	quantmod	13	SENT_98	[p6l1908t2255r2058b2336],
13	11	CD	NUMBER	11	num	14	SENT_98	[p6l2076t2257r2145b2314],
14	carriers	NNS	O	carrier	dobj	11	SENT_98	[p6l8t2354r257b2412],
15	of	IN	O	of	_	0	SENT_98	[p6l293t2351r361b2412],
16	this	DT	O	this	det	17	SENT_98	[p6l392t2351r513b2412],
17	allele	NN	O	allele	prep_of	14	SENT_98	[p6l550t2351r737b2412],
18	.	.	O	.	_	0	SENT_98	[p6l550t2351r737b2412],

1	Therefore	RB	O	therefore	advmod	11	SENT_99	[p6l776t2351r1119b2422],
2	,	,	O	,	_	0	SENT_99	[p6l776t2351r1119b2422],
3	although	IN	O	although	mark	8	SENT_99	[p6l1156t2351r1460b2433],
4	this	DT	O	this	nsubj	8	SENT_99	[p6l1494t2351r1614b2412],
5	is	VBZ	O	be	cop	8	SENT_99	[p6l1650t2354r1701b2412],
6	a	DT	O	a	det	8	SENT_99	[p6l1737t2371r1773b2411],
7	functional	JJ	O	functional	amod	8	SENT_99	[p6l1808t2351r2150b2412],
8	variant	NN	O	variant	advcl	11	SENT_99	[p6l6t2451r266b2519],
9	,	,	O	,	_	0	SENT_99	[p6l6t2451r266b2519],
10	we	PRP	O	we	nsubj	11	SENT_99	[p6l299t2469r401b2509],
11	had	VBD	O	have	_	0	SENT_99	[p6l432t2448r563b2508],
12	no	DT	O	no	det	13	SENT_99	[p6l596t2469r682b2509],
13	power	NN	O	power	dobj	11	SENT_99	[p6l714t2469r935b2530],
14	to	TO	O	to	aux	15	SENT_99	[p6l967t2457r1032b2509],
15	detect	VB	O	detect	infmod	13	SENT_99	[p6l1068t2448r1269b2509],
16	its	PRP$	O	its	poss	17	SENT_99	[p6l1302t2451r1378b2509],
17	effect	NN	O	effect	dobj	15	SENT_99	[p6l1412t2448r1592b2509],
18	due	JJ	O	due	_	0	SENT_99	[p6l1625t2448r1752b2509],
19	to	TO	O	to	_	0	SENT_99	[p6l1786t2457r1851b2509],
20	the	DT	O	the	det	22	SENT_99	[p6l1885t2448r1989b2509],
21	low	JJ	O	low	amod	22	SENT_99	[p6l2022t2448r2150b2509],
22	number	NN	O	number	prep_due_to	15	SENT_99	[p6l6t2546r275b2606],
23	of	IN	O	of	_	0	SENT_99	[p6l300t2545r368b2606],
24	individuals	NNS	O	individual	prep_of	22	SENT_99	[p6l388t2545r772b2606],
25	with	IN	O	with	_	0	SENT_99	[p6l794t2545r953b2605],
26	this	DT	O	this	det	27	SENT_99	[p6l975t2546r1096b2606],
27	genotype	NN	O	genotype	prep_with	24	SENT_99	[p6l1120t2554r1450b2627],
28	.	.	O	.	_	0	SENT_99	[p6l1120t2554r1450b2627],

1	The	DT	O	the	det	2	SENT_100	[p6l96t2642r226b2703],
2	limitations	NNS	O	limitation	nsubjpass	9	SENT_100	[p6l264t2642r637b2703],
3	of	IN	O	of	_	0	SENT_100	[p6l677t2642r746b2703],
4	this	DT	O	this	det	5	SENT_100	[p6l780t2642r905b2703],
5	study	NN	O	study	prep_of	2	SENT_100	[p6l944t2642r1142b2724],
6	should	MD	O	should	aux	9	SENT_100	[p6l1179t2642r1418b2703],
7	also	RB	O	also	advmod	9	SENT_100	[p6l1457t2642r1592b2703],
8	be	VB	O	be	auxpass	9	SENT_100	[p6l1628t2642r1710b2703],
9	considered	VBN	O	consider	_	0	SENT_100	[p6l1748t2642r2149b2713],
10	,	,	O	,	_	0	SENT_100	[p6l1748t2642r2149b2713],
11	including	VBG	O	include	_	0	SENT_100	[p6l7t2739r341b2821],
12	its	PRP$	O	its	poss	14	SENT_100	[p6l393t2742r472b2800],
13	cross-sectional	JJ	O	cross-sectional	amod	14	SENT_100	[p6l526t2739r1033b2800],
14	design	NN	O	design	prep_including	9	SENT_100	[p6l1087t2739r1317b2821],
15	and	CC	O	and	_	0	SENT_100	[p6l1369t2739r1500b2799],
16	the	DT	O	the	det	17	SENT_100	[p6l1553t2739r1660b2800],
17	inclusion	NN	O	inclusion	prep_including	9	SENT_100	[p6l1713t2739r2032b2800],
18	of	IN	O	of	_	0	SENT_100	[p6l2084t2739r2153b2800],
19	patients	NNS	O	patient	prep_of	17	SENT_100	[p6l6t2839r284b2918],
20	using	VBG	O	use	partmod	19	SENT_100	[p6l329t2839r522b2918],
21	different	JJ	O	different	amod	23	SENT_100	[p6l567t2836r865b2897],
22	HAART	NN	O	haart	nn	23	SENT_100	[p6l909t2838r1199b2896],
23	regimens	NNS	O	regimen	dobj	20	SENT_100	[p6l1243t2839r1579b2918],
24	.	.	O	.	_	0	SENT_100	[p6l1243t2839r1579b2918],

1	However	RB	O	however	advmod	8	SENT_101	[p6l1628t2839r1973b2908],
2	,	,	O	,	_	0	SENT_101	[p6l1628t2839r1973b2908],
3	due	JJ	O	due	amod	4	SENT_101	[p6l2020t2836r2150b2897],
4	tomdmgnmmmbhmgMmﬂwbbHﬂVmwmyRE	NN	O	tomdmgnmmmbhmgmmﬂwbbhﬂvmwmyre	nsubj	8	SENT_101	[p6l7t2933r2150b3015],
5	very	RB	O	very	advmod	6	SENT_101	[p6l6t3051r164b3112],
6	difficult	JJ	O	difficult	amod	4	SENT_101	[p6l208t3030r483b3091],
7	to	TO	O	to	aux	8	SENT_101	[p6l526t3039r592b3091],
8	study	VB	O	study	_	0	SENT_101	[p6l637t3030r835b3112],
9	a	DT	O	a	det	11	SENT_101	[p6l878t3051r914b3090],
10	considerable	JJ	O	considerable	amod	11	SENT_101	[p6l960t3030r1399b3091],
11	number	NN	O	number	dobj	8	SENT_101	[p6l1442t3030r1719b3091],
12	of	IN	O	of	_	0	SENT_101	[p6l1763t3030r1832b3091],
13	patients	NNS	O	patient	prep_of	11	SENT_101	[p6l1872t3033r2149b3112],
14	on	IN	O	on	_	0	SENT_101	[p6l8t3148r96b3188],
15	the	DT	O	the	det	18	SENT_101	[p6l122t3127r229b3188],
16	same	JJ	O	same	amod	18	SENT_101	[p6l258t3148r436b3188],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_101	[p6l464t3128r927b3188],
18	combinations	NNS	O	combination	prep_on	13	SENT_101	[p6l955t3127r1442b3188],
19	.	.	O	.	_	0	SENT_101	[p6l955t3127r1442b3188],

1	On	IN	O	on	_	0	SENT_102	[p6l1474t3129r1581b3188],
2	the	DT	O	the	det	4	SENT_102	[p6l1608t3128r1715b3188],
3	other	JJ	O	other	amod	4	SENT_102	[p6l1743t3128r1925b3188],
4	hand	NN	O	hand	pobj	1	SENT_102	[p6l1950t3128r2149b3198],
5	,	,	O	,	_	0	SENT_102	[p6l1950t3128r2149b3198],

1	this	DT	O	this	det	2	SENT_103	[p6l7t3225r132b3285],
2	heterogeneity	NN	O	heterogeneity	nsubj	3	SENT_103	[p6l174t3225r654b3306],
3	allows	VBZ	O	allow	_	0	SENT_103	[p6l697t3225r922b3285],
4	us	PRP	O	we	nsubj	6	SENT_103	[p6l965t3245r1043b3285],
5	to	TO	O	to	aux	6	SENT_103	[p6l1086t3233r1152b3285],
6	highlight	VB	O	highlight	xcomp	3	SENT_103	[p6l1194t3225r1515b3306],
7	the	DT	O	the	det	8	SENT_103	[p6l1556t3225r1663b3285],
8	effect	NN	O	effect	dobj	6	SENT_103	[p6l1706t3224r1892b3285],
9	of	IN	O	of	_	0	SENT_103	[p6l1934t3224r2003b3285],
10	the	DT	O	the	det	14	SENT_103	[p6l2043t3225r2150b3285],
11	UGTIAI	NNP	O	UGTIAI	nn	14	SENT_103	[p6l12t3323r304b3382],
12	*	CD	NUMBER	*	num	14	SENT_103	[p6l318t3323r422b3381],
13	28	CD	NUMBER	28	amod	14	SENT_103	[p6l318t3323r422b3381],
14	allele	NN	O	allele	prep_of	8	SENT_103	[p6l444t3321r624b3382],
15	in	IN	O	in	_	0	SENT_103	[p6l644t3324r712b3381],
16	the	DT	O	the	det	18	SENT_103	[p6l731t3322r838b3382],
17	ATV-containing	JJ	O	atv-containing	amod	18	SENT_103	[p6l858t3323r1424b3403],
18	regimens	NNS	O	regimen	prep_in	14	SENT_103	[p6l1443t3324r1764b3403],
19	in	IN	O	in	_	0	SENT_103	[p6l1784t3324r1852b3381],
20	contrast	NN	O	contrast	prep_in	18	SENT_103	[p6l1871t3330r2151b3382],
21	to	TO	O	to	_	0	SENT_103	[p6l7t3427r74b3479],
22	the	DT	O	the	det	25	SENT_103	[p6l99t3419r206b3479],
23	other	JJ	O	other	amod	25	SENT_103	[p6l232t3418r413b3479],
24	drug	NN	O	drug	nn	25	SENT_103	[p6l440t3419r608b3500],
25	combinations	NNS	O	combination	prep_to	6	SENT_103	[p6l633t3418r1120b3479],
26	.	.	O	.	_	0	SENT_103	[p6l633t3418r1120b3479],

1	In	IN	O	in	_	0	SENT_104	[p6l97t3518r169b3575],
2	conclusion	NN	O	conclusion	prep_in	15	SENT_104	[p6l198t3516r590b3587],
3	,	,	O	,	_	0	SENT_104	[p6l198t3516r590b3587],
4	the	DT	O	the	det	5	SENT_104	[p6l623t3516r730b3576],
5	presence	NN	O	presence	nsubj	15	SENT_104	[p6l760t3536r1065b3597],
6	of	IN	O	of	_	0	SENT_104	[p6l1097t3515r1166b3576],
7	the	DT	O	the	det	11	SENT_104	[p6l1194t3516r1301b3576],
8	LIGT1/l1	NN	O	ligt1/l1	nn	11	SENT_104	[p6l1338t3517r1747b3576],
9	"	''	O	"	punct	11	SENT_104	[p6l1338t3517r1747b3576],
10	28	CD	NUMBER	28	num	11	SENT_104	[p6l1338t3517r1747b3576],
11	allele	NN	O	allele	prep_of	5	SENT_104	[p6l1780t3516r1959b3576],
12	with	IN	O	with	_	0	SENT_104	[p6l1990t3516r2152b3576],
13	ATV	NN	O	atv	nn	14	SENT_104	[p6l7t3614r174b3672],
14	use	NN	O	use	prep_with	11	SENT_104	[p6l205t3633r321b3673],
15	increases	VBZ	O	increase	_	0	SENT_104	[p6l353t3615r667b3673],
16	the	DT	O	the	det	17	SENT_104	[p6l700t3612r807b3673],
17	risk	NN	O	risk	dobj	15	SENT_104	[p6l839t3613r970b3673],
18	of	IN	O	of	_	0	SENT_104	[p6l1001t3612r1070b3673],
19	developing	VBG	O	develop	amod	21	SENT_104	[p6l1100t3613r1493b3694],
20	severe	JJ	O	severe	amod	21	SENT_104	[p6l1525t3633r1745b3673],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	17	SENT_104	[p6l1775t3613r2150b3694, p7l9t138r354b199],
22	.	.	O	.	_	0	SENT_104	[p6l1775t3613r2150b3694, p7l9t138r354b199],

1	Although	IN	O	although	mark	4	SENT_105	[p7l381t138r719b220],
2	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubjpass	4	SENT_105	[p7l740t138r1420b220],
3	is	VBZ	O	be	auxpass	4	SENT_105	[p7l1445t141r1498b199],
4	considered	VBN	O	consider	advcl	11	SENT_105	[p7l1523t138r1904b199],
5	a	DT	O	a	det	8	SENT_105	[p7l1930t159r1966b198],
6	mild	JJ	O	mild	amod	8	SENT_105	[p7l1989t138r2151b198],
7	adverse	JJ	O	adverse	amod	8	SENT_105	[p7l10t236r280b296],
8	effect	NN	O	effect	dobj	4	SENT_105	[p7l320t235r524b307],
9	,	,	O	,	_	0	SENT_105	[p7l320t235r524b307],
10	it	PRP	O	it	nsubj	11	SENT_105	[p7l566t238r613b295],
11	has	VBZ	O	have	_	0	SENT_105	[p7l651t236r769b296],
12	clinical	JJ	O	clinical	amod	13	SENT_105	[p7l810t235r1055b296],
13	implications	NNS	O	implication	dobj	11	SENT_105	[p7l1094t236r1540b317],
14	.	.	O	.	_	0	SENT_105	[p7l1094t236r1540b317],

1	Jaundice	NNP	O	Jaundice	nsubj	25	SENT_106	[p7l1582t236r1886b310],
2	causes	VBZ	O	cause	_	0	SENT_106	[p7l1927t256r2151b296],
3	discomfort	NN	O	discomfort	dobj	2	SENT_106	[p7l10t332r387b393],
4	due	JJ	O	due	_	0	SENT_106	[p7l406t332r536b393],
5	to	TO	O	to	_	0	SENT_106	[p7l555t341r621b393],
6	the	DT	O	the	det	8	SENT_106	[p7l641t332r748b393],
7	yellowish	JJ	O	yellowish	amod	8	SENT_106	[p7l766t332r1105b414],
8	appearance	NN	O	appearance	prep_due_to	2	SENT_106	[p7l1124t353r1523b414],
9	of	IN	O	of	_	0	SENT_106	[p7l1544t332r1613b393],
10	the	DT	O	the	det	11	SENT_106	[p7l1628t332r1735b393],
11	skin	NN	O	skin	prep_of	8	SENT_106	[p7l1755t332r1917b403],
12	,	,	O	,	_	0	SENT_106	[p7l1755t332r1917b403],
13	which	WDT	O	which	nsubj	15	SENT_106	[p7l1936t332r2153b393],
14	may	MD	O	may	aux	15	SENT_106	[p7l8t450r162b511],
15	affect	VB	O	affect	rcmod	11	SENT_106	[p7l183t429r372b489],
16	the	DT	O	the	det	17	SENT_106	[p7l392t429r498b489],
17	quality	NN	O	quality	dobj	15	SENT_106	[p7l522t429r767b511],
18	of	IN	O	of	_	0	SENT_106	[p7l788t429r857b489],
19	life	NN	O	life	prep_of	17	SENT_106	[p7l876t429r982b489],
20	of	IN	O	of	_	0	SENT_106	[p7l1004t429r1073b489],
21	these	DT	O	these	det	22	SENT_106	[p7l1091t429r1269b489],
22	patients	NNS	O	patient	prep_of	19	SENT_106	[p7l1289t432r1567b511],
23	and	CC	O	and	_	0	SENT_106	[p7l1590t429r1721b489],
24	may	MD	O	may	aux	25	SENT_106	[p7l1742t450r1896b511],
25	lead	VB	O	lead	conj_and	2	SENT_106	[p7l1917t429r2063b489],
26	to	TO	O	to	_	0	SENT_106	[p7l2085t438r2151b489],
27	treatment	NN	O	treatment	nn	29	SENT_106	[p7l9t536r348b588],
28	discontinuation	NN	O	discontinuation	nn	29	SENT_106	[p7l376t513r1017b588],
29	.2	NN	NUMBER	.2	prep_to	25	SENT_106	[p7l376t513r1017b588],
30	’	CD	NUMBER	’	number	31	SENT_106	[p7l376t513r1017b588],
31	5	CD	NUMBER	5	dobj	25	SENT_106	[p7l376t513r1017b588],
32	This	DT	O	this	det	33	SENT_106	[p7l1046t528r1194b588],
33	finding	NN	O	finding	nsubj	37	SENT_106	[p7l1223t527r1477b609],
34	is	VBZ	O	be	cop	37	SENT_106	[p7l1504t531r1557b588],
35	a	DT	O	a	det	37	SENT_106	[p7l1586t548r1622b588],
36	good	JJ	O	good	amod	37	SENT_106	[p7l1652t528r1828b609],
37	example	NN	O	example	rcmod	31	SENT_106	[p7l1857t528r2151b609],
38	of	IN	O	of	_	0	SENT_106	[p7l9t624r79b685],
39	how	WRB	O	how	advmod	44	SENT_106	[p7l121t624r275b685],
40	pharmacogenomic	JJ	O	pharmacogenomic	amod	41	SENT_106	[p7l321t624r974b706],
41	studies	NNS	O	study	nsubj	44	SENT_106	[p7l1022t624r1267b685],
42	can	MD	O	can	aux	44	SENT_106	[p7l1315t645r1435b685],
43	be	VB	O	be	cop	44	SENT_106	[p7l1477t624r1559b685],
44	useful	JJ	O	useful	prepc_of	37	SENT_106	[p7l1606t624r1819b685],
45	and	CC	O	and	_	0	SENT_106	[p7l1866t624r1997b684],
46	the	DT	O	the	det	47	SENT_106	[p7l2044t624r2151b685],
47	consistency	NN	O	consistency	nsubj	53	SENT_106	[p7l9t725r410b804],
48	among	IN	O	among	_	0	SENT_106	[p7l430t743r672b804],
49	findings	NNS	O	finding	prep_among	47	SENT_106	[p7l692t722r978b804],
50	in	IN	O	in	_	0	SENT_106	[p7l998t725r1066b782],
51	different	JJ	O	different	amod	52	SENT_106	[p7l1085t722r1384b783],
52	populations	NNS	O	population	prep_in	49	SENT_106	[p7l1402t723r1821b804],
53	indicates	VBZ	O	indicate	conj_and	2	SENT_106	[p7l1842t722r2151b783],
54	that	IN	O	that	complm	59	SENT_106	[p7l9t820r145b880],
55	perhaps	RB	O	perhaps	advmod	57	SENT_106	[p7l168t820r450b901],
56	the	DT	O	the	det	57	SENT_106	[p7l476t820r582b880],
57	time	NN	O	time	nsubj	59	SENT_106	[p7l608t823r762b880],
58	has	VBZ	O	have	aux	59	SENT_106	[p7l786t820r904b880],
59	come	VBN	O	come	ccomp	53	SENT_106	[p7l930t840r1113b880],
60	to	TO	O	to	aux	61	SENT_106	[p7l1139t828r1205b880],
61	transfer	VB	O	transfer	xcomp	59	SENT_106	[p7l1231t819r1500b880],
62	these	DT	O	these	det	63	SENT_106	[p7l1525t820r1703b880],
63	results	NNS	O	result	dobj	61	SENT_106	[p7l1729t820r1957b880],
64	from	IN	O	from	_	0	SENT_106	[p7l1983t819r2152b880],
65	basic	JJ	O	basic	amod	66	SENT_106	[p7l6t916r182b977],
66	research	NN	O	research	prep_from	61	SENT_106	[p7l214t916r506b977],
67	to	TO	O	to	_	0	SENT_106	[p7l536t925r603b977],
68	clinical	JJ	O	clinical	amod	69	SENT_106	[p7l636t916r881b977],
69	practice	NN	O	practice	prep_to	61	SENT_106	[p7l911t919r1201b998],
70	.	.	O	.	_	0	SENT_106	[p7l911t919r1201b998],

1	It	PRP	O	it	nsubj	3	SENT_107	[p7l1238t919r1289b976],
2	is	VBZ	O	be	cop	3	SENT_107	[p7l1320t919r1373b977],
3	important	JJ	O	important	_	0	SENT_107	[p7l1406t919r1758b998],
4	to	TO	O	to	aux	5	SENT_107	[p7l1789t925r1855b977],
5	keep	VB	O	keep	xcomp	3	SENT_107	[p7l1888t916r2052b998],
6	in	IN	O	in	_	0	SENT_107	[p7l2085t919r2153b975],
7	mind	NN	O	mind	prep_in	5	SENT_107	[p7l8t1013r193b1073],
8	that	IN	O	that	complm	15	SENT_107	[p7l217t1014r354b1073],
9	the	DT	O	the	det	12	SENT_107	[p7l376t1013r483b1074],
10	variant	JJ	O	variant	amod	12	SENT_107	[p7l505t1016r757b1073],
11	allele	NN	O	allele	nn	12	SENT_107	[p7l780t1013r959b1074],
12	frequencies	NNS	O	frequency	nsubjpass	15	SENT_107	[p7l984t1013r1380b1095],
13	should	MD	O	should	aux	15	SENT_107	[p7l1404t1013r1643b1074],
14	be	VB	O	be	auxpass	15	SENT_107	[p7l1664t1013r1746b1074],
15	considered	VBN	O	consider	ccomp	5	SENT_107	[p7l1770t1013r2151b1074],
16	in	IN	O	in	_	0	SENT_107	[p7l9t1115r76b1171],
17	each	DT	O	each	det	18	SENT_107	[p7l109t1112r267b1172],
18	population	NN	O	population	prep_in	15	SENT_107	[p7l298t1112r685b1193],
19	before	IN	O	before	_	0	SENT_107	[p7l715t1111r935b1172],
20	initiating	VBG	O	initiate	prepc_before	15	SENT_107	[p7l970t1115r1287b1193],
21	a	DT	O	a	det	23	SENT_107	[p7l1321t1132r1357b1172],
22	genotyping	VBG	O	genotype	amod	23	SENT_107	[p7l1392t1115r1792b1193],
23	program	NN	O	program	dobj	20	SENT_107	[p7l1824t1132r2148b1193],
24	.	.	O	.	_	0	SENT_107	[p7l1824t1132r2148b1193],

1	Evidently	RB	O	evidently	advmod	6	SENT_108	[p7l9t1208r367b1289],
2	,	,	O	,	_	0	SENT_108	[p7l9t1208r367b1289],
3	cost-effectiveness	NN	O	cost-effectiveness	nn	4	SENT_108	[p7l410t1208r1015b1269],
4	analyses	NNS	O	analysis	nsubjpass	6	SENT_108	[p7l1059t1208r1353b1289],
5	are	VBP	O	be	auxpass	6	SENT_108	[p7l1396t1228r1501b1269],
6	needed	VBN	O	need	_	0	SENT_108	[p7l1542t1208r1796b1269],
7	to	TO	O	to	aux	8	SENT_108	[p7l1838t1216r1905b1269],
8	determine	VB	O	determine	xcomp	6	SENT_108	[p7l1948t1208r2151b1268, p7l8t1309r183b1367],
9	the	DT	O	the	det	10	SENT_108	[p7l210t1307r316b1367],
10	utility	NN	O	utility	dobj	8	SENT_108	[p7l343t1307r553b1388],
11	of	IN	O	of	_	0	SENT_108	[p7l581t1306r649b1367],
12	genotyping	NN	O	genotyping	prep_of	10	SENT_108	[p7l674t1309r1074b1388],
13	as	IN	O	as	_	0	SENT_108	[p7l1101t1327r1171b1367],
14	a	DT	O	a	det	16	SENT_108	[p7l1200t1327r1236b1366],
15	screening	JJ	O	screening	amod	16	SENT_108	[p7l1263t1309r1595b1388],
16	measure	NN	O	measure	prep_as	8	SENT_108	[p7l1621t1327r1916b1367],
17	previous	JJ	O	previous	amod	16	SENT_108	[p7l1943t1309r2152b1388, p7l9t1406r130b1446],
18	to	TO	O	to	_	0	SENT_108	[p7l156t1394r222b1446],
19	atazanavir	NN	O	atazanavir	nn	20	SENT_108	[p7l249t1389r618b1445],
20	use	NN	O	use	prep_to	8	SENT_108	[p7l642t1406r775b1446],
21	.	.	O	.	_	0	SENT_108	[p7l642t1406r775b1446],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_109	[p7l9t1553r715b1628],

1	This	DT	O	this	det	2	SENT_110	[p7l98t1699r249b1760],
2	study	NN	O	study	nsubjpass	4	SENT_110	[p7l271t1700r472b1781],
3	was	VBD	O	be	auxpass	4	SENT_110	[p7l491t1720r632b1760],
4	supported	VBN	O	support	_	0	SENT_110	[p7l654t1700r1019b1781],
5	by	IN	O	by	_	0	SENT_110	[p7l1038t1700r1129b1781],
6	Departamento	NNP	O	Departamento	agent	4	SENT_110	[p7l1149t1702r1663b1781],
7	de	IN	O	de	_	0	SENT_110	[p7l1686t1699r1770b1760],
8	DST	NNP	ORGANIZATION	DST	nn	10	SENT_110	[p7l1791t1701r1963b1770],
9	,	,	O	,	_	0	SENT_110	[p7l1791t1701r1963b1770],
10	Aids	NNP	O	Aids	prep_de	6	SENT_110	[p7l1985t1700r2151b1760],
11	e	SYM	O	e	dep	13	SENT_110	[p7l9t1818r44b1858],
12	Hepatites	NNPS	PERSON	Hepatites	nn	13	SENT_110	[p7l84t1800r425b1879],
13	Virais	NNP	PERSON	Virais	dep	6	SENT_110	[p7l465t1800r695b1868],
14	,	,	O	,	_	0	SENT_110	[p7l465t1800r695b1868],
15	Ministério	NNP	PERSON	Ministério	nn	17	SENT_110	[p7l737t1800r1102b1858],
16	da	NNP	PERSON	da	nn	17	SENT_110	[p7l1145t1797r1230b1857],
17	Saude	NNP	PERSON	Saude	appos	13	SENT_110	[p7l1272t1797r1508b1868],
18	,	,	O	,	_	0	SENT_110	[p7l1272t1797r1508b1868],
19	Brazil	NNP	LOCATION	Brazil	appos	13	SENT_110	[p7l1550t1797r1776b1868],
20	,	,	O	,	_	0	SENT_110	[p7l1550t1797r1776b1868],
21	Conselho	NNP	ORGANIZATION	Conselho	nn	25	SENT_110	[p7l1818t1797r2151b1858],
22	Brasileiro	NNP	ORGANIZATION	Brasileiro	nn	25	SENT_110	[p7l9t1895r346b1956],
23	de	IN	ORGANIZATION	de	amod	25	SENT_110	[p7l401t1895r484b1956],
24	Desenvolvimento	NNP	ORGANIZATION	Desenvolvimento	nn	25	SENT_110	[p7l537t1895r1165b1956],
25	Cientifico	NNP	ORGANIZATION	Cientifico	appos	13	SENT_110	[p7l1218t1895r1560b1956],
26	e	LS	O	e	dep	29	SENT_110	[p7l1614t1916r1648b1956],
27	Tecnologico	NNP	PERSON	Tecnologico	nn	29	SENT_110	[p7l1701t1895r2150b1977],
28	,	,	O	,	_	0	SENT_110	[p7l1701t1895r2150b1977],
29	PRONEX/CNPq/FAPERGS	NNP	O	PRONEX/CNPq/FAPERGS	dep	6	SENT_110	[p7l9t1993r1014b2081],
30	and	CC	O	and	prep	29	SENT_110	[p7l1053t1994r1186b2053],
31	Coordenacao	NNP	O	Coordenacao	nn	38	SENT_110	[p7l1224t1993r1697b2070],
32	de	FW	O	de	nn	38	SENT_110	[p7l1736t1994r1820b2053],
33	Aperfeicoamento	FW	O	aperfeicoamento	nn	38	SENT_110	[p7l1857t1993r2152b2075, p7l9t2099r354b2168],
34	de	FW	O	de	nn	38	SENT_110	[p7l382t2091r466b2152],
35	Pessoal	FW	O	pessoal	nn	38	SENT_110	[p7l491t2091r753b2152],
36	de	FW	O	de	nn	38	SENT_110	[p7l779t2091r863b2152],
37	Nivel	NNP	ORGANIZATION	Nivel	nn	38	SENT_110	[p7l889t2091r1086b2152],
38	Superior	NNP	ORGANIZATION	Superior	dep	30	SENT_110	[p7l1111t2092r1434b2173],
39	.	.	O	.	_	0	SENT_110	[p7l1111t2092r1434b2173],

1	Author	NN	O	author	_	0	SENT_111	[p7l9t2261r270b2320],
2	Disclosure	NN	O	disclosure	nn	3	SENT_111	[p7l303t2260r707b2320],
3	Statement	NN	O	statement	dep	1	SENT_111	[p7l738t2260r1122b2320],

1	No	DT	O	no	det	4	SENT_112	[p7l98t2410r204b2468],
2	competing	VBG	O	compete	amod	4	SENT_112	[p7l231t2410r602b2489],
3	financial	JJ	O	financial	amod	4	SENT_112	[p7l626t2407r926b2468],
4	interests	NNS	O	interest	nsubj	5	SENT_112	[p7l951t2410r1241b2468],
5	exist	VBP	O	exist	_	0	SENT_112	[p7l1268t2410r1441b2468],
6	.	.	O	.	_	0	SENT_112	[p7l1268t2410r1441b2468],

1	References	NNS	O	reference	_	0	SENT_113	[p7l13t2577r436b2637],

1	1	LS	NUMBER	1	_	0	SENT_114	[p7l49t2727r97b2781],
2	.	.	O	.	_	0	SENT_114	[p7l49t2727r97b2781],

1	Tozzi	NNP	PERSON	Tozzi	nn	2	SENT_115	[p7l141t2727r324b2782],
2	V	NNP	O	V	_	0	SENT_115	[p7l355t2727r423b2781],
3	:	:	O	:	_	0	SENT_115	[p7l355t2727r423b2781],
4	Pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_115	[p7l458t2725r1057b2802],
5	of	IN	O	of	_	0	SENT_115	[p7l1091t2724r1156b2782],
6	antiretrovirals	NNS	O	antiretroviral	prep_of	4	SENT_115	[p7l1186t2725r1669b2782],
7	.	.	O	.	_	0	SENT_115	[p7l1186t2725r1669b2782],

1	Antiviral	JJ	O	antiviral	amod	2	SENT_116	[p7l1705t2725r2004b2781],
2	Res	NNP	O	Res	_	0	SENT_116	[p7l2036t2727r2151b2782],

1	2	LS	NUMBER	2	_	0	SENT_117	[p7l46t2911r97b2964],
2	.	.	O	.	_	0	SENT_117	[p7l46t2911r97b2964],

1	Hawkins	NNP	PERSON	Hawkins	nn	2	SENT_118	[p7l141t2909r441b2966],
2	T	NN	O	t	_	0	SENT_118	[p7l477t2911r536b2964],
3	:	:	O	:	_	0	SENT_118	[p7l477t2911r536b2964],
4	Understanding	VBG	O	understand	dep	2	SENT_118	[p7l574t2909r1076b2985],
5	and	CC	O	and	_	0	SENT_118	[p7l1113t2909r1237b2965],
6	managing	VBG	O	manage	dep	2	SENT_118	[p7l1272t2912r1605b2985],
7	the	DT	O	the	det	9	SENT_118	[p7l1640t2909r1742b2966],
8	adverse	JJ	O	adverse	amod	9	SENT_118	[p7l1778t2909r2033b2966],
9	effects	NNS	O	effect	dobj	4	SENT_118	[p7l2070t2909r2152b2966, p7l141t3002r288b3060],
10	of	IN	O	of	_	0	SENT_118	[p7l310t3002r375b3060],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_118	[p7l395t3003r832b3060],
12	therapy	NN	O	therapy	prep_of	9	SENT_118	[p7l852t3003r1123b3080],
13	.	.	O	.	_	0	SENT_118	[p7l852t3003r1123b3080],

1	Antiviral	JJ	O	antiviral	amod	2	SENT_119	[p7l1147t3003r1446b3060],
2	Res	NNP	O	Res	_	0	SENT_119	[p7l1467t3005r1581b3060],
3	2010	CD	DATE	2010	dep	2	SENT_119	[p7l1603t3005r2148b3070],
4	;	:	O	;	_	0	SENT_119	[p7l1603t3005r2148b3070],
5	85:201	CD	NUMBER	85:201	num	6	SENT_119	[p7l1603t3005r2148b3070],
6	-209	CD	NUMBER	-209	dep	2	SENT_119	[p7l1603t3005r2148b3070],
7	.	.	O	.	_	0	SENT_119	[p7l1603t3005r2148b3070],

1	3	LS	NUMBER	3	_	0	SENT_120	[p7l46t3098r97b3153],
2	.	.	O	.	_	0	SENT_120	[p7l46t3098r97b3153],

1	Burchell	NNP	PERSON	Burchell	nn	2	SENT_121	[p7l142t3095r415b3153],
2	B	NNP	O	B	_	0	SENT_121	[p7l440t3097r482b3151],
3	and	CC	O	and	_	0	SENT_121	[p7l508t3095r631b3152],
4	Hume	NNP	PERSON	Hume	nn	5	SENT_121	[p7l656t3097r863b3153],
5	R	NN	O	r	conj_and	2	SENT_121	[p7l888t3097r951b3151],
6	:	:	O	:	_	0	SENT_121	[p7l888t3097r951b3151],
7	Molecular	JJ	O	molecular	amod	9	SENT_121	[p7l979t3095r1313b3153],
8	genetic	JJ	O	genetic	amod	9	SENT_121	[p7l1339t3098r1571b3172],
9	basis	NN	O	basis	dep	2	SENT_121	[p7l1593t3095r1757b3153],
10	of	IN	O	of	_	0	SENT_121	[p7l1783t3095r1848b3153],
11	Gilbert	NNP	PERSON	Gilbert	poss	13	SENT_121	[p7l1870t3095r2151b3153],
12	's	POS	O	's	_	0	SENT_121	[p7l1870t3095r2151b3153],
13	syndrome	NN	O	syndrome	prep_of	9	SENT_121	[p7l142t3188r490b3265],
14	.	.	O	.	_	0	SENT_121	[p7l142t3188r490b3265],

1	J	NNP	O	J	nn	3	SENT_122	[p7l519t3190r544b3259],
2	Gastroenterol	NNP	O	Gastroenterol	nn	3	SENT_122	[p7l571t3188r1023b3246],
3	Hepatol	NNP	O	Hepatol	_	0	SENT_122	[p7l1050t3188r1317b3265],
4	1999	CD	DATE	1999	num	3	SENT_122	[p7l1347t3190r1889b3255],
5	;	:	O	;	_	0	SENT_122	[p7l1347t3190r1889b3255],
6	14:960	CD	NUMBER	14:960	number	7	SENT_122	[p7l1347t3190r1889b3255],
7	-966	CD	NUMBER	-966	dep	3	SENT_122	[p7l1347t3190r1889b3255],
8	.	.	O	.	_	0	SENT_122	[p7l1347t3190r1889b3255],

1	4	LS	NUMBER	4	_	0	SENT_123	[p7l45t3284r97b3337],
2	.	.	O	.	_	0	SENT_123	[p7l45t3284r97b3337],

1	Lankisch	NNP	O	Lankisch	_	0	SENT_124	[p7l141t3281r456b3339],
2	TO	TO	O	to	infmod	1	SENT_124	[p7l491t3283r617b3349],
3	,	,	O	,	_	0	SENT_124	[p7l491t3283r617b3349],
4	Moebius	NNP	PERSON	Moebius	nn	5	SENT_124	[p7l655t3281r955b3339],
5	U	NNP	PERSON	U	appos	1	SENT_124	[p7l991t3284r1068b3349],
6	,	,	O	,	_	0	SENT_124	[p7l991t3284r1068b3349],
7	Wehmeier	NNP	PERSON	Wehmeier	nn	8	SENT_124	[p7l1105t3282r1464b3338],
8	M	NNP	O	M	appos	5	SENT_124	[p7l1500t3284r1590b3349],
9	,	,	O	,	_	0	SENT_124	[p7l1500t3284r1590b3349],
10	et	FW	O	et	nn	11	SENT_124	[p7l1627t3287r1681b3338],
11	al.	FW	O	al.	appos	5	SENT_124	[p7l1717t3281r1812b3338],
12	:	:	O	:	_	0	SENT_124	[p7l1717t3281r1812b3338],
13	Gilbert	NNP	PERSON	Gilbert	poss	15	SENT_124	[p7l1852t3281r2151b3338],
14	's	POS	O	's	_	0	SENT_124	[p7l1852t3281r2151b3338],
15	disease	NN	O	disease	dep	11	SENT_124	[p7l143t3375r393b3432],
16	and	CC	O	and	_	0	SENT_124	[p7l465t3375r593b3431],
17	atazanavir	NN	O	atazanavir	dep	11	SENT_124	[p7l665t3377r1051b3431],
18	:	:	O	:	_	0	SENT_124	[p7l665t3377r1051b3431],
19	From	IN	O	from	_	0	SENT_124	[p7l1126t3377r1310b3432],
20	phenotype	NN	O	phenotype	prep_from	5	SENT_124	[p7l1380t3374r1753b3452],
21	to	TO	O	to	_	0	SENT_124	[p7l1823t3383r1888b3432],
22	UDPglucuronosyltransferase	NN	O	udpglucuronosyltransferase	nn	23	SENT_124	[p7l1960t3377r2152b3432, p7l142t3466r936b3542],
23	haplotype	NN	O	haplotype	prep_to	20	SENT_124	[p7l1005t3466r1355b3542],
24	.	.	O	.	_	0	SENT_124	[p7l1005t3466r1355b3542],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_125	[p7l1428t3466r1820b3542],
2	2006	CD	DATE	2006	num	1	SENT_125	[p7l1887t3468r2148b3533],
3	;	:	O	;	_	0	SENT_125	[p7l1887t3468r2148b3533],
4	44	CD	NUMBER	44	num	6	SENT_125	[p7l1887t3468r2148b3533],
5	:	:	O	:	_	0	SENT_125	[p7l1887t3468r2148b3533],
6	1324-1332	CD	DATE	1324-1332	dep	1	SENT_125	[p7l145t3562r496b3617],
7	.	.	O	.	_	0	SENT_125	[p7l145t3562r496b3617],

1	.	.	O	.	_	0	SENT_126	[p8l88t71r97b80],

1	Rotger	NNP	O	Rotger	nn	2	SENT_127	[p8l141t26r363b101],
2	M	NNP	O	M	_	0	SENT_127	[p8l384t26r470b91],
3	,	,	O	,	_	0	SENT_127	[p8l384t26r470b91],
4	Taffé	NNP	PERSON	Taffé	nn	5	SENT_127	[p8l494t24r660b82],
5	P	NN	PERSON	p	appos	2	SENT_127	[p8l682t26r743b91],
6	,	,	O	,	_	0	SENT_127	[p8l682t26r743b91],
7	Bleiber	NNP	O	Bleiber	nn	8	SENT_127	[p8l766t24r995b82],
8	G	NNP	O	G	appos	2	SENT_127	[p8l1017t25r1089b91],
9	,	,	O	,	_	0	SENT_127	[p8l1017t25r1089b91],
10	et	FW	O	et	nn	11	SENT_127	[p8l1112t30r1164b81],
11	al.	FW	O	al.	appos	2	SENT_127	[p8l1185t24r1273b81],
12	:	:	O	:	_	0	SENT_127	[p8l1185t24r1273b81],
13	Gilbert	NNP	PERSON	Gilbert	nn	14	SENT_127	[p8l1297t24r1527b82],
14	syndrome	NN	O	syndrome	dep	2	SENT_127	[p8l1549t24r1881b101],
15	and	CC	O	and	_	0	SENT_127	[p8l1904t24r2028b81],
16	the	DT	O	the	det	17	SENT_127	[p8l2050t24r2151b82],
17	development	NN	O	development	dep	2	SENT_127	[p8l143t117r577b194],
18	of	IN	O	of	_	0	SENT_127	[p8l621t117r686b175],
19	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_127	[p8l727t117r1164b175],
20	therapy-associated	JJ	O	therapy-associated	amod	21	SENT_127	[p8l1206t117r1827b194],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	17	SENT_127	[p8l1869t117r2152b194, p8l141t211r539b267],
22	.	.	O	.	_	0	SENT_127	[p8l1869t117r2152b194, p8l141t211r539b267],

1	I	PRP	O	I	nsubj	2	SENT_128	[p8l569t213r594b281],
2	Infect	VBP	O	infect	_	0	SENT_128	[p8l621t210r806b267],
3	Dis	NNP	O	Dis	dobj	2	SENT_128	[p8l833t213r942b267],
4	2005	CD	DATE	2005	num	3	SENT_128	[p8l970t213r1629b277],
5	;	:	O	;	_	0	SENT_128	[p8l970t213r1629b277],
6	192:1381	CD	DURATION	192:1381	num	7	SENT_128	[p8l970t213r1629b277],
7	-1386	CD	DURATION	-1386	dep	3	SENT_128	[p8l970t213r1629b277],
8	.	.	O	.	_	0	SENT_128	[p8l970t213r1629b277],

1	.	.	O	.	_	0	SENT_129	[p8l88t350r97b360],

1	Rodriguez-Novoa	NNP	LOCATION	Rodriguez-Novoa	nn	2	SENT_130	[p8l141t304r737b381],
2	S	NNP	O	S	_	0	SENT_130	[p8l770t305r825b371],
3	,	,	O	,	_	0	SENT_130	[p8l770t305r825b371],
4	Martin-Carbonero	NNP	PERSON	Martin-Carbonero	nn	5	SENT_130	[p8l857t304r1460b361],
5	L	NNP	PERSON	L	appos	2	SENT_130	[p8l1493t306r1554b371],
6	,	,	O	,	_	0	SENT_130	[p8l1493t306r1554b371],
7	Barreiro	NNP	PERSON	Barreiro	nn	8	SENT_130	[p8l1587t306r1854b361],
8	P	NN	PERSON	p	appos	2	SENT_130	[p8l1886t306r1947b371],
9	,	,	O	,	_	0	SENT_130	[p8l1886t306r1947b371],
10	et	FW	O	et	nn	11	SENT_130	[p8l1979t310r2031b360],
11	al.	FW	O	al.	appos	2	SENT_130	[p8l2061t303r2150b360],
12	:	:	O	:	_	0	SENT_130	[p8l2061t303r2150b360],
13	Genetic	JJ	O	genetic	amod	14	SENT_130	[p8l142t396r390b452],
14	factors	NNS	O	factor	dep	2	SENT_130	[p8l438t395r657b452],
15	inﬂuencing	VBG	O	inﬂuencing	partmod	14	SENT_130	[p8l706t395r1078b471],
16	atazanavir	NN	O	atazanavir	nn	18	SENT_130	[p8l1126t398r1475b451],
17	plasma	NN	O	plasma	nn	18	SENT_130	[p8l1521t395r1759b471],
18	concentrations	NNS	O	concentration	dobj	15	SENT_130	[p8l1808t403r2152b452, p8l141t491r300b546],
19	and	CC	O	and	_	0	SENT_130	[p8l330t489r454b546],
20	the	DT	O	the	det	21	SENT_130	[p8l482t489r583b546],
21	risk	NN	O	risk	conj_and	18	SENT_130	[p8l611t489r734b546],
22	of	IN	O	of	_	0	SENT_130	[p8l761t488r826b546],
23	severe	JJ	O	severe	amod	24	SENT_130	[p8l852t508r1059b546],
24	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	21	SENT_130	[p8l1086t489r1744b566],
25	.	.	O	.	_	0	SENT_130	[p8l1086t489r1744b566],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_131	[p8l1775t490r1955b546],
2	2007	CD	DATE	2007	num	1	SENT_131	[p8l1983t491r2150b556],
3	;	:	O	;	_	0	SENT_131	[p8l1983t491r2150b556],
4	21:41	CD	TIME	21:41	number	5	SENT_131	[p8l141t583r439b638],
5	-46	CD	NUMBER	-46	dep	1	SENT_131	[p8l141t583r439b638],
6	.	.	O	.	_	0	SENT_131	[p8l141t583r439b638],

1	Baudhuin	NNP	ORGANIZATION	Baudhuin	nn	2	SENT_132	[p8l142t674r469b731],
2	LM	NNP	ORGANIZATION	LM	nsubj	14	SENT_132	[p8l515t676r648b741],
3	,	,	O	,	_	0	SENT_132	[p8l515t676r648b741],
4	Highsmith	NNP	PERSON	Highsmith	nn	5	SENT_132	[p8l696t674r1052b751],
5	EW	NNP	O	EW	appos	2	SENT_132	[p8l1098t676r1236b741],
6	,	,	O	,	_	0	SENT_132	[p8l1098t676r1236b741],
7	Skierka	NNP	LOCATION	Skierka	nn	8	SENT_132	[p8l1285t674r1529b732],
8	]	NNP	O	]	appos	2	SENT_132	[p8l1574t676r1617b745],
9	,	,	O	,	_	0	SENT_132	[p8l1574t676r1617b745],
10	Holtegaard	NNP	ORGANIZATION	Holtegaard	nn	11	SENT_132	[p8l1665t674r2040b751],
11	L	NNP	ORGANIZATION	L	appos	2	SENT_132	[p8l2089t676r2150b741],
12	,	,	O	,	_	0	SENT_132	[p8l2089t676r2150b741],
13	Moore	NNP	PERSON	Moore	appos	2	SENT_132	[p8l141t770r357b825],
14	BE	VBP	O	be	_	0	SENT_132	[p8l379t770r486b835],
15	,	,	O	,	_	0	SENT_132	[p8l379t770r486b835],
16	and	CC	O	and	_	0	SENT_132	[p8l510t768r634b824],
17	O’Kane	NN	O	o’kane	nsubj	18	SENT_132	[p8l656t769r905b825],
18	D	NN	O	d	conj_and	14	SENT_132	[p8l926t770r1022b838],
19	]	CD	NUMBER	]	dobj	18	SENT_132	[p8l926t770r1022b838],
20	:	:	O	:	_	0	SENT_132	[p8l926t770r1022b838],
21	Comparison	NN	O	comparison	dep	19	SENT_132	[p8l1048t769r1458b845],
22	of	IN	O	of	_	0	SENT_132	[p8l1479t767r1544b825],
23	three	CD	NUMBER	three	num	24	SENT_132	[p8l1563t768r1729b825],
24	methods	NNS	O	method	prep_of	21	SENT_132	[p8l1750t767r2037b825],
25	for	IN	O	for	_	0	SENT_132	[p8l2059t767r2152b825],
26	genotyping	VBG	O	genotype	prepc_for	24	SENT_132	[p8l142t863r520b938],
27	the	DT	O	the	det	34	SENT_132	[p8l553t860r654b918],
28	UGT1A1	NN	O	ugt1a1	nn	34	SENT_132	[p8l686t861r976b918],
29	(	CD	NUMBER	(	num	34	SENT_132	[p8l1017t860r1199b932],
30	TA	NNP	ORGANIZATION	TA	nn	34	SENT_132	[p8l1017t860r1199b932],
31	)	CD	NUMBER	)	num	34	SENT_132	[p8l1017t860r1199b932],
32	n	NN	O	n	nn	34	SENT_132	[p8l1017t860r1199b932],
33	repeat	NN	O	repeat	nn	34	SENT_132	[p8l1231t869r1438b938],
34	polymorphism	NN	O	polymorphism	dobj	26	SENT_132	[p8l1469t860r1977b938],
35	.	.	O	.	_	0	SENT_132	[p8l1469t860r1977b938],

1	Clin	NNP	O	Clin	nn	2	SENT_133	[p8l2014t861r2153b918],
2	Biochem	NNP	O	Biochem	_	0	SENT_133	[p8l142t953r427b1010],
3	2007	CD	DATE	2007	num	2	SENT_133	[p8l454t955r999b1020],
4	;	:	O	;	_	0	SENT_133	[p8l454t955r999b1020],
5	40:710	CD	NUMBER	40:710	number	6	SENT_133	[p8l454t955r999b1020],
6	-717	CD	NUMBER	-717	dep	2	SENT_133	[p8l454t955r999b1020],
7	.	.	O	.	_	0	SENT_133	[p8l454t955r999b1020],

1	.	.	O	.	_	0	SENT_134	[p8l88t1093r97b1102],

1	Fellay	NNP	PERSON	Fellay	nn	2	SENT_135	[p8l141t1046r340b1124],
2	]	NNP	O	]	_	0	SENT_135	[p8l376t1049r419b1117],
3	,	,	O	,	_	0	SENT_135	[p8l376t1049r419b1117],
4	Boubaker	NNP	PERSON	Boubaker	nn	5	SENT_135	[p8l459t1046r776b1104],
5	K	NNP	PERSON	K	appos	2	SENT_135	[p8l815t1049r885b1114],
6	,	,	O	,	_	0	SENT_135	[p8l815t1049r885b1114],
7	Ledergerber	NNP	O	Ledergerber	nn	8	SENT_135	[p8l926t1046r1330b1124],
8	B	NNP	O	B	appos	2	SENT_135	[p8l1370t1049r1431b1114],
9	,	,	O	,	_	0	SENT_135	[p8l1370t1049r1431b1114],
10	et	FW	O	et	nn	11	SENT_135	[p8l1471t1052r1523b1103],
11	al.	FW	O	al.	appos	2	SENT_135	[p8l1561t1046r1649b1103],
12	:	:	O	:	_	0	SENT_135	[p8l1561t1046r1649b1103],
13	Prevalence	NN	O	prevalence	dep	2	SENT_135	[p8l1691t1046r2048b1104],
14	of	IN	O	of	_	0	SENT_135	[p8l2089t1046r2154b1104],
15	adverse	JJ	O	adverse	amod	16	SENT_135	[p8l142t1138r398b1195],
16	events	NNS	O	event	prep_of	13	SENT_135	[p8l436t1146r647b1195],
17	associated	VBN	O	associate	partmod	16	SENT_135	[p8l687t1138r1024b1195],
18	with	IN	O	with	_	0	SENT_135	[p8l1061t1138r1214b1194],
19	potent	JJ	O	potent	amod	21	SENT_135	[p8l1250t1146r1464b1214],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_135	[p8l1503t1138r1940b1195],
21	treatment	NN	O	treatment	prep_with	17	SENT_135	[p8l1977t1146r2152b1195, p8l141t1239r324b1289],
22	:	:	O	:	_	0	SENT_135	[p8l1977t1146r2152b1195, p8l141t1239r324b1289],
23	Swiss	JJ	MISC	swiss	amod	24	SENT_135	[p8l357t1233r540b1289],
24	HIV	NN	O	hiv	dep	13	SENT_135	[p8l569t1234r709b1288],
25	Cohort	NN	O	cohort	nn	26	SENT_135	[p8l737t1232r969b1289],
26	Study	NN	O	study	dep	24	SENT_135	[p8l996t1231r1205b1309],
27	.	.	O	.	_	0	SENT_135	[p8l996t1231r1205b1309],

1	Lancet	NNP	O	Lancet	_	0	SENT_136	[p8l1237t1234r1456b1289],
2	2001	CD	DATE	2001	num	1	SENT_136	[p8l1483t1234r2142b1299],
3	;	:	O	;	_	0	SENT_136	[p8l1483t1234r2142b1299],
4	358:1322	CD	DURATION	358:1322	number	5	SENT_136	[p8l1483t1234r2142b1299],
5	-1327	CD	DURATION	-1327	dep	1	SENT_136	[p8l1483t1234r2142b1299],
6	.	.	O	.	_	0	SENT_136	[p8l1483t1234r2142b1299],

1	.	.	O	.	_	0	SENT_137	[p8l88t1371r97b1380],

1	Smiderle	JJ	O	smiderle	amod	2	SENT_138	[p8l142t1325r434b1381],
2	L	NN	O	l	_	0	SENT_138	[p8l473t1327r534b1392],
3	,	,	O	,	_	0	SENT_138	[p8l473t1327r534b1392],
4	Galvao	NNP	ORGANIZATION	Galvao	nn	5	SENT_138	[p8l574t1324r810b1381],
5	ACS	NNP	ORGANIZATION	ACS	appos	2	SENT_138	[p8l849t1326r1016b1392],
6	,	,	O	,	_	0	SENT_138	[p8l849t1326r1016b1392],
7	Fontana	NNP	ORGANIZATION	Fontana	nn	8	SENT_138	[p8l1057t1327r1324b1381],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_138	[p8l1363t1326r1433b1392],
9	,	,	O	,	_	0	SENT_138	[p8l1363t1326r1433b1392],
10	et	FW	O	et	nn	11	SENT_138	[p8l1472t1331r1524b1381],
11	al.	FW	O	al.	appos	2	SENT_138	[p8l1561t1324r1649b1381],
12	:	:	O	:	_	0	SENT_138	[p8l1561t1324r1649b1381],
13	Evaluation	NN	O	evaluation	dep	2	SENT_138	[p8l1691t1324r2051b1381],
14	of	IN	O	of	_	0	SENT_138	[p8l2089t1324r2154b1381],
15	UGT1A1	NN	O	ugt1a1	nn	18	SENT_138	[p8l141t1417r431b1473],
16	and	CC	O	and	_	0	SENT_138	[p8l464t1416r588b1472],
17	SULT1A1	NN	O	sult1a1	nn	18	SENT_138	[p8l616t1417r933b1473],
18	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_138	[p8l965t1416r1489b1492],
19	with	IN	O	with	_	0	SENT_138	[p8l1516t1416r1669b1472],
20	lipid	NN	O	lipid	nn	21	SENT_138	[p8l1695t1416r1847b1492],
21	levels	NNS	O	level	prep_with	18	SENT_138	[p8l1876t1416r2061b1473],
22	in	IN	O	in	_	0	SENT_138	[p8l2089t1419r2153b1471],
23	women	NNS	O	woman	prep_in	21	SENT_138	[p8l140t1527r390b1565],
24	with	IN	O	with	_	0	SENT_138	[p8l414t1508r567b1564],
25	different	JJ	O	different	amod	27	SENT_138	[p8l594t1508r876b1565],
26	hormonal	JJ	O	hormonal	amod	27	SENT_138	[p8l900t1508r1224b1565],
27	status	NN	O	status	prep_with	23	SENT_138	[p8l1251t1516r1458b1565],
28	.	.	O	.	_	0	SENT_138	[p8l1251t1516r1458b1565],

1	Gynecol	NNP	O	Gynecol	nn	2	SENT_139	[p8l1489t1508r1762b1584],
2	Endocrinol	NNP	O	Endocrinol	_	0	SENT_139	[p8l1788t1508r2152b1565],
3	2011	CD	DATE	2011	num	2	SENT_139	[p8l141t1604r286b1658],
4	;	:	O	;	_	0	SENT_139	[p8l293t1604r610b1668],
5	27:20	CD	NUMBER	27:20	number	6	SENT_139	[p8l293t1604r610b1668],
6	-26	CD	NUMBER	-26	dep	2	SENT_139	[p8l293t1604r610b1668],
7	.	.	O	.	_	0	SENT_139	[p8l293t1604r610b1668],

1	Roff	NNP	PERSON	Roff	nn	2	SENT_140	[p8l141t1694r283b1752],
2	DA	NNP	O	DA	_	0	SENT_140	[p8l321t1696r436b1750],
3	and	CC	O	and	_	0	SENT_140	[p8l478t1694r602b1751],
4	Bentzen	NNP	PERSON	Bentzen	nn	5	SENT_140	[p8l644t1696r909b1752],
5	P	NN	O	p	conj_and	2	SENT_140	[p8l949t1696r1007b1750],
6	:	:	O	:	_	0	SENT_140	[p8l949t1696r1007b1750],
7	The	DT	O	the	det	9	SENT_140	[p8l1052t1694r1174b1752],
8	statistical	JJ	O	statistical	amod	9	SENT_140	[p8l1216t1694r1524b1752],
9	analysis	NN	O	analysis	dep	2	SENT_140	[p8l1566t1694r1829b1771],
10	of	IN	O	of	_	0	SENT_140	[p8l1872t1694r1938b1752],
11	mitochondrial	JJ	O	mitochondrial	amod	13	SENT_140	[p8l1975t1697r2152b1752, p8l142t1788r457b1845],
12	DNA	NN	O	dna	nn	13	SENT_140	[p8l477t1790r654b1845],
13	polymorphisms	NNS	O	polymorphism	prep_of	9	SENT_140	[p8l674t1788r1214b1865],
14	:	:	O	:	_	0	SENT_140	[p8l674t1788r1214b1865],
15	;	:	O	;	_	0	SENT_140	[p8l1241t1775r1303b1859],
16	(	NN	O	(	dep	2	SENT_140	[p8l1241t1775r1303b1859],
17	2	CD	NUMBER	2	dep	16	SENT_140	[p8l1241t1775r1303b1859],
18	and	CC	O	and	_	0	SENT_140	[p8l1325t1788r1449b1845],
19	the	DT	O	the	det	20	SENT_140	[p8l1470t1789r1571b1845],
20	problem	NN	O	problem	dep	2	SENT_140	[p8l1591t1788r1871b1865],
21	of	IN	O	of	_	0	SENT_140	[p8l1892t1788r1957b1845],
22	small	JJ	O	small	amod	23	SENT_140	[p8l1976t1788r2152b1845],
23	samples	NNS	O	sample	prep_of	20	SENT_140	[p8l142t1882r424b1959],
24	.	.	O	.	_	0	SENT_140	[p8l142t1882r424b1959],

1	Mol	NNP	O	Mol	nn	3	SENT_141	[p8l455t1881r588b1939],
2	Biol	NNP	O	Biol	nn	3	SENT_141	[p8l615t1881r743b1939],
3	Evol	NNP	O	Evol	_	0	SENT_141	[p8l770t1882r919b1939],
4	1989	CD	DATE	1989	num	3	SENT_141	[p8l950t1884r1453b1949],
5	;	:	O	;	_	0	SENT_141	[p8l950t1884r1453b1949],
6	6:539	CD	NUMBER	6:539	number	7	SENT_141	[p8l950t1884r1453b1949],
7	-545	CD	NUMBER	-545	dep	3	SENT_141	[p8l950t1884r1453b1949],
8	.	.	O	.	_	0	SENT_141	[p8l950t1884r1453b1949],

1	Zembrzuski	NNP	O	Zembrzuski	nn	2	SENT_142	[p8l141t1973r541b2030],
2	VM	NNP	O	VM	_	0	SENT_142	[p8l569t1975r711b2040],
3	,	,	O	,	_	0	SENT_142	[p8l569t1975r711b2040],
4	Callegari-Jacques	NNP	O	Callegari-Jacques	nn	5	SENT_142	[p8l740t1973r1313b2049],
5	SM	NNP	O	SM	conj_and	2	SENT_142	[p8l1342t1974r1468b2040],
6	,	,	O	,	_	0	SENT_142	[p8l1342t1974r1468b2040],
7	and	CC	O	and	_	0	SENT_142	[p8l1498t1973r1622b2029],
8	Hutz	NNP	PERSON	Hutz	nn	9	SENT_142	[p8l1651t1975r1817b2029],
9	MH	NNP	O	MH	conj_and	2	SENT_142	[p8l1847t1975r1994b2029],
10	:	:	O	:	_	0	SENT_142	[p8l1847t1975r1994b2029],
11	Application	NN	O	application	dep	2	SENT_142	[p8l2025t1975r2152b2049, p8l140t2065r430b2141],
12	of	IN	O	of	_	0	SENT_142	[p8l456t2065r521b2122],
13	an	DT	O	a	det	16	SENT_142	[p8l545t2084r625b2121],
14	African	JJ	MISC	african	amod	16	SENT_142	[p8l649t2065r897b2122],
15	Ancestry	NNP	MISC	Ancestry	nn	16	SENT_142	[p8l922t2067r1219b2141],
16	Index	NNP	MISC	Index	prep_of	11	SENT_142	[p8l1244t2065r1431b2122],
17	as	IN	O	as	_	0	SENT_142	[p8l1458t2084r1524b2122],
18	a	DT	O	a	det	21	SENT_142	[p8l1551t2084r1585b2121],
19	genomic	JJ	O	genomic	amod	21	SENT_142	[p8l1613t2068r1893b2141],
20	control	NN	O	control	nn	21	SENT_142	[p8l1920t2065r2152b2122],
21	approach	NN	O	approach	prep_as	16	SENT_142	[p8l142t2158r454b2236],
22	in	IN	O	in	_	0	SENT_142	[p8l512t2161r576b2214],
23	a	DT	O	a	det	25	SENT_142	[p8l634t2178r668b2215],
24	Brazilian	JJ	LOCATION	brazilian	amod	25	SENT_142	[p8l728t2158r1024b2215],
25	population	NN	O	population	prep_in	21	SENT_142	[p8l1080t2158r1460b2236],
26	.	.	O	.	_	0	SENT_142	[p8l1080t2158r1460b2236],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_143	[p8l1523t2160r1668b2214],
2	Hum	NNP	PERSON	Hum	nn	3	SENT_143	[p8l1726t2161r1899b2215],
3	Genet	NNP	PERSON	Genet	_	0	SENT_143	[p8l1957t2159r2152b2216],
4	2006	CD	DATE	2006	num	3	SENT_143	[p8l141t2254r686b2318],
5	;	:	O	;	_	0	SENT_143	[p8l141t2254r686b2318],
6	70:822	CD	NUMBER	70:822	number	7	SENT_143	[p8l141t2254r686b2318],
7	-828	CD	NUMBER	-828	dep	3	SENT_143	[p8l141t2254r686b2318],
8	.	.	O	.	_	0	SENT_143	[p8l141t2254r686b2318],

1	Azevedo	NNP	LOCATION	Azevedo	nn	2	SENT_144	[p8l141t2345r436b2402],
2	LA	NNP	LOCATION	LA	_	0	SENT_144	[p8l471t2346r590b2412],
3	,	,	O	,	_	0	SENT_144	[p8l471t2346r590b2412],
4	Santin	NNP	ORGANIZATION	Santin	nn	5	SENT_144	[p8l625t2346r834b2402],
5	AP	NNP	ORGANIZATION	AP	conj_and	2	SENT_144	[p8l867t2346r986b2412],
6	,	,	O	,	_	0	SENT_144	[p8l867t2346r986b2412],
7	Wagner	NNP	ORGANIZATION	Wagner	nn	8	SENT_144	[p8l1020t2346r1284b2422],
8	SC	NNP	ORGANIZATION	SC	conj_and	2	SENT_144	[p8l1317t2346r1425b2412],
9	,	,	O	,	_	0	SENT_144	[p8l1317t2346r1425b2412],
10	Zaleski	NNP	PERSON	Zaleski	nn	11	SENT_144	[p8l1460t2344r1700b2402],
11	CF	NN	O	cf	conj_and	2	SENT_144	[p8l1733t2346r1844b2412],
12	,	,	O	,	_	0	SENT_144	[p8l1733t2346r1844b2412],
13	Bock	NNP	PERSON	Bock	nn	14	SENT_144	[p8l1879t2345r2040b2402],
14	H	NNP	O	H	conj_and	2	SENT_144	[p8l2072t2347r2150b2412],
15	,	,	O	,	_	0	SENT_144	[p8l2072t2347r2150b2412],
16	Saraiva-Pereira	NNP	O	Saraiva-Pereira	nn	17	SENT_144	[p8l142t2439r644b2495],
17	ML	NNP	O	ML	conj_and	2	SENT_144	[p8l671t2440r804b2504],
18	,	,	O	,	_	0	SENT_144	[p8l671t2440r804b2504],
19	and	CC	O	and	_	0	SENT_144	[p8l834t2437r957b2494],
20	Castro	NNP	PERSON	Castro	nn	21	SENT_144	[p8l985t2439r1200b2495],
21	SM	NNP	O	SM	conj_and	2	SENT_144	[p8l1228t2439r1351b2495],
22	:	:	O	:	_	0	SENT_144	[p8l1228t2439r1351b2495],
23	Prevalence	NN	O	prevalence	dep	2	SENT_144	[p8l1382t2438r1739b2495],
24	of	IN	O	of	_	0	SENT_144	[p8l1767t2437r1833b2495],
25	UGT1A1	NN	O	ugt1a1	prep_of	23	SENT_144	[p8l1857t2439r2147b2495],

1	gene	NN	O	gene	nn	2	SENT_145	[p8l138t2792r290b2850],
2	polymorphism	NN	O	polymorphism	_	0	SENT_145	[p8l329t2772r817b2850],
3	in	IN	O	in	_	0	SENT_145	[p8l857t2775r920b2829],
4	patients	NNS	O	patient	prep_in	2	SENT_145	[p8l958t2775r1216b2850],
5	with	IN	O	with	_	0	SENT_145	[p8l1257t2773r1408b2829],
6	hemolytic	JJ	O	hemolytic	amod	7	SENT_145	[p8l1446t2772r1769b2850],
7	anemia	NN	O	anemia	prep_with	4	SENT_145	[p8l1811t2775r2047b2830],
8	in	IN	O	in	_	0	SENT_145	[p8l2088t2775r2152b2829],
9	southern	JJ	O	southern	amod	10	SENT_145	[p8l138t2865r426b2922],
10	Brazil	NNP	LOCATION	Brazil	prep_in	2	SENT_145	[p8l450t2865r652b2922],
11	.	.	O	.	_	0	SENT_145	[p8l450t2865r652b2922],

1	Genet	NNP	O	Genet	nn	4	SENT_146	[p8l682t2866r874b2922],
2	Test	NNP	O	Test	nn	4	SENT_146	[p8l899t2868r1034b2922],
3	Mol	NNP	O	Mol	nn	4	SENT_146	[p8l1058t2865r1189b2922],
4	Biomarkers	NNS	O	biomarker	_	0	SENT_146	[p8l1215t2865r1587b2922],
5	2011	CD	DATE	2011	dep	4	SENT_146	[p8l1612t2868r2147b2932],
6	;	:	O	;	_	0	SENT_146	[p8l1612t2868r2147b2932],
7	15:107	CD	NUMBER	15:107	num	8	SENT_146	[p8l1612t2868r2147b2932],
8	-110	CD	NUMBER	-110	dep	4	SENT_146	[p8l1612t2868r2147b2932],
9	.	.	O	.	_	0	SENT_146	[p8l1612t2868r2147b2932],

1	Rodriguez-Novoa	NNP	LOCATION	Rodriguez-Novoa	nn	2	SENT_147	[p8l137t2959r734b3036],
2	S	NNP	LOCATION	S	_	0	SENT_147	[p8l764t2960r818b3026],
3	,	,	O	,	_	0	SENT_147	[p8l764t2960r818b3026],
4	Barreiro	NNP	PERSON	Barreiro	nn	5	SENT_147	[p8l848t2961r1115b3016],
5	P	NN	PERSON	p	conj_and	2	SENT_147	[p8l1145t2961r1205b3026],
6	,	,	O	,	_	0	SENT_147	[p8l1145t2961r1205b3026],
7	Jimenez-Nacher	NN	O	jimenez-nacher	nn	8	SENT_147	[p8l1232t2959r1765b3030],
8	I	NN	O	i	conj_and	2	SENT_147	[p8l1794t2961r1834b3026],
9	,	,	O	,	_	0	SENT_147	[p8l1794t2961r1834b3026],
10	and	CC	O	and	_	0	SENT_147	[p8l1865t2959r1988b3016],
11	Soriano	NNP	PERSON	Soriano	nn	12	SENT_147	[p8l2018t2960r2150b3016, p8l137t3054r278b3109],
12	V	NNP	O	V	conj_and	2	SENT_147	[p8l307t3054r375b3108],
13	:	:	O	:	_	0	SENT_147	[p8l307t3054r375b3108],
14	Overview	NN	O	overview	dep	2	SENT_147	[p8l407t3053r734b3109],
15	of	IN	O	of	_	0	SENT_147	[p8l764t3051r830b3109],
16	the	DT	O	the	det	17	SENT_147	[p8l855t3052r957b3109],
17	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	14	SENT_147	[p8l984t3052r1585b3129],
18	of	IN	O	of	_	0	SENT_147	[p8l1616t3051r1681b3109],
19	HIV	NN	MISC	hiv	nn	20	SENT_147	[p8l1706t3054r1847b3108],
20	therapy	NN	O	therapy	prep_of	17	SENT_147	[p8l1875t3052r2146b3129],
21	.	.	O	.	_	0	SENT_147	[p8l1875t3052r2146b3129],

1	Pharmacogenom	NN	O	pharmacogenom	_	0	SENT_148	[p8l137t3144r700b3221],
2	I	CD	NUMBER	i	num	3	SENT_148	[p8l724t3146r749b3215],
3	2006	CD	DATE	2006	dep	1	SENT_148	[p8l776t3146r1284b3211],
4	;	:	O	;	_	0	SENT_148	[p8l776t3146r1284b3211],
5	6:234	CD	NUMBER	6:234	num	6	SENT_148	[p8l776t3146r1284b3211],
6	—	NN	O	—	dep	1	SENT_148	[p8l776t3146r1284b3211],
7	245	CD	NUMBER	245	dep	6	SENT_148	[p8l776t3146r1284b3211],
8	.	.	O	.	_	0	SENT_148	[p8l776t3146r1284b3211],

1	Parra	NNP	ORGANIZATION	Parra	nn	2	SENT_149	[p8l137t3239r314b3293],
2	FC	NNP	ORGANIZATION	FC	_	0	SENT_149	[p8l355t3238r466b3304],
3	,	,	O	,	_	0	SENT_149	[p8l355t3238r466b3304],
4	Amado	NNP	ORGANIZATION	Amado	nn	5	SENT_149	[p8l507t3237r755b3294],
5	RC	NNP	ORGANIZATION	RC	conj_and	2	SENT_149	[p8l796t3238r916b3304],
6	,	,	O	,	_	0	SENT_149	[p8l796t3238r916b3304],
7	Lambertucci	NNP	ORGANIZATION	Lambertucci	nn	8	SENT_149	[p8l958t3237r1371b3294],
8	IR	NNP	ORGANIZATION	IR	conj_and	2	SENT_149	[p8l1408t3239r1502b3307],
9	,	,	O	,	_	0	SENT_149	[p8l1408t3239r1502b3307],
10	Rocha	NNP	PERSON	Rocha	nn	11	SENT_149	[p8l1543t3237r1747b3294],
11	I	NNP	O	I	conj_and	2	SENT_149	[p8l1785t3239r1828b3307],
12	,	,	O	,	_	0	SENT_149	[p8l1785t3239r1828b3307],
13	Antunes	NNP	PERSON	Antunes	nn	14	SENT_149	[p8l1869t3239r2149b3294],
14	CM	NN	O	cm	conj_and	2	SENT_149	[p8l137t3331r278b3398],
15	,	,	O	,	_	0	SENT_149	[p8l137t3331r278b3398],
16	and	CC	O	and	_	0	SENT_149	[p8l315t3330r439b3387],
17	Pena	NNP	PERSON	Pena	nn	19	SENT_149	[p8l476t3333r635b3388],
18	SD	NN	O	sd	nn	19	SENT_149	[p8l671t3331r806b3401],
19	]	NN	O	]	conj_and	2	SENT_149	[p8l671t3331r806b3401],
20	:	:	O	:	_	0	SENT_149	[p8l671t3331r806b3401],
21	Color	NNP	O	Color	dep	2	SENT_149	[p8l847t3330r1032b3388],
22	and	CC	O	and	_	0	SENT_149	[p8l1068t3330r1192b3387],
23	genomic	JJ	O	genomic	amod	24	SENT_149	[p8l1229t3333r1509b3408],
24	ancestry	NN	O	ancestry	conj_and	21	SENT_149	[p8l1546t3338r1821b3408],
25	in	IN	O	in	_	0	SENT_149	[p8l1857t3333r1920b3386],
26	Brazilians	NNS	MISC	brazilian	prep_in	24	SENT_149	[p8l1955t3333r2150b3387, p8l137t3423r306b3480],
27	.	.	O	.	_	0	SENT_149	[p8l1955t3333r2150b3387, p8l137t3423r306b3480],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_150	[p8l337t3426r484b3480],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_150	[p8l512t3423r657b3480],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_150	[p8l683t3423r857b3480],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_150	[p8l886t3424r978b3480],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_150	[p8l1005t3424r1160b3480],
6	2003	CD	DATE	2003	num	5	SENT_150	[p8l1187t3426r1771b3490],
7	;	:	O	;	_	0	SENT_150	[p8l1187t3426r1771b3490],
8	100:177	CD	NUMBER	100:177	number	9	SENT_150	[p8l1187t3426r1771b3490],
9	-182	CD	NUMBER	-182	dep	5	SENT_150	[p8l1187t3426r1771b3490],
10	.	.	O	.	_	0	SENT_150	[p8l1187t3426r1771b3490],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_151	[p9l137t20r466b77],
2	PL	NNP	O	PL	_	0	SENT_151	[p9l517t22r623b87],
3	,	,	O	,	_	0	SENT_151	[p9l517t22r623b87],
4	Lamba	NNP	PERSON	Lamba	appos	2	SENT_151	[p9l677t20r904b77],
5	I	PRP	O	I	dep	4	SENT_151	[p9l955t22r997b91],
6	,	,	O	,	_	0	SENT_151	[p9l955t22r997b91],
7	Aquilante	NNP	O	Aquilante	nn	8	SENT_151	[p9l1050t20r1379b97],
8	CL	NN	O	cl	dep	4	SENT_151	[p9l1431t21r1547b87],
9	,	,	O	,	_	0	SENT_151	[p9l1431t21r1547b87],
10	Schuetz	NNP	PERSON	Schuetz	nn	11	SENT_151	[p9l1600t20r1856b77],
11	E	NNP	O	E	conj_and	5	SENT_151	[p9l1910t22r1972b87],
12	,	,	O	,	_	0	SENT_151	[p9l1910t22r1972b87],
13	and	CC	O	and	_	0	SENT_151	[p9l2026t20r2150b77],
14	Fletcher	NNP	PERSON	Fletcher	nn	15	SENT_151	[p9l137t113r401b170],
15	CV	NNP	O	CV	conj_and	5	SENT_151	[p9l440t114r562b170],
16	:	:	O	:	_	0	SENT_151	[p9l440t114r562b170],
17	Pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_151	[p9l606t113r1174b190],
18	characteristics	NNS	O	characteristic	dep	2	SENT_151	[p9l1216t113r1681b170],
19	of	IN	O	of	_	0	SENT_151	[p9l1723t112r1788b170],
20	indinavir	NN	O	indinavir	nn	22	SENT_151	[p9l1826t113r2148b180],
21	,	,	O	,	_	0	SENT_151	[p9l1826t113r2148b180],
22	zidovudine	NN	O	zidovudine	prep_of	18	SENT_151	[p9l137t205r534b272],
23	,	,	O	,	_	0	SENT_151	[p9l137t205r534b272],
24	and	CC	O	and	_	0	SENT_151	[p9l559t205r683b262],
25	lamivudine	NN	O	lamivudine	nn	26	SENT_151	[p9l706t205r1086b263],
26	therapy	NN	O	therapy	prep_of	18	SENT_151	[p9l1109t205r1366b282],
27	in	IN	O	in	_	0	SENT_151	[p9l1388t208r1452b261],
28	HIV-infected	JJ	O	hiv-infected	amod	29	SENT_151	[p9l1474t205r1902b263],
29	adults	NNS	O	adult	prep_in	18	SENT_151	[p9l1927t205r2146b263],
30	:	:	O	:	_	0	SENT_151	[p9l1927t205r2146b263],
31	a	DT	O	a	det	32	SENT_151	[p9l138t317r172b355],
32	pilot	NN	O	pilot	dep	2	SENT_151	[p9l193t298r346b375],
33	study	NN	O	study	dep	32	SENT_151	[p9l367t298r569b375],
34	.	.	O	.	_	0	SENT_151	[p9l367t298r569b375],

1	I	PRP	O	I	nsubj	2	SENT_152	[p9l591t300r617b369],
2	Acquir	VBP	MISC	acquir	_	0	SENT_152	[p9l637t300r865b375],
3	Immune	JJ	MISC	immune	amod	5	SENT_152	[p9l887t300r1167b355],
4	Defic	JJ	MISC	defic	amod	5	SENT_152	[p9l1189t298r1359b355],
5	Syndr	NN	MISC	syndr	dobj	2	SENT_152	[p9l1382t298r1580b375],
6	2006	CD	DATE	2006	num	5	SENT_152	[p9l1600t300r2147b365],
7	;	:	O	;	_	0	SENT_152	[p9l1600t300r2147b365],
8	42:441	CD	NUMBER	42:441	num	9	SENT_152	[p9l1600t300r2147b365],
9	-449	CD	NUMBER	-449	dobj	2	SENT_152	[p9l1600t300r2147b365],
10	.	.	O	.	_	0	SENT_152	[p9l1600t300r2147b365],

1	Brasil	NNP	PERSON	Brasil	_	0	SENT_153	[p9l137t391r342b449],
2	.	.	O	.	_	0	SENT_153	[p9l137t391r342b449],

1	Ministério	NNP	O	Ministério	nn	3	SENT_154	[p9l389t394r734b449],
2	da	NNP	O	da	nn	3	SENT_154	[p9l779t391r860b448],
3	Satide	NNP	O	Satide	_	0	SENT_154	[p9l903t391r1125b449],
4	.	.	O	.	_	0	SENT_154	[p9l903t391r1125b449],

1	Secretaria	NNP	O	Secretaria	nn	5	SENT_155	[p9l1172t392r1500b449],
2	de	NNP	O	de	nn	5	SENT_155	[p9l1545t391r1623b449],
3	Vigilancia	NNP	O	Vigilancia	nn	5	SENT_155	[p9l1665t391r2007b469],
4	em	NNP	O	em	nn	5	SENT_155	[p9l2050t411r2151b449],
5	Satide	NNP	O	Satide	_	0	SENT_155	[p9l137t484r359b542],
6	.	.	O	.	_	0	SENT_155	[p9l137t484r359b542],

1	Programa	NNP	ORGANIZATION	Programa	nn	4	SENT_156	[p9l393t487r724b562],
2	Nacional	NNP	ORGANIZATION	Nacional	nn	4	SENT_156	[p9l755t484r1058b542],
3	de	IN	O	de	amod	4	SENT_156	[p9l1088t484r1168b542],
4	DST	NNP	O	DST	nsubj	6	SENT_156	[p9l1197t485r1341b542],
5	e	SYM	O	e	dep	6	SENT_156	[p9l1371t504r1404b542],
6	Aids	NNPS	MISC	Aids	_	0	SENT_156	[p9l1434t484r1607b542],
7	.	.	O	.	_	0	SENT_156	[p9l1434t484r1607b542],

1	Boletim	NNP	O	Boletim	nn	2	SENT_157	[p9l1642t484r1901b542],
2	Epidemiologico	NNP	O	Epidemiologico	_	0	SENT_157	[p9l1930t484r2150b562, p9l137t578r470b655],
3	2010	CD	DATE	2010	dep	2	SENT_157	[p9l533t580r702b635],
4	.	.	O	.	_	0	SENT_157	[p9l533t580r702b635],

1	Available	JJ	O	available	_	0	SENT_158	[p9l767t578r1091b635],
2	at	IN	O	at	_	0	SENT_158	[p9l1154t586r1215b635],
3	http://www.aids.goV.br/	NNP	O	http://www.aids.goV.br/	nn	6	SENT_158	[p9l1275t578r2145b655],
4	TURATTI	NNP	O	TURATTI	nn	6	SENT_158	[p9l1521t698r1861b757],
5	ET	NNP	O	ET	nn	6	SENT_158	[p9l1898t698r1995b756],
6	AL.	NNP	O	AL.	prep_at	1	SENT_158	[p9l2025t698r2149b756],
7	.	.	O	.	_	0	SENT_158	[p9l2025t698r2149b756],

1	publicacao	NN	O	publicacao	_	0	SENT_159	[p9l135t914r500b992],
2	/	:	O	/	punct	1	SENT_159	[p9l509t914r1493b992],
3	boletim-epidemiologico-201	NN	O	boletim-epidemiologico-201	nn	4	SENT_159	[p9l509t914r1493b992],
4	o.	NN	O	o.	nsubj	5	SENT_159	[p9l1503t917r1553b972],
5	Accessed	VBN	O	access	dep	1	SENT_159	[p9l1639t914r1948b972],
6	06	CD	NUMBER	06	dobj	5	SENT_159	[p9l2031t917r2105b972],
7	/	:	O	/	punct	8	SENT_159	[p9l2114t914r2147b979],
8	30	CD	NUMBER	30	dep	6	SENT_159	[p9l136t1010r209b1065],
9	/	:	O	/	punct	8	SENT_159	[p9l219t1007r252b1072],
10	201	CD	NUMBER	201	num	11	SENT_159	[p9l260t1010r369b1065],
11	1	CD	NUMBER	1	dep	8	SENT_159	[p9l381t1010r408b1063],
12	.	.	O	.	_	0	SENT_159	[p9l420t1054r429b1063],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_160	[p9l136t1101r775b1178],
2	Knowledge	NNP	O	Knowledge	nn	3	SENT_160	[p9l800t1101r1176b1178],
3	Base	NNP	O	Base	_	0	SENT_160	[p9l1202t1103r1349b1158],
4	(	NN	O	(	nn	6	SENT_160	[p9l1378t1101r1811b1173],
5	PharmGKB	NN	O	pharmgkb	nn	6	SENT_160	[p9l1378t1101r1811b1173],
6	)	NN	O	)	dep	3	SENT_160	[p9l1378t1101r1811b1173],
7	.	.	O	.	_	0	SENT_160	[p9l1378t1101r1811b1173],

1	Available	JJ	O	available	_	0	SENT_161	[p9l1841t1101r2153b1158],
2	at	IN	O	at	_	0	SENT_161	[p9l137t1202r200b1251],
3	http	NN	O	http	prep_at	1	SENT_161	[p9l235t1194r396b1271],
4	:	:	O	:	_	0	SENT_161	[p9l235t1194r396b1271],
5	/	:	O	/	punct	1	SENT_161	[p9l410t1194r443b1259],
6	/	:	O	/	punct	1	SENT_161	[p9l440t1194r473b1259],
7	www	NN	O	www	dep	1	SENT_161	[p9l481t1194r1203b1271],
8	.	.	O	.	_	0	SENT_161	[p9l481t1194r1203b1271],

1	pharmgl	NN	O	pharmgl	_	0	SENT_162	[p9l481t1194r1203b1271],
2	<	JJR	O	<	dep	1	SENT_162	[p9l481t1194r1203b1271],
3	b.org	CD	NUMBER	b.org	dep	2	SENT_162	[p9l481t1194r1203b1271],
4	/	:	O	/	punct	5	SENT_162	[p9l1211t1194r1245b1259],
5	images	NNS	O	image	dep	3	SENT_162	[p9l1254t1196r1497b1271],
6	/	:	O	/	punct	1	SENT_162	[p9l1508t1194r1541b1259],
7	header	NN	O	header	dep	1	SENT_162	[p9l1549t1194r1787b1251],
8	/	:	O	/	punct	7	SENT_162	[p9l1796t1194r1829b1259],
9	title	NN	O	title	dep	7	SENT_162	[p9l1840t1194r2149b1271],
10	.	.	O	.	_	0	SENT_162	[p9l1840t1194r2149b1271],

1	png	NN	O	png	_	0	SENT_163	[p9l1840t1194r2149b1271],
2	.	.	O	.	_	0	SENT_163	[p9l1840t1194r2149b1271],

1	Accessed	VBN	O	access	_	0	SENT_164	[p9l136t1286r454b1344],
2	10/07/2011	CD	DATE	10/07/2011	dobj	1	SENT_164	[p9l488t1286r915b1351],
3	.	.	O	.	_	0	SENT_164	[p9l488t1286r915b1351],

1	Address	NN	O	address	nn	2	SENT_165	[p9l1158t1513r1451b1573],
2	correspondence	NN	O	correspondence	_	0	SENT_165	[p9l1482t1513r2035b1594],
3	to	TO	O	to	dep	2	SENT_165	[p9l2065t1521r2148b1573],
4	:	:	O	:	_	0	SENT_165	[p9l2065t1521r2148b1573],
5	Vanessa	NNP	PERSON	Vanessa	nn	10	SENT_165	[p9l1518t1613r1776b1670],
6	S.	NNP	PERSON	S.	nn	10	SENT_165	[p9l1809t1612r1863b1670],
7	Mattevi	NNP	PERSON	Mattevi	nn	10	SENT_165	[p9l1896t1611r2153b1670],
8	Raa	NNP	PERSON	Raa	nn	10	SENT_165	[p9l1502t1711r1633b1768],
9	Sarmento	NNP	PERSON	Sarmento	nn	10	SENT_165	[p9l1665t1710r1970b1768],
10	Leite	NNP	PERSON	Leite	dep	15	SENT_165	[p9l2000t1710r2153b1768],
11	245	CD	NUMBER	245	num	12	SENT_165	[p9l1735t1809r1854b1866],
12	sala	NN	O	salum	dep	10	SENT_165	[p9l1883t1806r2003b1866],
13	309	CD	NUMBER	309	num	14	SENT_165	[p9l2034t1809r2151b1866],
14	CEP	NN	O	cep	dep	15	SENT_165	[p9l1041t1906r1189b1965],
15	90050-170	CD	NUMBER	90050-170	dep	20	SENT_165	[p9l1218t1906r1563b1964],
16	Porto	NNP	ORGANIZATION	Porto	nn	17	SENT_165	[p9l1592t1907r1766b1964],
17	Alegre	NNP	ORGANIZATION	Alegre	dep	15	SENT_165	[p9l1793t1904r2025b1985],
18	,	,	O	,	_	0	SENT_165	[p9l1793t1904r2025b1985],
19	RS	NN	O	r	appos	17	SENT_165	[p9l2056t1906r2150b1965],
20	Brazil	NNP	LOCATION	Brazil	dep	2	SENT_165	[p9l1962t2002r2152b2062],

1	E	NN	O	e	nn	3	SENT_166	[p9l1037t2162r1268b2223],
2	—	CD	NUMBER	—	num	3	SENT_166	[p9l1037t2162r1268b2223],
3	mail	NN	O	mail	_	0	SENT_166	[p9l1037t2162r1268b2223],
4	:	:	O	:	_	0	SENT_166	[p9l1037t2162r1268b2223],
5	vmattevi@ufcspa.edu.br	NN	O	vmattevi@ufcspa.edu.br	dep	3	SENT_166	[p9l1298t2163r2152b2244],

